UBI - Tissue Array

USBiomaxLogoSm
Cat No. Human Tissue Array, Tissue Microarray (TMA)
Multiple Organ
TMA-BN00011 Multiple organ normal tissue array, 48 cases/48 cores; 48 cores/48 cases
TMA-BN00015 Multiple organ normal tissue array, 47 cases/48 cores; 48 cores/47 cases
TMA-BN00112 Multiple organ normal tissue array, 40cases/40 cores, replaced by BN00119; 40 cores/40 cases
TMA-BN1002 Multiple organ (20) normal tissue array, 100 cases/100 cores, replaced by BN1002a; 100 cores/100 cases
TMA-BN1002a Multiple organ normal tissue array, 100 cases/100 cores, replacing BN1002; 100 cores/100 cases
TMA-BN113 Multiple organ normal tissue array, replaced by BN126, 45 cases/45 cores; 45 cores/45 cases
TMA-BN114 Multiple normal human organ tissue array, 48 cases/48 cores; 48 cores/48 cases
TMA-BN115 Multiple organ normal tissue array, 46 cases/46 cores; 46 cores/46 cases
TMA-BN116 Multiple organ normal tissue array, 48 cases/48 cores, replaced by BN129; 48 cores/48 cases
TMA-BN117 Multiple organ normal tissue array, 45 cases/45 cores; 45 cores/45 cases
TMA-BN242 Multiple normal (12 type) tissue array, 12 cases/24 cores, replaced by BN242a; 24 cores/12 cases
TMA-BN243 Multiple normal (12 type) tissue array, 12 cases/24 cores, replaced by BN243a; 24 cores/12 cases
TMA-BN243a Multiple organ normal tissue array, 12 cases/24 cores, replaced by BN243b; 24 cores/12 cases
TMA-BN481 Multiple human normal organ (12 type) tissue microarray, 24 cases/48 cores; 48 cores/24 cases
TMA-BN482 Normal human tissue microarray from 12 organs from autopsy, 24 cases/48 cores; 48 cores/24 cases
TMA-BN501 Normal human top 10 organ tissue array, 50 cases/50 cores, replacing BN00012 and BN00013; 50 cores/50 cases
TMA-BN961 Normal human tissue panel (24 organs) with two serial tissue array sections in parallel, 24 cases/102 cores, replacing BN861; 102 cores/24 cases
TMA-FDA800 Multiple organ tumor tissue array, 72 cases of variety of cancers/72 cores, replaced by FDA800a; 72 cores/72 cases
TMA-FDA801 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA802, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies.; 144 cores/144 cases
TMA-FDA802 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA803, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies.; 144 cores/144 cases
TMA-FDA803 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA804, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies.; 144 cores/144 cases
TMA-FDA804 FDA normal and tumor organ tissue array of human (2 slide set), replaced by FDA805, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies; 144 cores/144 cases
TMA-FDA805 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA804, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies; 144 cores/144 cases
TMA-FDA806 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA805, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies; 144 cores/144 cases
TMA-FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies; 144 cores/144 cases
TMA-FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA808b; 144 cores/144 cases
TMA-FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies, replacing FDA808; 144 cores/144 cases
TMA-FDA808b FDA normal and tumor organ tissue array of human (2 slide set), for FDA guidelines to test tissue specificity of antibodies, replacing FDA808a, 144 cases/144 cores, replaced by FDA808c; 144 cores/144 cases
TMA-FDA992 FDA normal organ tissue array of human tissue, 67cases/100 cores; 100 cores/67 cases
TMA-FDA993 FDA normal human organ tissue array, 67cases/100 cores, replaced by FDA995; 100 cores/67 cases
TMA-FDA994 FDA normal human organ tissue array, 99 cores/33 sites/75 cases, replacing FDA993, replaced by FDA995; 99 cores/75 cases
TMA-FDA995 FDA normal human organ tissue array, 99 cores/33 sites/75 cases, replaced by FDA997; 99 cores/75 cases
TMA-FDA997 FDA normal organ tissue array of human, 47 cases/99 cores, for FDA guidelines to test tissue specificity of antibodies, replaced by FDA998; 99 cores/47 cases
TMA-FDA998 FDA normal organ tissue array of human, 47 cases/99 cores, replaced by FDA999; 99 cores/47 cases
TMA-FDA999 Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999a; 99 cores/99 cases
TMA-LUP541 Visceral pleura tissue array, 27 cases/54 cores; 54 cores/27 cases
TMA-MNO341 Antibody cross-reactivity testing tissue array, 33 cases/34 cores; 34 cores/33 cases
TMA-MNO381 Tissue profiling tissue array with 19 types of normal human tissues, 19 cases/38 cores; 38 cores/19 cases
TMA-MNO661 Normal organ tissue array of human, 66 cases/66 cores; 66 cores/66 cases
TMA-MNO961 35 types of normal human tissue array, 90 cases/96 cores; 96 cores/90 cases
TMA-MNT241a Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, including TNM, stage and pathology grade, 12 cases/ 24 cores, replacing MNT241; 24 cores/12 cases
TMA-MTU951 Multiple tumor tissue array covering 40 types of all the common benign, malignant and metastatic entities, 40 cases/95 cores; 95 cores/40 cases
TMA-T0014 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-TMA2081 High density (156 cases/208 cores) tissue array of normal colon, prostate and breast tissue; 208 cores/156 cases
TMA-TMA2401 High density multiple organ (top 4) cancer tissue array (240 cores); 240 cores/220 cases
TMA-BC00012 Multiple organ diseased tissue array, 30 cases/60 cores, replaced by MC801; 60 cores/30 cases
TMA-BC00014 Multiple organ diseased tissue array, 63 cases/63 cores, replaced by MC631; 63 cores/63 cases
TMA-BC00016 Multiple organ diseased tissues, 54 cases/54 cores, replaced by MC541; 54 cores/54 cases
TMA-BC00019 Multiple organ squamous cell carcinoma tissue array, 63 cases/63 cores; 63 cores/63 cases
TMA-BC00111 Multiple organ normal and diseased tissue array (replaced by MCN601), 54 cases/60 cores; 60 cores/54 cases
TMA-BC00112 Multiple organ paired normal and cancer (8 types) tissue array, 48 cases/48 cores; 48 cores/48 cases
TMA-MNT241 Multiple tumor and normal tissue array for IHC antibody and ISH probe optimization and initial screening, 12 cases/24 cores, replaced by MNT241a; 24 cores/12 cases
TMA-MTU241 Multiple tumor and normal tissue array, with 12 major types of cancer paired with matched NAT, 12 cases/24 cores; 95 cores/12 cases
TMA-MTU391 Top 10 cancer tissue array (15 major types from Oriental and Western population), 20 cases/39 cores; 39 cores/20 cases
TMA-UGD381 Urinary/genital system disease tissue array, 38 cases/38 cores; 38 cores/38 cases
TMA-BC001111 Multiple organ normal and diseased tissue array, 58 cases/60 cores, replaced by MCN601; 60 cores/58 cases
TMA-BC00114 Multiple organ normal and diseased tissue array, 36 cases/60 cores; 60 cores/36 cases
TMA-BC00115 Multiple organ normal and diseased tissue array, 44 cases/64 cores, replaced by MC802; 64 cores/44 cases
TMA-BC00116 Carcinoma with adjacent-tissue combined panel tissue array, 44 cases/48 cores; 48 cores/44 cases
TMA-BC00119 Multiple organ diseased tissue array, 32 cases/32 cores, replaced by MC483; 32 cores/32 cases
TMA-BCN721 Multiple cancer (12 common types) tissue array with unmatched normal adjacent tissue, 71 cases/72 cores; 72 cores/71 cases
TMA-BCN801 Multiple organ cancer with adjacent tissue combined panel tissue array, 48 cases/80 cores; 80 cores/48 cases
TMA-BCN961 Multiple organ cancer tissue array with adjacent cancer tissue control tissue array, 57 cases/96 cores, replaced by BCN963; 96 cores/57 cases
TMA-BCN962 Combined multiple normal and cancer tissue array, containing germline, embryonic tumors and normal adjacent tissue, 60 cases/96 cores; 96 cores/60 cases
TMA-CM241 Common 4 types of cancer tissue array, 12 cases/24 cores; 24 cores/12 cases
TMA-CM481 Common 4 types of cancer tissue array, 48 cases/54 cores, with stage and grade data; 54 cores/48 cases
TMA-GI481 GI cancer (gastric, colon and rectal carcinoma) tissue array, 24 cases/48 cores; 48 cores/24 cases
TMA-GI961 GI cancer (esophageal, gastric, liver, gall bladder, large intestine and small intestine carcinoma) tissue array, 48 cases/96 cores; 96 cores/48 cases
TMA-MC2081 Top 5 types of cancer (colon, rectum, breast, prostate and lung) 208 core high-density tissue array, 208 cases/208 cores, replaced by MC2081a; 208 cores/208 cases
TMA-MC241 Multiple cancer (12 type) tissue array, 12 cases/24 cores, replaced by MC244; 24 cores/12 cases
TMA-MC242 Multiple cancer (12 type) tissue array, 16 cases/24 cores, replaced by MC245; 24 cores/16 cases
TMA-MC243 Multiple cancer (3 types) tissue array, 24 cases/24 cores, with grade and stage data, replaced by MC243a; 24 cores/24 cases
TMA-MC481 Multiple cancer (12 types) tissue microarray, 33 cases/48 cores; 48 cores/33 cases
TMA-MC482 Multiple cancer (12 type) tissue microarray, 40 cases/48 cores, with stage and grade information; 48 cores/40 cases
TMA-MC483 Multiple types of cancer tissue array with normal control, replacing BC00119, 26 cases/48 cores, with stage and grade data; 48 cores/26 cases
TMA-MC484 Multiple organs tumor and normal adjacent tissue, replacing BC00113, 44 cases/48 cores; 48 cores/44 cases
TMA-MC5001 High density (495 cases/500 cores) tissue array of multiple organ cancer and normal, with stage and grade information, replaced by MC5002; 500 cores/495 cases
TMA-MC541 Multiple organ, diseased tissue array (54 cases/54 cores, 18 types of cancers), replaced by MC542; 54 cores/54 cases
TMA-MC631 Multiple organ, diseased tissue array (63 cases/63 cores, 20 types of cancer and disease), replacing BC00014; 63 cores/63 cases
TMA-MC801 Multiple cancer tissue array, replacing BC00012, 80 cases/80 cores, with grade information; 80 cores/80 cases
TMA-MC802 Multiple cancer tissue array with matched or unmatched normal control, replacing BC00115, 44 cases/80 cores, with grade information; 80 cores/44 cases
TMA-MC961 Multiple organ cancer tissue array for testing tumor tissue specificity of therapeutic antibodies, 96 cases/96 cores, replaced by MC964; 96 cores/96 cases
TMA-MCN601 Multiple organ tumor and normal tissue array, 58 cases/60 cores, replaced by MCN602; 60 cores/58 cases
TMA-TMA2001 Multiple organ cancer with normal tissue array, with TNM data, 180 cases/200 cores; 200 cores/180 cases
TMA-TOP4-240 High density tissue array of top 4 types of cancers with normal tissue control, 220 cases/240 cores; 240 cores/220 cases
TMA-TP242 Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a; 24 cores/24 cases
TMA-TP481 Top 4 types of cancer (colon, breast, prostate and lung) 48 core tissue array, 48 cases/48 cores; 48 cores/48 cases
TMA-TP482 Top 4 types of cancer (colon, breast, lung and prostate) tissue microarray, 22 cases/48 cores, plus grade, stage and Gleason Score information; 48 cores/22 cases
TMA-TP483 Top 4 types of cancer (colon, breast, prostate and lung) tissue microarray, 48 case/48 cores, with grade, Gleason score and stage data; 48 cores/48 cases
TMA-TP484 Tissue microarray of top 4 types of cancer (colon, breast, prostate and lung) and normal tissue, 24 cases/48 cores; 48 cores/24 cases
TMA-BC000110 Colorectal cancer tissue array, 85 cases/170 cores; 170 cores/85 cases
TMA-BC000111 Multiple organ cancer tissue array, 39 cases/39 cores; 39 cores/39 cases
TMA-BC000119 Multi-organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases/200 cores; 200 cores/200 cases
TMA-BC000120 Multi-organ carcinoma tissue array, including TNM, clinical stage and pathology grade, 200 cases/200 cores; 200 cores/200 cases
TMA-BC001128 Top five cancer tissue array, including TNM and pathology grade, 148 cases/175 cores, replaced by MC1801; 175 cores/148 cases
TMA-BC00113 Multiple organs tumor and normal tissue, 48 cases/48 cores; 48 cores/48 cases
TMA-BC001130 Pancreatic carcinoma and multi-organ adjacent tissue array, including TNM, clinical stage and pathology grade, 81 cases/121 cores; 121 cores/81 cases
TMA-BC001134 Multiple organs tumor and normal tissue array, including TNM, clinical stage and pathology grade, 150 cases/150 cores; 150 cores/150 cases
TMA-BC001157 Multiple organ tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 72 cases/72 cores; 72 cores/72 cases
TMA-BC00432 Multiple organ tumor and adjacent normal tissue array, 39 cases/43 cores; 43 cores/39 cases
TMA-BCC000128 Multiple organ digestive system diseased tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 40 cases/40 cores; 40 cores/40 cases
TMA-BCN963 Multiple organ cancer and adjacent normal tissue array, including TNM and pathology grade, 78 cases/96 cores, replaced by BCN963a; 96 cores/78 cases
TMA-BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases/96 cores, replacing BCN963; 96 cores/81 cases
TMA-BN00119 Multiple organ normal tissue array, 40 cases/40 cores, replacing BN00112; 40 cores/40 cases
TMA-BN126 Multiple organ normal tissue array, replacing BN113, 45 cases/45 cores; 45 cores/45 cases
TMA-BN129 Multiple organ adjacent normal tissue array, 48 cases/48 cores, replacing BN116; 24 cores/12 cases
TMA-BN242a Multiple organ noraml tissue array, 12 cases/24 cores, replacing BN242; 24 cores/12 cases
TMA-BN243b Multiple organ normal tissue array, 12 cases/24 cores, replacing BN243a; 24 cores/12 cases
TMA-BN483 Multiple organ normal tissue array, 24 cases/ 48 cores, replaced by BN483a; 48 cores/24 cases
TMA-BN483a Multiple organ normal tissue array, 24 cases/ 48 cores, replacing BN483; 48 cores/24 cases
TMA-BN484 Multiple organ normal tissue array, 24 cases/48 cores; 48 cores/24 cases
TMA-CyFDA241 FDA multiple organ normal tissue array of cynomolgus monkey, 23 organs/ 24 cores; 24 cores/23 cases
TMA-DGS2081 Digestive system tissue array, including TNM, stage and grade, 104 cases/208 cores; 208 cores/104 cases
TMA-DID381 Digestive system disease tissue array, 38 cases/38 cores; 38 cores/38 cases
TMA-FDA800a Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 72 cases/ 72 cores, replacing FDA800; 72 cores/72 cases
TMA-FDA808c FDA normal and tumor organ tissue array of human (2 slide set), for FDA guidelines to test tissue specificity of antibodies, 144 cases/144 cores, replaced by FDA808d; 144 cores/144 cases
TMA-FDA808ci FDA normal and tumor organ tissue array of human (2 slide set), for FDA guidelines to test tissue specificity of antibodies, replacing FDA808c, 147 cases/147 cores, single core per case, special desig; 147 cores/147 cases
TMA-FDA808d FDA normal and tumor organ tissue array of human (2 slide set), for FDA guidelines to test tissue specificity of antibodies, 144 cases/144 cores, replacing FDA808c or FDA808ci; 144 cores/144 cases
TMA-FDA999a Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999b; 99 cores/47 cases
TMA-FDA999b Multiple organ normal tissue array, 47 cases/99 cores, replacing FDA999a; 99 cores/47 cases
TMA-FRS801 Female reproductive system tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-GI101 Multiple organ gastrointestinal (GI) tract cancer metastasis tissue array, 50 cases/100 cores; 100 cores/50 cases
TMA-GIST481 Gastrointestinal stromal tumor tissue array, 24 cases/48 cores; 48 cores/24 cases
TMA-GIST801 Gastrointestinal stromal tumor (GIST) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-GIST802 Multiple organ stromal tumor tissue array (containing stomach, colon, rectum, small intestine, cardia, pancreas, retroperitoneum stroma and pelvic cavity), 80 cases/80 cores, no overlapping with GIST8; 80 cores/80 cases
TMA-LN802 Multiple organ lymph tissue array, 80 cases/80 cores, replacing LN801; 80 cores/80 cases
TMA-MBN481 Multiple organ normal tissue array, 48 cases/48 cores; 48 cores/48 cases
TMA-MC1801 Multiple organs tumor tissue array, including TNM, clinical stage and pathology grade, 180 cases/180 cores, replacing BC001128; 180 cores/180 cases
TMA-MC2081a Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases/208 cores, replacing MC2081; 208 cores/208 cases
TMA-MC2082 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-MC243a Multiple cancer (3 types) tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores, replacing MC243; 24 cores/24 cases
TMA-MC244 Multiple organ cancer and normal adjacent tissue array, replacing MC241, 12 cases/24 cores, replaced by MC246; 24 cores/12 cases
TMA-MC245 Multiple cancer (12 type) and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing MC242; 24 cores/16 cases
TMA-MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing MC244; 24 cores/12 cases
TMA-MC2501 Multiple organs tumor and normal tissue array, with TNM, clinical stage and pathology grade, 250 cases/250 cores; 250 cores/250 cases
TMA-MC485 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores; 48 cores/24 cases
TMA-MC5002 High-density multiple organ tumor tissue array, with adjacent normal tissue, information of TNM, stage and grade, 500 cases/500 cores, replacing MC5001; 500 cores/500 cases
TMA-MC5003 High-density multiple organ tumor and normal tissue array, with TNM and pathology grade, 500 cases/500 cores, replaced by MC5003a; 500 cores/500 cases
TMA-MC5003a High-density multiple organ tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 500 cases/500 cores, replacing MC5003; 500 cores/500 cases
TMA-MC501 Multiple organs tumor and matched adjacent tissue array, 27 cases/50 cores; 50 cores/27 cases
TMA-MC542 Multiple organ,diseased tissue array, including TNM and pathology grade, 54 cases/54 cores, replacing MC541; 54 cores/54 cases
TMA-MC601 Multi-organ cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases/60 cores; 60 cores/60 cases
TMA-MC602 Neuroblastoma and peripheral nerve tissue array, 30 cases/ 60 cores; 60 cores/30 cases
TMA-MC616 High-density lung, breast, brain and colon cancer array, with stage, grade and normal tissue array, 308 cases/616 cores; 616 cores/308 cases
TMA-MC6162 High-density stomach, colonrectal cancer tissue array, with stage, grade and normal tissue, 616 cases/616 cores; 616 cores/616 cases
TMA-MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases/616 cores; 616 cores/616 cases
TMA-MC8010 Multiple organ cancer tissue array, including TNM and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-MC803 Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a; 80 cores/40 cases
TMA-MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases/80 cores, replacing MC803; 80 cores/40 cases
TMA-MC804 Adamantinoma and hamartoma tissue array, 40 cases/80 cores; 80 cores/40 cases
TMA-MC805 Synovial sarcoma and cancer sarcomatodes tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-MC806 Gangliocytoma and paraganglioma tissue array, 40 cases/80 cores; 80 cores/40 cases
TMA-MC807 Multiple types of cancer tissue array, with stage and TNM information, 40 cases/80 cores; 80 cores/40 cases
TMA-MC808 Multiple tumor tissue array - 58 different tumors and their corresponding normal tissues with TNM data, 58 cases/96 cores; 80 cores/40 cases
TMA-MC809 Neuroblastoma and retinoblastoma tissue array, with TNM and grade info, 80 cases/80 cores, replaced by MC809a; 80 cores/80 cases
TMA-MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing MC809; 80 cores/80 cases
TMA-MC962 Multiple carcinoma tissue array with matched normal organ tissue, 58 cases/96 cores; 96 cores/58 cases
TMA-MC963 Multiple cancer tissue array with four 24 core array squares mounted on glass, 12 cases/96 cores; 96 cores/13 cases
TMA-MC964 Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, for testing tumor tissue specificity of therapeutic antibodies, 96 cases/96 cores, replaced by MC964a; 96 cores/96 cases
TMA-MC964a Multiple organ tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases/96 cores, replacing MC964; 96 cores/96 cases
TMA-MCN602 Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 58 cases/60 cores, replaced by MCN602a; 60 cores/58 cases
TMA-MCN602a Multiple organ tumor and cancer adjacent normal tissue array, including TNM, clinical stage and pathology grade, 60 cases/ 60 cores, replacing MCN602; 60 cores/60 cases
TMA-MGS801 Male genitourinary system tissue array with normal, inflammation, disease and cancer tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-MT2081 Multiple organ metastatic cancer tissue array, 19 organ/104 cases/208 cores; 208 cores/104 cases
TMA-MT801 Multiple organ cancer metastasis tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-MTU481 Multiple tumor tissue array, 48 cases/48 cores; 48 cores/48 cases
TMA-ON481 Oncocytoma tissue array, 24 cases/48 cores; 48 cores/24 cases
TMA-PC701 Pediatric malignant tumor tissue array with normal tissue as control, 70 cases/ 70 cores; 70 cores/70 cases
TMA-RE601 Colon and rectum cancer tissue array, including TNM, clinical stage and pathology grade, 60 cases/60 cores; 60 cores/60 cases
TMA-SLC601 Stomach cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores; 60 cores/60 cases
TMA-T0010 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T0011 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T0012 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T0013 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T003 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T004 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T005 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T006 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T007 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T008 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T009 Multiple organ cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T303 Heart tumor test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T383 Malignant melanoma test tissue array, with normal skin tissue, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T423 Small intestine cancer test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T433 Adrenal gland cancer test tissue array, with normal tissue, 2 serial sections, 6 cases/26 cores; 26 cores/6 cases
TMA-TP241 Top 4 types of cancer (colon, breast, lung and prostate) tissue array, including TNM and pathology grade, 12 cases/24 cores; 24 cores/12 cases
TMA-TP242a Top 4 types of cancer (colon, breast, lung and prostate) tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 24cases/ 24cores, replacing TP242; 24 cores/24 cases
TMA-UNC241 Universal control tissue array, used for screening of more than 90% routine IHC markers, 12 cases/24 cores; 24 cores/12 cases
Stomach
TMA-BB01011 Gastric ulcer tissue array, 14 cases /24 cores, replaced by BB01011a; 24 cores/14 cases
TMA-CKIT061 Ckit molecule IHC control array, 3 cases/6 cores; 6 cores/3 cases
TMA-DOG1061 GIST DOG1 molecule IHC control array, 3 cases/6 cores; 6 cores/3 cases
TMA-BN01013 Normal stomach tissue (multi-sites) array, 70 cases /72 cores, replaced by BN01013a; 72 cores/70 cases
TMA-BC01011 Stomach carcinoma (multi-tissue combined panel) tissue array, 24 cases /72 cores, replaced by ST721; 72 cores/24 cases
TMA-BC01022 Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases /63 cores; 63 cores/21 cases
TMA-BC01023 Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases /63 cores; 63 cores/21 cases
TMA-BC01024 Stomach adenocarcinoma (combination of adjacent and normal) tissue array, 21 cases /63 cores, replaced by ST722; 63 cores/21 cases
TMA-BC01071 Carcinoma of stomach, liver and rectum tissue array, 45 cases /48 cores, replaced by BC01071a; 48 cores/45 cases
TMA-BC01081 Adenocarcinoma of stomach, colon and rectum high density tissue array, 556 cases/616 cores; 616 cores/556 cases
TMA-BS01012 Stomach adenocarcinoma tissue array, 72 cases /72 cores, replaced by BS01012a; 72 cores/72 cases
TMA-BS01032 Stomach adenocarcinoma (grade II) tissue array, 63 cases /63 cores, replaced by ST808; 63 cores/63 cases
TMA-BS01041 Stomach adenocarcinoma (grade III) tissue array, 22 cases /63 cores; 63 cores/22 cases
TMA-BS01042 Stomach adenocarcinoma (grade III) tissue array, 22 cases /63 cores, replaced by ST723; 63 cores/22 cases
TMA-BB01011a Gastric ulcer tissue array with normal gastric tissue as control, 14 cases/24 cores, replacing BB01011; 24 cores/14 cases
TMA-BC01001 Tissue array of gastric diseases biopsied from gastroscope, including TNM, clinical stage and pathology grade, 18 cases/18 cores; 18 cores/18 cases
TMA-BC01014 Stomach carcinoma tissue array (multi-tissue combined panel), 71 cases /72 cores, replaced by ST807; 72 cores/71 cases
TMA-BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing BC01071; 48 cores/48 cases
TMA-BC01114 Stomach adenocarcinoma with matched adjacent tissue and normal tissue array, including TNM, clinical stage and pathology grade, 55 cases/100 cores, replaced by ST1004; 100 cores/55 cases
TMA-BN01011 Normal stomach tissue (multi-sites) array, 21 cases /63 cores, replaced by BN01011b; 63 cores/21 cases
TMA-BN01011b Normal stomach tissue array, 24 cases/72 cores, replacing BN01011; 72 cores/24 cases
TMA-BN01013a Normal gastric tissue array (multi-sites), 72 cases/72 cores, replacing BN01013; 72 cores/72 cases
TMA-BS01011 Stomach cancer tissue array, 72 cases/72 cores; 72 cores/72 cases
TMA-BS01012a Stomach adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BS01012; 72 cores/72 cases
TMA-BS01012b Stomach adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases/ 72 cores, replacing BS01012a; 72 cores/72 cases
TMA-IC00011 Tissue array of gastritis with intestinal metaplasia and gastric carcinoma, 80 cases /80 cores, replaced by IC00011b; 80 cores/80 cases
TMA-IC00011b Gastric carcinoma, gastritis with intestinal metaplasia tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing IC00011; 80 cores/80 cases
TMA-ST1001 Stomach disease spectrum (stomach cancer progression) tissue array, 100 cases/100 cores; 100 cores/100 cases
TMA-ST1002 Stomach carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-ST1003 Stomach cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-ST1004 Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases/100 cores, replacing BC01114; 100 cores/55 cases
TMA-ST1021 Stomach cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 102 cases/ 102 cores; 102 cores/102 cases
TMA-ST1501 Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-ST1502 Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-ST1503 Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-ST1504 Stomach cancer tissue with matched cancer adjacent tissue array as control, including TNM,stage and pathology grade,50 cases/150 cores; 150 cores/50 cases
TMA-ST1505 Stomach cancer tissue array with matched cancer adjacent tissue as control, including TNM,stage and pathology grade, 50 cases/150 cores; 150 cores/50 cases
TMA-ST1921 Middle-advanced stage stomach cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-ST2001 Stomach cancer high density (200 cases/200 cores) tissue array, including TNM and pathology grade, replaced by ST2091; 200 cores/200 cases
TMA-ST208 Stomach cancer and normal tissue high density (70 cases/208 core) tissue microarray; 208 cores/70 cases
TMA-ST2082 High-density stomach cancer tissue array with normal tissues, with stage and grade info, 104 cases/208 cores; 208 cores/104 cases
TMA-ST2083 Stomach cancer and normal stomach tissue array with stage and grade, 69 cases/208 cores; 208 cores/69 cases
TMA-ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases/208 cores, replacing ST2001; 208 cores/208 cases
TMA-ST2161 Stomach cancer tissue array, including TNM and pathology grade, 216 cases/216 cores; 216 cores/216 cases
TMA-ST241 Stomach cancer test tissue array with self-matching normal adjacent tissues, 6 cases/24 cores, replaced by ST244a; 24 cores/6 cases
TMA-ST242 Multiple stomach cancer tissue array with self-matching normal adjacent tissues, 10 cases/24 cores; 24 cores/10 cases
TMA-ST244a Stomach cancer tissue array with matched adjacent normal tissue as control, including pathology grade, 6cases/ 24cores, replacing ST241; 24 cores/6 cases
TMA-ST481 Stomach cancer tissue array with corresponding (self-matching) normal adjacent tissues (12 cases/48 cores), with stage and grade info; 48 cores/12 cases
TMA-ST482 Multiple stomach cancer tissue array with 4 normal tissues control from autopsy (24 caeas/48 cores), with stage and grade info; 48 cores/24 cases
TMA-ST483 Multiple stomach cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with stage and grade info, replaced by ST483b; 48 cores/48 cases
TMA-ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing ST483; 48 cores/48 cases
TMA-ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replaced by ST483c; 48 cores/48 cases
TMA-ST483c Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing ST483b; 48 cores/48 cases
TMA-ST484 Stomach cancer tissue array, including TNM and pathology grade, 48 cases/48 cores, replaced by ST484a; 48 cores/48 cases
TMA-ST484a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing ST484; 48 cores/48 cases
TMA-ST485 Stomach cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-ST721 Stomach adenocarcinoma and normal tissue array with TNM and pathology grade data, 24 cases/72 cores, replacing BC01011; 72 cores/24 cases
TMA-ST722 Stomach adenocarcinoma with self-matched adjacent and normal tissue array, with stage and grade info, 24 cases/72 cores; 72 cores/24 cases
TMA-ST723 Stomach poorly differentiated adenocarcinoma tissue array with adjacent normal control, stage and grade info, 24 cases/72 cores, replacing BS01042; 72 cores/24 cases
TMA-ST781 Stomach adenocarcinoma (grade I-III) tissue array with self-matched adjacent and normal tissues, 26 cases/78 cores; 78 cores/26 cases
TMA-ST801 Stomach cancer tissue array, with matched adjacent normal tissue, 40 cases/80 cores, replaced by ST801a; 80 cores/40 cases
TMA-ST8011 Gastric cardia disease spectrum (cardia cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-ST8012 Stomach adenocarcinoma and normal tissue array, with stage and grade information, 40 cases/80 cores; 80 cores/40 cases
TMA-ST8013 Stomach cancer metastatic tissue array, 40 cases/80 cores; 80 cores/40 cases
TMA-ST8014 Stomach cancer and normal tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-ST8015 Stomach cancer and adjacent normal tissue array, including TNM and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-ST801a Stomach cancer tissue array with matched adjacent normal stomach tissue, including TNM and clinical stage, 40 cases/80 cores, replacing ST801; 80 cores/40 cases
TMA-ST802 Stomach carcinoma (multi-tissue combined panel) tissue array, 78 cases/80 cores; 80 cores/78 cases
TMA-ST803 Stomach adenocarcinoma tissue array, in various type, 40 cases/80 cores; 80 cores/40 cases
TMA-ST804 Stomach adenocarcinoma tissue array, mucous type, 40 cases/80 cores; 80 cores/40 cases
TMA-ST805 Stomach cancer progression tissue array (containing normal, inflammation, hyperplasia and adenocarcinoma), 80 cases/80 cores; 80 cores/80 cases
TMA-ST806 Gastritis, stomach hyperplasia and dysplasia, 80 cases/80 cores; 80 cores/80 cases
TMA-ST807 Stomach carcinoma (multi-tissue combined panel) tissue array (replacing BC01014), 80 cases/80 cores; 80 cores/80 cases
TMA-ST808 Stomach adenocarcinoma and normal tissue array, 80 cases/80 cores, replacing BS01032; 80 cores/80 cases
TMA-ST809 Stomach cancer tissue array with normal tissue as control, including TNM,stage and pathology grade,80 cases/80 cores; 80 cores/80 cases
TMA-ST810a Stomach cancer with matched lymph node metastasis tissue array, including TNM, clinical stage and pathology grade, 40cases/ 80cores, replacing ST810; 80 cores/40 cases
TMA-ST811 Stomach cancer tissue array with normal tissues from autopsy, 80 cases/80 cores, with grade and stage data; 80 cores/80 cases
TMA-ST812 Stomach cancer tissue array with normal tissues from autopsy, with clinical stage (TNM) and pathology grade info, 40 cases/80 cores; 80 cores/80 cases
TMA-ST961 Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-STC1021 Stomach cancer tissue array with normal and gastritis tissue control, having grade and stage info, 102 cases/102 cores; 102 cores/102 cases
TMA-STC1501 Stomach cancer mid-density tissue array, non-overlapping with STC1502 or STC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-STC1502 Human stomach cancer mid-density tissue array, non-overlapping with STC1501 or STC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-STC1503 Stomach cancer mid-density tissue array, non-overlapping with STC1501 or STC1502, 75 cases/150 cores; 150 cores/75 cases
TMA-STC2281 Stomach cancer high density tissue array, 228 cases/228 cores; 228 cores/228 cases
TMA-STC481 Stomach cancer and normal tissue array, 16 cases/48 cores; 48 cores/16 cases
TMA-STC961 Stomach cancer and normal tissue array, non-overlapping with STC962, 48 cases/96 cores; 96 cores/48 cases
TMA-STC962 Human stomach cancer and normal tissue array, non-overlapping with STC962, 48 cases/96 cores; 96 cores/48 cases
TMA-T011 Stomach cancer test tissue array, with TNM and grade info, 6 cases/24 cores; 24 cores/12 cases
TMA-T012 Stomach cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T012a; 24 cores/12 cases
TMA-T012a Stomach tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T012; 24 cores/12 cases
TMA-T013 Stomach cancer test tissue array, with normal stomach tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T014 Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-ST810 Stomach cancer with matched lymph node metastasis tissue array, 40 cases/80 cores, replaced by ST810a; 80 cores/40 cases
TMA-ST991 Stomach adenocarcinoma (combination of margin and normal tissue) tissue array, 33 cases/99 cores; 99 cores/33 cases
Esophagus
TMA-ES8012 Middle-advanced stage esophageal cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-BC02011 Multiple esophageal cancer tissue array, 69 cases/72 cores; 72 cores/69 cases
TMA-BC02012 Esophageal carcinoma (multi-tissue combined panel) tissue array, 72 cases/72 cores; 72 cores/72 cases
TMA-BC02013 Esophageal carcinoma (multi-tissue combined panel) tissue array, 72 cases/72 cores; 72 cores/72 cases
TMA-BC02021 Esophagus squamous carcinoma (combination of adjacent and normal) tissue array, 18 cases/54 cores; 54 cores/18 cases
TMA-BC02022 Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases/54 cores; 54 cores/18 cases
TMA-BC02023 Esophagus squamous cell carcinoma (combination of adjacent and normal) tissue array, 18 cases/54cores, replaced by ES722 ; 54 cores/18 cases
TMA-BC02111 Esophageal adenocarcinoma tissue array with matched normal adjacent tissue, 21 cases/80 cores; 80 cores/23 cases
TMA-BS02021 Esophagus squamous cell carcinoma (grade I) tissue array, 21 cases/63 cores; 63 cores/21 cases
TMA-BS02031 Esophagus squamous cell carcinoma (grade II) tissue array, 22 cases/63 cores, replaced by ES723; 63 cores/22 cases
TMA-BS02041 Esophagus squamous cell carcinoma (grade III) tissue array, 23 cases/63 cores; 63 cores/23 cases
TMA-BS02051 Esophagus adenocarcinoma tissue array, 33 cases/63 cores; 63 cores/33 cases
TMA-BBS02011 Esophageal mucous chronic inflammation, esophageal intraepithelial neoplasia, esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 60cases/ 120cores,; 120 cores/60 cases
TMA-BC001113 Esophageal adenocarcinoma, cardia adenocarcinoma, normal esophageal and cardia tissue array, 50 cases/50 cores (previously cat# ES501); 50 cores/50 cases
TMA-ES1001 Esophagus cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-ES1002 Esophageal cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-ES1021 Esophagus cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 102 cases/ 102 cores; 102 cores/102 cases
TMA-ES1201 Tissue array of esophageal squamous carcinoma and matched adjacent tissue, 60 cases/120 cores, replaced by ES1202; 120 cores/60 cases
TMA-ES1202 Esophageal tumor tissue array, with stage, grade and matched adjacent tissue, 60 cases/120 cores, replacing ES1201; 120 cores/60 cases
TMA-ES1501 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-ES1503 Esophagus cancer tissue array with matched cancer adjacent tissue as control, including TNM,stage and pathology grade,50 cases/150 cores; 150 cores/50 cases
TMA-ES1504 Esophagus cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores; 150 cores/50 cases
TMA-ES1921 Middle-advanced stage esophagus cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-ES2001 Esophagus squamous cell carcinoma and metastatic carcinoma tissue array, with adjacent tissue and adjacent normal tissue, including TNM and pathology grade, 120 cases/200 cores; 200 cores/120 cases
TMA-ES208 High density esophageal cancer tissue array, with normal tissue, grade and TNM, 69 cases/208 cores; 208 cores/69 cases
TMA-ES2081 Esophageal disease (progression) spectrum tissue array, 103 cases/208 cores; 208 cores/103 cases
TMA-ES2082 High-density esophageal cancer and normal tissue array, with TNM and grade info, 208 cases/208 cores; 208 cores/208 cases
TMA-ES241 Esophagus cancer test tissue array with self-matching normal adjacent tissue, 6 cases/24 cores; 24 cores/6 cases
TMA-ES242 Multiple esophagus cancer test tissue array with matched or unmatched normal adjacent tissue, 11 cases/24 cores; 24 cores/11 cases
TMA-ES243 Esophagus cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores; 48 cores/24 cases
TMA-ES244 Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases/24 cores; 24 cores/12 cases
TMA-ES481 Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases/48 cores) with stage and grade info; 48 cores/18 cases
TMA-ES482 Multiple esophagus cancer tissue array with unmatched normal tissues, 48 cases/48 cores, with grade and stage data; 48 cores/48 cases
TMA-ES483 Esophagus cancer and matched adjacent tissue array, including TNM and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-ES721 Esophagus cancer and normal tissue array with TNM and grade info, 24 cases/72 cores; 72 cores/24 cases
TMA-ES722 Esophageal cancer and adjacent tissue array, with stage and grade info, 30 cases/72 cores, replacing BC02023; 72 cores/30 cases
TMA-ES723 Esophageal squamous cell carcinoma tissue array, with stage, grade and normal tissue, 23 cases/72 cores, replacing BS02031; 72 cores/23 cases
TMA-ES781 Esophagus cancer tissue array, including TNM and pathology grade, 26 cases/78 cores, replacing BC02111; 78 cores/26 cases
TMA-ES801 Esophagus cancer, with matched normal adjacent tissue array, 40 cases/80 cores, replaced by ES8010; 80 cores/40 cases
TMA-ES8010 Esophageal cancer and adjacent normal tissue array, with TNM and grade info, 40 cases/80 cores, replacing ES801; 80 cores/40 cases
TMA-ES8011 Esophageal cancer tissue array, with normal tissue, TNM and grade info, 40 cases/80 cores; 80 cores/40 cases
TMA-ES802 Esophageal squamous cell carcinoma tissue array, grade I-III, 40 cases/80 cores, no overlaps with ES801; 80 cores/40 cases
TMA-ES803 Esophageal inflammation, hyperplasia and atypical hyperplasia tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-ES804 Esophageal cancer progression tissue array, 76 cases/80 cores; 80 cores/76 cases
TMA-ES805 Esophagus cancer and normal tissue array, with grade and stage data, 40 cases/80 cores; 80 cores/40 cases
TMA-ES806 Metastatic esophageal cancer tissue array, 40 cases/80 cores; 80 cores/40 cases
TMA-ES807 Esophageal cancer and normal tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-ES808 Esophagus cancer and normal tissue array, with TNM and grade info, 78 cases/80 cores; 80 cores/78 cases
TMA-ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases/80 cores; 80 cores/78 cases
TMA-ES811 Esophageal cancer tissue array with normal tissues from autopsy, 40 cases/80 cores, plus grade and stage information; 80 cores/40 cases
TMA-ES961 Esophagus squamous cell carcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-ES962 Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-ESC1021 Esophagus cancer tissue array, 102 cases/102 cores; 102 cores/102 cases
TMA-ESC1501 Esophageal cancer mid-density tissue array, non-overlapping with ESC1502,75 cases/150 cores; 150 cores/75 cases
TMA-ESC241 Esophagus cancer tissue array, 12 cases/24 cores; 24 cores/12 cases
TMA-ESC242 Esophagus cancer tissue array, 12 cases/24 cores; 24 cores/12 cases
TMA-ESC481 Esophagus cancer and normal tissue array, 16 cases/48 cores; 48 cores/16 cases
TMA-ESC961 Esophageal cancer tissue array, non-overlapping with ESC962, 48 cases/96 cores; 96 cores/48 cases
TMA-ESC962 Esophagus cancer tissue array, non-overlapping with ESC961, 48 cases/96 cores; 96 cores/48 cases
TMA-T021 Esophageal cancer tissue array, with normal tissues, TNM and grade info, 6 cases/24 cores; 24 cores/6 cases
TMA-T022 Esophageal cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T022a; 24 cores/12 cases
TMA-T022a Esophagus cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T022b; 24 cores/12 cases
TMA-T022b Esophagus cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T022a; 24 cores/12 cases
TMA-T023 Esophagus carcer test tissue array, with normal esophagus tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-ES810 Esophagus cancer with matched lymph node metastasis tissue array, 40 cases/80 cores; 80 cores/40 cases
Liver
TMA-BN03011 Normal liver tissue array (multi-sites), 20 cases/63 cores, replaced by LVN801; 63 cores/20 cases
TMA-BC03011 Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases/63 cores, replaced by LV8010; 63 cores/63 cases
TMA-BC03013 Liver carcinoma (multi-tissue combined panel) tissue array, 63 cases/63 cores, replaced by LV723; 63 cores/63 cases
TMA-BC03021 Liver carcinoma (combination of adjacent and normal) tissue array, 42 cases/63 cores, replaced by LV803; 63 cores/42 cases
TMA-BS03011 Hepatocellular carcinoma tissue array, 21 cases/63 cores, replaced by LV804; 63 cores/21 cases
TMA-BS03013 Hepatocellular carcinoma tissue array, 22 cases/63 cores, replaced by BS03013a; 63 cores/22 cases
TMA-BS03014 Hepatocellular carcinoma tissue array, 63 cases/63 cores, replaced by LV809; 63 cores/63 cases
TMA-LV2001 High-density liver cancer tissue array, paraffin section, 200 cases/200 cores; 200 cores/200 cases
TMA-BC03002 Liver disease spectrum tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores; 80 cores/40 cases
TMA-BC03116 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 70 cases/70 cores; 70 cores/70 cases
TMA-BC03117 Liver cancer, liver cirrhosis tissue array with normal tissue as control, including TNM, clinical stage, pathology grade and history of hepatitis, 70 cases/80 cores; 80 cores/70 cases
TMA-BC03118 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases/200 cores; 200 cores/100 cases
TMA-BC03119 Liver carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases/120 cores; 120 cores/120 cases
TMA-BS03013a Hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 23 cases/63 cores, replacing BS03013; 63 cores/23 cases
TMA-IC03001 Liver tissue, type B hepatitis and hepatic cirrhosis tissue array, 80 cases/ 80 cores, replaced by LV805; 80 cores/80 cases
TMA-LV1001 Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-LV1002 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-LV1003 Liver cancer tissue array, with HBV infection information, including TNM and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-LV1021 Liver cancer tissue array, 102 cases/ 102 cores; 102 cores/102 cases
TMA-LV1201 Multiple diseases of liver tissue array, including TNM, clinical stage and pathology grade, 120 cases/120 cores; 120 cores/120 cases
TMA-LV1501 Liver hepatocellular carcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-LV1503 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-LV1504 Liver cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores; 150 cores/50 cases
TMA-LV1505 Liver cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores; 150 cores/50 cases
TMA-LV1601 HBV(+) and HBV(-) noncancerous liver tissue array, 80 cases/ 160 cores; 160 cores/80 cases
TMA-LV1602 HBV(+) and HBV(-) noncancerous liver tissue array, 80 cases/ 160 cores; 160 cores/80 cases
TMA-LV1921 Liver late stage tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-LV2081 Hepatic disease spectrum (liver cancer progression) tissue array, 103 cases/208 cores; 208 cores/103 cases
TMA-LV20810 Liver cancer survey tissue array (2 of 3), with normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-LV20811 Liver cancer survey tissue array (3 of 3), with normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-LV20812 Liver disease tissue array, including HBV infection, TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LV2082 Liver cancer tissue array with normal tissues, with TNM and grade info, 104 cases/208 cores; 208 cores/104 cases
TMA-LV2083 High-density liver cancer tissue array with normal tissues, with stage and grade info, 69 cases/208 cores; 208 cores/69 cases
TMA-LV2084 Liver cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LV2085 Liver cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LV2086 Liver cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LV2087 Liver cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LV2088 Liver cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LV2089 Liver cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-LV2161 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 216 cases/216 cores; 216 cores/216 cases
TMA-LV241 Liver cancer test tissue array with self-matching normal adjacent tissue, 6 cases/24 cores; 24 cores/6 cases
TMA-LV242 Multiple Liver cancer test tissue array with unmatched normal adjacent tissue, 12 cases/24 cores; 24 cores/12 cases
TMA-LV243 Liver cancer tissue array with normal tissues from autopsy, 12 cases/24 cores, with grade and stage; 24 cores/12 cases
TMA-LV244 Liver cancer tissue array, with stage and grade info, 8 cases/24 cores; 24 cores/8 cases
TMA-LV245 Liver cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores; 48 cores/24 cases
TMA-LV246 Liver hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores; 24 cores/24 cases
TMA-LV247 Liver hepatocholangiocarcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores; 24 cores/24 cases
TMA-LV481 Liver cancer tissue array with normal adjacent tissues, 23 cases/48 cores, with grade and stage data; 48 cores/23 cases
TMA-LV482 Multiple liver cancer tissue array with 4 normal tissues control from autopsy, with TNM, 24 cases/48 cores; 48 cores/24 cases
TMA-LV483 Multiple liver cancer tissue array with normal tissue control from autopsy, with TNM data, 48 cases/48 cores; 48 cores/48 cases
TMA-LV484 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-LV485 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases/96 cores; 96 cores/48 cases
TMA-LV486 Liver cancer tissue array with matched adjacent tumor tissue, including TNM and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-LV487 Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases/48 cores,; 48 cores/16 cases
TMA-LV6161 High-density liver cancer array, with clinical stage, pathology grade and normal hepatic tissue, 322 cases/616 cores; 616 cores/322 cases
TMA-LV641 Liver hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores; 64 cores/64 cases
TMA-LV642 Liver hepatocholangiocarcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores; 64 cores/64 cases
TMA-LV721 Hepatocellular carcinoma and normal tissue array with stage and grade information, 24 cases/72 cores; 72 cores/24 cases
TMA-LV723 Liver cancer and adjacent normal tissue array, including TNM and pathology grade, 72 cases/72 cores, replacing BC03013; 72 cores/72 cases
TMA-LV801 Liver cancer tissue array, with matched or unmatched adjacent normal tissue, 75 cases/80 cores, replaced by LV801a; 80 cores/75 cases
TMA-LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases/80 cores, replacing BC03011; 80 cores/80 cases
TMA-LV8011 Liver disease spectrum (hepatic cancer progression) tissue array, 76 cases/80 cores; 80 cores/76 cases
TMA-LV8012 Mid-advanced stage liver cancer tissue array, including TNM and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-LV8013 Hepatocellular carcinoma tissue array, including TNM, pathology grade, HBV and HCV infection information, 40 cases/80 cores; 80 cores/40 cases
TMA-LV801a Liver cancer and cancer adjacent normal tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing LV801; 80 cores/80 cases
TMA-LV802a Liver cancer tissue array with cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80cases/ 80cores, replacing LV802; 80 cores/80 cases
TMA-LV804 Liver cancer tissue array with normal tissue from autopsy, 38 cases/80 cores, replacing BS03011; 80 cores/38 cases
TMA-LV806 Liver hemangiomas tissue array with normal tissue control from autopsy, 40 cases/80 cores; 80 cores/40 cases
TMA-LV807 Liver cancer and normal tissue array with TNM and grade, 40 cases/80 cores; 80 cores/40 cases
TMA-LV808 Liver cancer and normal tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-LV809 Hepatocellular carcinoma and normal tissue array, with stage, TNM and grade, 80 cases/80 cores, replacing BS03014; 80 cores/80 cases
TMA-LV961 Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-LVC1021 Liver cancer tissue array, 102 cases/102 cores; 102 cores/102 cases
TMA-LVC1501 Liver cancer mid-density tissue array, non-overlapping with LVC1502 or LVC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-LVC1502 Liver cancer mid-density tissue array, non-overlapping with LVC1501 or LVC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-LVC1503 Liver cancer mid-density tissue array, non-overlapping with LVC1501 or LVC1502, 75 cases/150 cores; 150 cores/75 cases
TMA-LVC2281 Liver cancer high density tissue array, 228 cases/228 cores, replaced by LV2161; 228 cores/228 cases
TMA-LVC481 Liver cancer and normal tissue array, non-overlapping with LVC482, 16 cases/48 cores; 48 cores/16 cases
TMA-LVC482 Liver cancer and normal tissue array, with TNM and grade info, non-overlapping with LVC481, 16 cases/48 cores; 48 cores/16 cases
TMA-LVC961 Liver cancer and normal tissue array, with TNM and grade info, non-overlapping with LVC962, 48 cases/96 cores, replaced by LV961; 96 cores/48 cases
TMA-LVC962 Liver cancer and normal tissue array, non-overlapping with LVC961, 48 cases/96 cores; 96 cores/48 cases
TMA-LVN801 Normal liver and hepatocellular carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replacing BN03011; 80 cores/40 cases
TMA-T031 Liver cancer test tissue array with normal liver tissues, with TNM, stage and grade info, 6 cases/24 cores, replaced by T031a; 24 cores/6 cases
TMA-T031a Liver cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 6cases/ 24cores, replacing T031; 24 cores/6 cases
TMA-T032 Liver cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T032a; 24 cores/12 cases
TMA-T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T032; 24 cores/12 cases
TMA-T033 Liver cancer test tissue array, with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replaced by T033a; 24 cores/6 cases
TMA-T033a Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/ 24 cores, replacing T033; 24 cores/6 cases
TMA-T034 Liver cancer test tissue array (4x (2x3) array),including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-TR031 Rat normal liver test tissue array, 6 cases/24 cores; 24 cores/6 cases
TMA-LV208 Liver cancer (hepatocellular carcinoma) and normal tissue high density (69 cases/208 cores) tissue microarray, with stage and grade info; 208 cores/69 cases
TMA-LV631 Hepatocellular carcinoma tissue array with matched normal cancer adjacent tissue, 55 cases/63 cores; 63 cores/55 cases
TMA-LV802 Liver carcinoma (multi-tissue combined panel) tissue array, 80 cases/80 cores, no overlaps with LV801, replaced by LV802a; 80 cores/80 cases
TMA-LV803 Liver carcinoma (combination of cancer, cancer adjacent and normal tissue), 53 cases/72 cores, replacing BC03021; 72 cores/53 cases
TMA-LV805 Liver cirrhosis and hepatitis tissue array, 80 cases/80 cores, replacing IC03001; 80 cores/80 cases
Lung
TMA-BN04011 Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725; 63 cores/22 cases
TMA-BC04011 Lung cancer tissue array, including pathology grade, 23 cases/63 cores, replaced by LC721; 63 cores/23 cases
TMA-BC04012 Lung carcinoma (multi-tissue combined panel) tissue array, 68 cases/72 cores, replaced by BC04016; 72 cores/68 cases
TMA-BC04014 Non-small cell lung carcinoma (NSCLC) tissue array, 63 cases/63 cores, replaced by LC807; 72 cores/72 cases
TMA-BC04015 Lung carcinoma (multi-tissue combined panel) tissue array, 23 cases/63 cores; 63 cores/23 cases
TMA-BC04016 Lung carcinoma tissue array, 72 cases/72 cores, replaced by LC726; 72 cores/72 cases
TMA-BC04021 Lung carcinoma (multi-tissue combined panel) tissue array, 18 cases /54 cores, replaced by BC04021a; 54 cores/18 cases
TMA-BC04022 Non-small cell lung carcinoma (NSCLC)(combination of adjacent and normal) tissue array, 18 cases/54 cores; 54 cores/18 cases
TMA-BS04011 Lung cancer tissue array, including pathology grade, 64 cases/64 core, replaced by LC808; 64 cores/64 cases
TMA-BS04031 Lung squamous cell carcinoma tissue array, 63 cases/64 cores, replaced by LC724; 63 cores/21 cases
TMA-BS04041 Lung squamous cell carcinoma (grade III) tissue array, 21 cases/63 cores; 63 cores/21 cases
TMA-BS04071 Lung adenocarcinoma (grade II) tissue array, 21 cases/63 cores, replaced by LC723; 63 cores/21 cases
TMA-BS04081 Lung adenocarcinoma (grade II) tissue array, 21 cases/63 cores; 63 cores/21 cases
TMA-BS04111 Lung small cell carcinoma tissue array, 33 cases/63 cores; 63 cores/33 cases
TMA-BC04002 Lung disease spectrum tissue array, including TNM, clinical stage and pathology grade, 99 cases/100 cores; 100 cores/99 cases
TMA-BC04013 Non-small cell lung carcinoma tissue array, 63 cases/63 core, replaced by LC806; 63 cores/63 cases
TMA-BC04021a Lung carcinoma (multi-tissue combined panel) tissue array, including TNM, clinical stage and pathology grade, 18 cases/54 cores, replacing BC04021; 54 cores/18 cases
TMA-BC041114 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases/200 cores; 200 cores/100 cases
TMA-BC041115 Lung carcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases/120 cores, replaced by BC041115a; 120 cores/120 cases
TMA-BC041115a Lung cancer tissue array with normal lung tissue, including TNM, clinical stage and pathology grade, 120 cases/120 cores, replacing BC041115; 120 cores/120 cases
TMA-BC04118 Lung squamous cell carcinoma and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-BC04119 Lung adenocarcinoma and normal tissue array, including TNM, clinical stage and pathology grade, 30 cases/40 cores, replaced by BC04119b; 40 cores/30 cases
TMA-BC04119b Lung adenocarcinoma tissue array with normal lung tissue, including TNM and pathology grade,30 cases/40 cores, replacing BC04119; 40 cores/30 cases
TMA-BCS04017 Lung adenocarcinoma tissue array, including TNM and pathology grade, with TTF-1 IHC results, 48 cases/96 cores; 96 cores/48 cases
TMA-BS04102 Large cell carcinoma of lung tissue array, 21 cases/63 cores, replaced by LC727; 63 cores/21 cases
TMA-LC10010 Small cell lung carcinoma tissue array, for antibody screening, including TNM and clinical stage, 50 cases/100 cores, replaced by LC10010a; 100 cores/50 cases
TMA-LC10010a Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases/100 cores, replacing LC10010; 100 cores/50 cases
TMA-LC10011 Non-small cell lung carcinoma (NSCLC) tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-LC10012 Lung non-small cell cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 50 cases/100 cores, replacing LC1006; 100 cores/50 cases
TMA-LC10013 Lung adenocarcinoma tissue array with adjacent normal lung tissue, including TNM and pathology grade, replacing LC1002; 100 cores/50 cases
TMA-LC1002 Lung adenocarcinoma (grade II-III) tissue array with self-matched adjacent normal tissue, and 4 non-cancer normal lung tissue, with TNM info, 52 cases/100 cores, replaced by LC10013; 100 cores/52 cases
TMA-LC1004 Lung carcinoma (multi-tissue combined panel) tissue array, 50 cases/100 cores; 100 cores/50 cases
TMA-LC1005 Lung carcinoma progression tissue array, 77 cases/100 cores; 100 cores/77 cases
TMA-LC1006 Non-small cell lung carcinoma (NSCLC) tissue array with matched adjacent normal tissue as control, 56 cases/100 cores, with stage and grade data, replacing LC1001; 100 cores/56 cases
TMA-LC1007 Lung tuberculosis tissue array with normal tissue, 48 cases/100 cores; 100 cores/48 cases
TMA-LC1008 Non-small cell lung carcinoma array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-LC1009 Lung small cell carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-LC1021 Lung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 102 cases/102 cores; 102 cores/102 cases
TMA-LC1201 Lung disease spectrum tissue array, 116 cases/120 cores, with grade and stage information; 120 cores/116 cases
TMA-LC121 Non-small cell lung cancer tissue array, including TNM, clinical stage and pathology grade, 120 cases/120 cores, replaced by LC121a; 120 cores/120 cases
TMA-LC121a Non-small cell lung cancer tissue array, including TNM, clinical stage and pathology grade, 120 cases/120 cores, replacing LC121; 120 cores/120 cases
TMA-LC1501 Lung adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-LC1503 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-LC1504 Lung adenocarcinoma tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores; 150 cores/50 cases
TMA-LC1505 Lung squamous cell carcinoma tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores; 150 cores/50 cases
TMA-LC1921 High density non-small cell lung carcinoma (NSCLC) tissue array, with stage and grade info, 192 cases/192 cores; 192 cores/192 cases
TMA-LC1922 Middle-advanced stage lung non-small cell carcinoma tissue array, including TNM and pathology grade, 96 cases/192 cores, replaced by LC1922a; 192 cores/96 cases
TMA-LC1922a Lung non-small cell carcinoma tissue array, including TNM and pathology grade, 96 cases/192 cores, replacing LC1922; 192 cores/96 cases
TMA-LC20810 Lung cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LC20811 Lung cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LC20812 Lung cancer tissue array (1 of 5), with normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-LC20813 Lung cancer tissue array (2 of 5), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-LC20814 Lung cancer tissue array (3 of 5), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-LC20815 Lung cancer tissue array (4 of 5), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-LC20816 Lung cancer tissue array (5 of 5), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-LC2083 Lung disease spectrum (pulmonary cancer progression) tissue array, 193 cases/208 cores; 208 cores/193 cases
TMA-LC2084 High-density Lung cancer tissue array with normal tissues, with stage and grade info, 104 cases/208 cores; 208 cores/104 cases
TMA-LC2085a High-density (188 cases/208 cores), multiple types of lung cancer (I-3 grade) tissue array with normal lung from autopsy and cancer adjacent tissue; 208 cores/188 cases
TMA-LC2085b High-density (208 cores), multiple types of lung cancer (grade 1-3) tissue array with normal lung and cancer adjacent tissue, and staging info, 188 cases/208 cores, replaced by LC2085c; 208 cores/188 cases
TMA-LC2085c High-density lung cancer tissue array with normal and cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 186 cases/208 cores, replacing LC2085b; 208 cores/186 cases
TMA-LC2086 Normal lung tissue array, 104 cases/208 cores; 208 cores/104 cases
TMA-LC2087 Lung tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LC2088 Lung cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LC2089 Lung cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-LC2161 Lung cancer tissue array, including TNM and pathology grade, 216 cases/216 cores; 216 cores/216 cases
TMA-LC241 Non-small cell lung carcinoma (NSCLC) test tissue array, with self-matching normal adjacent tissue, 6 cases/24 cores; 24 cores/6 cases
TMA-LC242 Non-small cell lung carcinoma (NSCLC) test tissue array, with unmatched normal adjacent tissue, 12 cases/24 cores, replaced by LC242a; 24 cores/12 cases
TMA-LC242a Non-small cell lung carcinoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing LC242; 24 cores/12 cases
TMA-LC243 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores; 48 cores/24 cases
TMA-LC481 Tissue array of lung carcinoma and matched adjacent tissue, 12 cases/48 cores; 48 cores/12 cases
TMA-LC482 Non-small cell lung carcinoma (NSCLC) tissue array, with 4 normal tissue control from autopsy, 24 cases/48 cores, with grade and stage status; 48 cores/24 cases
TMA-LC483 Multiple lung cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores; 48 cores/48 cases
TMA-LC484 Lung cancer tissue array, including TNM and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-LC485 Lung cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-LC486 Lung cancer and matched adjacent lung tissue array, including TNM and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-LC487 Lung disease spectrum tissue array, including TNM and pathology grade, 24 cases/48 cores; 48 cores/24 cases
TMA-LC488 Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-LC501 Tissue array of multi-type lung cancer and normal tissue with TNM and grade, 50 cases/50 cores; 50 cores/50 cases
TMA-LC6161 High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores; 616 cores/322 cases
TMA-LC641 Lung adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores; 64 cores/64 cases
TMA-LC701 Lung adjacent normal tissue array, 72 cases/72 cores; 72 cores/72 cases
TMA-LC702 Lung cancer with necrosis tissue array, including TNM, clinical stage and pathology grade, 30 cases/30 cores; 30 cores/30 cases
TMA-LC703 Lung small cell cancer tissue array, including TNM, clinical stage and pathology grade, 44 cases/44 cores; 44 cores/44 cases
TMA-LC704 Lung squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 76 cases/76 cores; 76 cores/76 cases
TMA-LC705 Lung mucinous adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 21 cases/21 cores; 21 cores/21 cases
TMA-LC706 Lung adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 75 cases/75 cores; 75 cores/75 cases
TMA-LC721 Non-small cell lung carcinoma (NSCLC) tissue array, 24 cases/72 cores, replacing BC04011; 72 cores/24 cases
TMA-LC722 Lung cancer and normal tissue array, with TNM and grade data, 24 cases/72 cores; 72 cores/24 cases
TMA-LC723 Lung adenocarcinoma and adjacent normal tissue array, with TNM and grade info, 24 cases/72 cores, replacing BS04071; 72 cores/24 cases
TMA-LC724 Lung cancer and adjacent normal tissue array, with TNM and grade info, 24 cases/72 cores, replacing BS04031; 72 cores/24 cases
TMA-LC725 Normal lung tissue array, 24 cases/72 cores, replacing BN04011; 72 cores/24 cases
TMA-LC726 Lung carcinoma tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replaced by LC726a; 72 cores/72 cases
TMA-LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing LC726; 72 cores/72 cases
TMA-LC726ai Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores; 72 cores/72 cases
TMA-LC727 Lung large cell carcinoma tissue array, including TNM and clinical stage, 24 cases/72 cores, replacing BS04102; 72 cores/24 cases
TMA-LC801 Lung carcinoma (multi-tissue combined panel) tissue array, 79 cases/80 cores; 80 cores/79 cases
TMA-LC802 Lung small cell carcinoma tissue array, with normal lung tissue, 40 cases/80 cores; 80 cores/40 cases
TMA-LC802a Lung small cell carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 40 cases/80 cores, replacing LC802; 80 cores/40 cases
TMA-LC803 Lung carcinoma (multi-tissue combined panel, 80 cases/80 cores) tissue array; 80 cores/80 cases
TMA-LC805 Lung large cell carcinoma and bronchioloalveolar carcinoma tissue array, 40 cases/80 cores; 80 cores/40 cases
TMA-LC806 Multiple types of lung carcinoma tissue array, 80 cases/80 cores, replacing BC04013; 80 cores/80 cases
TMA-LC807 Lung cancer and normal tissue array, with TNM and grade info, 77 cases/80 cores, replaced by LC807a; 80 cores/77 cases
TMA-LC807a Lung cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 77 cases/80 cores, replacing LC807; 80 cores/77 cases
TMA-LC808 Lung squamous cell carcinoma tissue array, with TNM, stage and grade, 80 cases/80 cores, replacing BS04011; 80 cores/80 cases
TMA-LC809 Lung disease spectrum (pulmonary cancer progression) tissue array, 78 cases/80 cores; 80 cores/78 cases
TMA-LC811 Lung cancer tissue array with normal tissues, 80 cases/80 cores; 80 cores/80 cases
TMA-LC812 Lung cancer tissue array with normal tissues from autopsy, with TNM data, 40 cases/80 cores; 80 cores/40 cases
TMA-LC813 Multiple non-small cell lung carcinoma (NSCLC) and small cell lung carcinoma tissue array with normal lung tissue, 77 cases/80 cores, replacing BC04014; 80 cores/77 cases
TMA-LC814 Lung cancer with matched lymph node metastasis tissue array, 40 cases/80 cores, replacing LC810; 80 cores/40 cases
TMA-LC815 Lung cancer and normal tissue array with stage and grade info, 40 cases/80 cores; 80 cores/40 cases
TMA-LC816 Advanced lung cancer and normal tissue array, with stage TNM and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases/80 cores; 80 cores/40 cases
TMA-LC951 Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases/95 cores, replaced by LC952; 95 cores/40 cases
TMA-LC952 Lung cancer tissue array with normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 40 cases/95 cores, replacing LC951; 95 cores/40 cases
TMA-LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-LC962 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-LC991 Lung squamous cell carcinoma (grade I-III) tissue array with matched tumor adjacent and normal control, 33 cases/99 cores; 99 cores/33 cases
TMA-LC992 Lung adenocarcinoma (grade I-III, 33 cases) tissue array with matched tumor adjacent and normal control, 33 cases/99 cores; 99 cores/33 cases
TMA-LCN721 Normal lung tissue array with adenocarcinoma tissue as control, including TNM, clinical stage, pathology grade and IHC result, 24 cases/ 72 cores; 72 cores/24 cases
TMA-LUC1021 Lung cancer tissue array, 102 cases/102 cores; 102 cores/102 cases
TMA-LUC1501 Lung cancer mid-density tissue array, non-overlapping with LUC1502 or LUC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-LUC1502 Lung cancer mid-density tissue array, non-overlapping with LUC1501 or LUC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-LUC1503 Lung cancer mid-density tissue array, non-overlapping with LUC1501 or LUC1502, 75 cases/150 cores; 150 cores/75 cases
TMA-LUC2281 High density lung cancer tissue array, 228 cases/228 cores; 228 cores/228 cases
TMA-LUC481 Lung cancer and normal tissue array, non-overlapping with LUC482 , 16 cases/48 cores; 48 cores/16 cases
TMA-LUC482 Lung cancer and normal tissue array, non-overlapping with LUC481, 16 cases/48 cores; 48 cores/16 cases
TMA-LUC961 Lung cancer and normal tissue array, without overlapping with LUC962, 48 cases/96 cores; 96 cores/48 cases
TMA-LUC962 Lung cancer and normal tissue array, without overlapping with LUC961, 48 cases/96 cores; 96 cores/48 cases
TMA-LUD151 Lung disease tissue array, 15 cases/15 cores; 15 cores/15 cases
TMA-LUD481 Lung disease and normal tissue array, 16 cases/48 cores; 48 cores/24 cases
TMA-RS321 Tissue microarray of normal human respiratory tract, 32 cases/32 cores; 32 cores/32 cases
TMA-T041 Lung cancer test tissue array, with normal lung control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T042 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T044; 24 cores/12 cases
TMA-T043 Lung cancer test tissue array, with normal lung tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T044 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T045; 24 cores/12 cases
TMA-T045 Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T045c; 24 cores/12 cases
TMA-T045b Lung cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T045; 24 cores/12 cases
TMA-T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases/24 cores, replacing T045; 24 cores/12 cases
TMA-T046 Lung cancer test tissue array (4x (2x3)array),including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T047 Non-small cell lung cancer test tissue array (4x (2x3)array),including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-VLC11 Lung cancer tissue array, with TNM and grade info, 11 cases/11 cores; 11 cores/11 cases
TMA-VLC12 Lung cancer tissue array, with TNM and grade info, 12 cases/12 cores; 12 cores/12 cases
TMA-LC810 Lung cancer with matched lymph node metastasis tissue array, 40 cases/80 cores, replaced by LC814; 80 cores/40 cases
TMA-LC2081 Multiple lung carcinoma (Non-small cell lung carcinoma, NSCLC) and normal tissue form necroscopy tissue array, 70 cases/208 cores, with stage and grade information; 208 cores/70 cases
TMA-LC2082 Multiple lung carcinoma and normal tissue array, 70 cases/208 cores; 208 cores/70 cases
TMA-LC601 Non-small cell lung carcinoma (NSCLC) and normal tissue array, 25 cases plus normal tissues, with TNM data; 60 cores/25 cases
Colon
TMA-BN05011 Normal colon tissue (multi-site) array, 23 cases/63 cores, replaced by BN05014; 63 cores/23 cases
TMA-BS05041 Colon adenocarcinoma (grade III) tissue array, 23 cases/63 cores, replaced by CO725; 63 cores/23 cases
TMA-CO808 Colon disease spectrum (colon cancer progression) tissue array, 76 cases/80 cores; 80 cores/76 cases
TMA-BC050112 Colon metastatic carcinoma tissue array, 23 cases/63 cores, replaced by CO726; 63 cores/23 cases
TMA-BC05012 Colon carcinoma (multi-tissue combined panel) tissue array, 70 cases/72 cores, replaced by BC05012a; 72 cores/70 cases
TMA-BC05021 Colon adenocarcinoma (combination of adjacent and adjacent normal) tissue array, 18 cases/54 cores, no overlapping with BC05022, replaced by CO722; 54 cores/18 cases
TMA-BC05022 Colon adenocarcinoma (combination of adjacent and normal) tissue array, 18 cases/54 cores, no overlapping with BC05021; 54 cores/18 cases
TMA-BC05023 Colon adenocarcinoma (combination of adjacent and normal) tissue array, with grade and stage (TNM) info, 18 cases/54 cores; 54 cores/18 cases
TMA-CO481 Colonic adenocarcinoma and matched adjacent tissue array, with TNM data, 12 cases/48 cores; 48 cores/12 cases
TMA-BS05011 Colon adenocarcinoma tissue array, 23 cases/63 cores.; 63 cores/23 cases
TMA-BS05021 Colon adenocarcinoma (grade I) tissue array, 23 cases/63 cores, replaced by CO723; 63 cores/23 cases
TMA-BS05031 Colon adenocarcinoma (grade II) tissue array, 21 cases/63 cores, replaced by CO724; 63 cores/21 cases
TMA-BC05002 Colon disease spectrum tissue array, including TNM, clinical stage and pathology grade, 79 cases/80 cores; 80 cores/79 cases
TMA-BC05012a Colon cancer tissue array with cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC05012; 72 cores/72 cases
TMA-BC051110 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 120 cases/120 cores, replaced by BC051110a; 120 cores/120 cases
TMA-BC051110a Colon cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 120 cases/120 cores, replacing BC051110; 120 cores/120 cases
TMA-BC051111 Colon cancer and normal tissue array, including TNM, clinical stage and pathology grade, 100 cases/200 cores; 200 cores/100 cases
TMA-BC05115 Colon cancer, metastasize to lymph node and liver, and normal tissue array, including TNM, clinical stage and pathology grade, 68 cases/69 cores, replaced by CO702; 69 cores/69 cases
TMA-BC05118 Colon cancer and matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replaced by BC05118a; 100 cores/50 cases
TMA-BC05118a Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replaced by BC05118b; 100 cores/50 cases
TMA-BC05118b Colon cancer tissue array with matched adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing BC05118a; 100 cores/50 cases
TMA-BN05014 Colon normal tissue array, including TNM and pathology grade of 3 cases adenocarcinoma, 24 cases/72 cores, replacing BN05011; 72 cores/24 cases
TMA-CLC601 Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores; 60 cores/60 cases
TMA-CO1002 Colon and rectum carcinoma and normal tissue array, 73 cases/100 cores, replaced by CO1002b; 100 cores/73 cases
TMA-CO1002b Colorectal carcinoma and matched adjacent normal tissue array with lymph node metastasis carcinoma, including TNM and pathology grade, 64 cases/100 cores, replacing CO1002; 100 cores/64 cases
TMA-CO1003 Colon carcinoma antibody screening array, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-CO1004 Colon carcinoma tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases/102 cores; 102 cores/102 cases
TMA-CO1501 Colon adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-CO1503 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-CO1504 Colon cancer tissue array with matched adjacent tissue as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores; 150 cores/50 cases
TMA-CO1505 Colon cancer tissue array with matched adjacent tissue as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores; 150 cores/50 cases
TMA-CO1921 High-density colon cancer tissue array with normal tissues, 192 cases/192 cores; 192 cores/192 cases
TMA-CO1922 Advanced colon tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-CO2001 Colon cancer high-density tissue array, including TNM and pathology grade, 196 cases/200 core; 200 cores/196 cases
TMA-CO208 High-density, multiple colon cancer (1-4 grade) and normal colon tissue array, 70 cases/208 cores; 208 cores/70 cases
TMA-CO2081 Colon disease spectrum (colon cancer progression) tissue array, including TNM and pathology grade, 103 cases/208 cores; 208 cores/103 cases
TMA-CO20810 Colon cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-CO20811 Colon tumor survey tissue array (1 of 4), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-CO20812 Colon tumor survey tissue array (2 of 4), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-CO20813 Colon tumor survey tissue array (3 of 4), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-CO20814 Colon tumor survey tissue array (4 of 4), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-CO2083 High-density colon cancer tissue array with normal tissue, stage and grade info, 104 cases/208 cores; 208 cores/104 cases
TMA-CO2085a High-density (208 cases/208 cores), multiple type colon adenocarcinoma (I-4 grade) tissue array with normal colon from autopsy and cancer adjacent tissue; 208 cores/208 cases
TMA-CO2085b TMA BLOCK of high-density (208 cases/208 cores), multiple type colon adenocarcinoma (I-4 grade) with normal colon from autopsy and cancer adjacent tissue; 208 cores/208 cases
TMA-CO2086 Colon tumor survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-CO2087 Colon cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-CO2088 Colon cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-CO2089 Colon cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-CO208b TMA Block of high-density (70 cases/208 cores), multiple colon cancer (1-4 grade) and normal colon tissue array block; 208 cores/70 cases
TMA-CO2161 Colon cancer and normal colon tissue array, including TNM and pathology grade, 216 cases/216 cores; 216 cores/216 cases
TMA-CO241 Colon cancer test tissue array with self-matching normal adjacent tissue, 6 cases/24 cores, replaced by CO241a; 24 cores/6 cases
TMA-CO241a Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by CO241b; 24 cores/6 cases
TMA-CO241b Colon cancer tissue array with adjacent normal colon tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing CO241a; 24 cores/6 cases
TMA-CO242 Multiple colon cancer test tissue array with self-matching normal adjacent tissue, 10 cases/24 cores, replaced by CO242a; 24 cores/10 cases
TMA-CO242a Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing CO242; 24 cores/12 cases
TMA-CO243 Colon cancer tissue array with normal tissue controls, 9 cases/24 cores, replaced by CO243a; 24 cores/9 cases
TMA-CO243a Colon carcinoma tissue array with matched adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing CO243; 24 cores/12 cases
TMA-CO244 Colon cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores; 48 cores/24 cases
TMA-CO482 Tissue array of colonic carcinoma with TNM data and normal colon tissue, 24 cases/48 cores; 48 cores/24 cases
TMA-CO483 Multiple colon cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with stage and grade information; 48 cores/48 cases
TMA-CO484 Colon cancer tissue array with normal tissues with TNM and grade, 48 cases/48 cores, replaced by CO484a; 48 cores/48 cases
TMA-CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing CO484; 48 cores/48 cases
TMA-CO485 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-CO486 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases/96 cores; 96 cores/48 cases
TMA-CO487 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-CO488 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-CO6161 High-density colon cancer array, with stage, grade and normal colon tissue, 322 cases/616 cores; 616 cores/322 cases
TMA-CO641 Colon cancer tissue array, including TNM,stage and pathology grade,64 cases/ 64 cores; 64 cores/64 cases
TMA-CO701 Colon cancer tissue array, with grade 1-4 and normal colon tissue, 70 cases/70 cores, with stage and grade information; 70 cores/70 cases
TMA-CO702 Colon cancer tissue array, with metastasis tissue and adjacent normal tissue, including TNM and pathology grade, 69 cases/69 cores, repalcing BC05115; 69 cores/69 cases
TMA-CO721 Colon cancer tissue array with stage and grade info, 24 cases/72 cores; 72 cores/24 cases
TMA-CO722 Colon adenocarcinoma tissue array with matched tumor adjacent and adjacent normal tissue control, with stage and grade info, 24 cases/72 cores, replacing BC05021; 72 cores/24 cases
TMA-CO723 Colon well differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases/72 cores, replacing BS05021; 72 cores/24 cases
TMA-CO724 Colon moderately differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases/72 cores, replacing BS05031; 72 cores/24 cases
TMA-CO725 Colon poorly differentiated adenocarcinoma and adjacent normal tissue array, with stage and grade info, 24 cases/72 cores, replacing BS05041; 72 cores/24 cases
TMA-CO726 Metastatic colon carcinoma tissue array, 24 cases/72 cores, replacing BC050112; 72 cores/24 cases
TMA-CO727 Normal colon tissue array with colon cancer tissue as control, including TNM, clinical stage and pathology grade, 24 cases/ 72 cores; 72 cores/24 cases
TMA-CO801 Colon cancer tissue array, with matched or unmatched adjacent normal tissue, 40 cases/80 cores, no overlaps with CO802; 80 cores/40 cases
TMA-CO802 Colon carcinoma (multi-tissue combined panel) tissue array, 80 cases/80 cores, no overlaps with CO801, replaced by CO802b; 80 cores/80 cases
TMA-CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases/80 cores, replacing CO802; 80 cores/80 cases
TMA-CO802b Colon cancer tissue array with adjacent normal colon tissue, including pathology grade and clinical stage, 80 cases/80 cores, replacing CO802; 80 cores/80 cases
TMA-CO803 Colon cancer tissue array, with matched tumor and adjacent normal tissue, 40 cases/80 cores; 80 cores/40 cases
TMA-CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replcing CO804; 80 cores/80 cases
TMA-CO805 Colon adenocarcinoma and normal tissue array with stage and grade information, 40 cases/80 cores; 80 cores/40 cases
TMA-CO806 Colon normal adjacent tissue array, replacing BN05012, 80 cases/80 cores; 80 cores/80 cases
TMA-CO807 Advanced colon cancer tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-CO809 Colon polyp and colitis tissue array, including colon adenoma and normal tissue, 80 cases/80 cores, replaced by CO809a; 80 cores/80 cases
TMA-CO809a Colon disease tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing CO809; 80 cores/77 cases
TMA-CO811 Colon cancer tissue array with normal tissues from autopsy, with TNM data, 80 cases/80 cores; 80 cores/80 cases
TMA-CO812 Colon carcinoma and normal tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-CO951 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores, to be replaced by CO952; 95 cores/30 cases
TMA-CO952 Colon cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores, replacing CO951; 95 cores/30 cases
TMA-CO961 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-CO992 Colorectal (colon and rectum) cancer with matched lymph node metastasis and normal adjacent tissue array, 43 cases/99 cores, replacing CO991; 99 cores/43 cases
TMA-COC1021 Colon cancer tissue array, 102 cases/102 cores; 102 cores/102 cases
TMA-COC1501 Colon cancer mid-density tissue array, non-overlapping with either COC1502 or COC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-COC1502 Colon cancer mid-density tissue array, non-overlapping with either COC1501 or COC1503 75 cases/150 cores; 150 cores/75 cases
TMA-COC1503 Colon cancer mid-density tissue array, non-overlapping with either COC1501 or COC1502, 75 cases/150 cores; 150 cores/75 cases
TMA-COC2281 High density colon cancer tissue array, 228 cases/ 228 cores; 228 cores/228 cases
TMA-COC481 Colon cancer and normal tissue array, non-overlapping with COC482,16 cases/48 cores; 48 cores/16 cases
TMA-COC482 Colon cancer and normal tissue array, non-overlapping with COC481,16 cases/48 cores; 48 cores/16 cases
TMA-COC961 Colon cancer and normal tissue array, non-overlapping with COC962,48 cases/96 cores; 96 cores/48 cases
TMA-COC962 Colon cancer and normal tissue array, non-overlapping with COC961, 48 cases/96 cores; 96 cores/48 cases
TMA-LC2001 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 192 cases/ 200 cores; 200 cores/192 cases
TMA-T051 Colon cancer test tissue array, with normal colon tissues as control, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T052 Colon cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores; 24 cores/12 cases
TMA-T053 Colon cancer test tissue array, with normal colon tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T054 Colon tumor test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases/24 cores, replaced by T054a; 24 cores/12 cases
TMA-T054a Colon cancer tissue array with normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T054; 24 cores/12 cases
TMA-T055 Colon cancer test tissue array (4x (2x3) array),including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-BC05011 Multiple types of colon carcinoma tissue array, 72 cases/72 cores, replaced by CO804; 72 cores/72 cases
TMA-CO804 Multiple types of colon carcinoma tissue array (replacing BC05011), 80 cases/80 cores, replaced by CO804a; 80 cores/80 cases
TMA-CO991 Colorectal (colon and rectum) cancer with matched lymph node metastasis tissue array, 44 cases/99 cores, replaced by CO992.; 99 cores/44 cases
Rectum
TMA-BN06011 Normal rectum tissue (multi-sites) tissue array, 23 cases/63 cores; 63 cores/23 cases
TMA-BN06012 Normal rectum tissue (multi-sites) tissue array, 70 cases/72 cores; 72 cores/70 cases
TMA-BC06011 Rectum carcinoma (multi-tissue combined panel) tissue array, 71 cases/72 cores; 72 cores/71 cases
TMA-BC06022 Rectum carcinoma (combination of adjacent and normal) tissue array, 18 cases/54 cores, replaced by RE722; 54 cores/18 cases
TMA-BS06011 Rectum adenocarcinoma tissue array, 22 cases/63 cores; 63 cores/22 cases
TMA-BS06021 Rectum adenocarcinoma (grade I) tissue array, 21 cases/63 cores; 63 cores/21 cases
TMA-BS06031 Rectum adenocarcinoma (grade II) tissue array, 21 cases/63 cores, replaced by RE723; 63 cores/21 cases
TMA-BS06041 Rectum adenocarcinoma (grade III) tissue array, 21 cases/63 cores, replaced by RE724; 63 cores/21 cases
TMA-BC06002 Rectum disease spectrum (rectum cancer progression) tissue array, including TNM and pathology grade, 63 cases/72 cores; 72 cores/63 cases
TMA-RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases/102 cores; 102 cores/102 cases
TMA-RE1501 Rectum adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-RE1502 Rectum adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-RE1504 Rectum cancer tissue array with matched cancer adjacent tissue as control, including TNM, clinical stage and pathology grade, 50 cases/ 150 cores; 150 cores/50 cases
TMA-RE2001 Rectum cancer high-density (200 core) tissue array, 192 cases/208 cores; 200 cores/192 cases
TMA-RE2081 Rectum disease spectrum (rectal cancer progression) tissue array, 98 cases/208 cores; 208 cores/98 cases
TMA-RE2161 Rectum adenocarcinoma tissue array, including TNM and pathology grade, 216 cases/216 cores; 216 cores/216 cases
TMA-RE241 Rectal cancer test tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-RE242 Multiple rectal cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-RE481 Tissue array of rectal adenocarcinoma and matched adjacent tissue, 12 cases/48 cores; 48 cores/12 cases
TMA-RE482 Multiple rectal cancer tissue array with normal tissue, stage and grade data, 48 cases/48 cores; 48 cores/48 cases
TMA-RE483 Rectum adenocarcinoma tissue array with matched adjacent rectum tissue, including TNM and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-RE721 Normal rectum and cancer tissue array, 22 cases/72 cores; 72 cores/22 cases
TMA-RE722 Rectal cancer tissue array with matched adjacent normal tissue, including stage and grade info, 24 cases/72 cores, replacing BC06022; 72 cores/24 cases
TMA-RE723 Rectal adenocarcinoma (grade 2) tissue array, with stage, TNM and grade, 24 cases/72 cores, replacing BS06031; 72 cores/24 cases
TMA-RE724 Rectal adenocarcinoma (grade 3) tissue array, with stage, TNM and grade info, 24 cases/72 cores, replacing BS06041; 72 cores/24 cases
TMA-RE801 Rectal cancer tissue array, with matched adjacent normal tissue, 40 cases/80 cores; 80 cores/40 cases
TMA-RE802 Rectal normal adjacent tissue and cancer tissue array, 74 cases/80 cores; 80 cores/74 cases
TMA-RE803 Rectal cancer and normal tissue array, with TNM and grade info, 73 cases/80 cores; 80 cores/73 cases
TMA-RE804 Rectal disease spectrum (rectum cancer progression) tissue array, 75 cases/80 cores; 80 cores/75 cases
TMA-RE811 Rectal cancer tissue array with normal tissues from autopsy, with TNM and grade data, 80 cases/80 cores; 80 cores/80 cases
TMA-RE812 Rectal cancer tissue array with normal tissue from autopsy, 40 cases/80 cores, with grade and stage data; 80 cores/40 cases
TMA-RE961 Rectum adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-RE962 Rectum adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-REC1021 Rectal cancer tissue array, 102 cases/102 cores; 102 cores/102 cases
TMA-REC1501 Rectal cancer mid-density tissue array, non-overlapping with REC1502 or REC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-REC1502 Rectal cancer mid-density tissue array, non-overlapping with REC1501 or REC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-REC1503 Rectum cancer mid-density tissue array, non-overlapping with REC1501 or REC1502, 75 cases/150 cores; 150 cores/75 cases
TMA-REC2281 Rectum cancer high density tissue array, 228 cases/228 cores; 228 cores/228 cases
TMA-REC481 Rectum cancer and normal tissue array, 16 cases/48 cores; 48 cores/16 cases
TMA-REC961 Rectum cancer and normal tissue array, non-overlapping with REC962, 48 cases/96 cores; 96 cores/48 cases
TMA-REC962 Rectal cancer and normal tissue array, non-overlapping with REC961,48 cases/96 cores; 96 cores/48 cases
TMA-T061 Rectal cancer test tissue array, with normal rectal control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T063 Rectum cancer test tissue array, with normal rectum tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
Kidney
TMA-BN07011 Normal kidney tissue array (multi-sites), 20 cases/54 cores, replaced by BN07011a; 54 cores/20 cases
TMA-BN07012 Normal kidney tissue (multi-sites) tissue array, 70 cases/72 cores, replaced by KD803; 72 cores/70 cases
TMA-KIC241 Kidney cancer tissue array, 12 cases/24 cores; 24 cores/12 cases
TMA-KIC481 Kidney cancer and normal tissue array, 16 cases/48 cores; 48 cores/16 cases
TMA-KIC961 Kidney cancer and normal tissue array, non-overlapping with KIC962, 48 cases/96 cores; 96 cores/48 cases
TMA-KIC962 Kidney cancer and normal tissue array, non-overlapping with KIC961, 48 cases/96 cores; 96 cores/48 cases
TMA-BC07011 Kidney carcinoma (multi-tissue combined panel) tissue array, 23 cases/63 cores, replaced by BC07013; 63 cores/23 cases
TMA-BC07012 Kidney carcinoma (multi-tissue combined panel) tissue array, 72 cases/72 cores, replaced by BC07015; 72 cores/72 cases
TMA-BC07013 Kidney carcinoma (multi-tissue combined panel) tissue array, 23 cases/63 cores, replacing BC07011; 63 cores/23 cases
TMA-BC07014 Kidney carcinoma (multi-tissue combined panel) tissue array, 72 cases/72 cores; 72 cores/72 cases
TMA-BC07001 Kidney disease spectrum (kidney cancer progression) tissue array, including TNM and pathology grade, 40 cases/80 cores; 80 cores/40 cases
TMA-BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC07014; 72 cores/72 cases
TMA-BC07015 Multiple type kidney cancer tissue array with normal tissues, 71 cases/72 cores, replacing BC07012; 72 cores/71 cases
TMA-BC07114 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 100 cases/200 cores; 200 cores/100 cases
TMA-BC07115 Kidney clear cell carcinoma tissue array, including TNM and pathology grade, 120 cases/120 cores; 120 cores/120 cases
TMA-BN07011a Adjacent normal kidney tissue and cancer tissue array, including TNM, clinical stage and pathology grade, 20 cases/54 cores, replacing BN07011; 54 cores/20 cases
TMA-KD1001 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-KD1002 Kidney cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-KD1502 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-KD1503 Kidney cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores; 150 cores/50 cases
TMA-KD1504 Kidney cancer tissue array with matched cancer adjacent tissue as control, including TNM, stage and pathology grade, 50 cases/ 150 cores; 150 cores/50 cases
TMA-KD1921 Mid-advanced stage kidney cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-KD208 High density tissue array (70 cases/208 cores) of kidney cancer and normal tissue; 208 cores/70 cases
TMA-KD20810 Kidney cancer survey tissue array (1 of 3), with normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-KD20811 Kidney cancer survey tissue array (2 of 3), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-KD20812 Kidney cancer survey tissue array (3 of 3), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-KD2082 High density kidney cancer tissue array with normal tissues, with TNM and grade info, 104 cases/208 cores; 208 cores/104 cases
TMA-KD2083 Kidney cancer tissue array with normal tissues, with stage and grade info, 69 cases/208 cores; 208 cores/69 cases
TMA-KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases/208 cores; 208 cores/104 cases
TMA-KD2085 Kidney cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-KD2086 Kidney cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-KD2087 Kidney cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-KD2088 Kidney cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-KD2089 Kidney cancer survey tissue array (5 of 5), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-KD241 Kidney cancer test tissue array with matched cancer adjacent normal tissue, 6 cases/24 cores; 24 cores/6 cases
TMA-KD242 Multiple Kidney cancer test tissue array with unmatched normal adjacent tissue, 10 cases/24 cores; 24 cores/12 cases
TMA-KD243 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases/48 cores; 48 cores/24 cases
TMA-KD244 Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases/24 cores; 24 cores/12 cases
TMA-KD481 Tissue array of kidney clear cell carcinoma and matched adjacent tissue, with stage and grade data, 12 cases/48 cores; 48 cores/12 cases
TMA-KD482 Tissue array of kidney carcinoma and matched adjacent tissue, with stage and grade data, 24 cases/48 cores; 48 cores/24 cases
TMA-KD483 Multiple Kidney cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with stage and grade data; 48 cores/48 cases
TMA-KD484 Kidney cancer tissue array, including TNM and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-KD485 Kidney cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-KD486 Kidney clear cell carcinoma with matched adjacent kidney tissue array, including TNM and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-KD6161 High-density renal cancer array, with stage, grade and normal renal tissue, 322 cases/616 cores; 616 cores/322 cases
TMA-KD801 Kidney cancer tissue array, with matched adjacent normal tissue, 40 cases/80 cores; 80 cores/40 cases
TMA-KD802 Kidney multiple cancer tissue array (clear, granular and transitional cell carcinoma, etc), 80 cases/80 cores; 80 cores/80 cases
TMA-KD803 Normal kidney tissue array, replacing BN07012, 80 cases/80 cores; 80 cores/80 cases
TMA-KD804 Multiple types of kidney cancer and normal, adjacent normal tissue array, 80 cases/80 cores, with stage and grade information; 80 cores/80 cases
TMA-KD806 Advanced kidney cancer tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-KD807 Kidney disease spectrum (renal cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-KD808 Mid-advanced stage kidney cancer and metastatic carcinoma tissue array, including TNM and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-KD811 Kidney carcinoma and normal tissue array, with TNM, 40 cases/80 cores; 80 cores/40 cases
TMA-KD951 Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases/95 cores; 95 cores/32 cases
TMA-KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-KD962 Kidney cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-KD991 Kidney cancer tissue array with matched cancer adjacent and cancer adjacent normal tissue, 33 cases/99 cores; 99 cores/33 cases
TMA-KIC1501 Kidney cancer mid-density tissue array, non-overlapping with KIC1502, 75 cases/150 cores; 150 cores/75 cases
TMA-KIC1502 Kidney cancer mid-density tissue array, non-overlapping with KIC1501, 75 cases/150 cores; 150 cores/75 cases
TMA-T071 Kidney cancer test tissue array, with normal renal tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T072 Kidney cancer test tissue array, with normal tissue, TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T072a; 24 cores/12 cases
TMA-T072a Kidney cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T072; 24 cores/12 cases
TMA-T073 Kidney cancer test tissue array, with normal kidney tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T074 Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
Breast
TMA-BN08013 Normal breast tissue (multi-sites) array, 71 cases/72 cores, replaced by BRN801; 72 cores/71 cases
TMA-BR1502 Breast cancer mid-density tissue array, wiht AR/ER/PR/Her-2/P53/EGFR/Ki67 IHC results, 75 cases/150 cores, replaced by BR1503; 150 cores/75 cases
TMA-BR1503 Breast cancer tissue array, including TNM and pathology grade, 75 cases/150 cores, replaced by BR1503a; 150 cores/75 cases
TMA-BR962 Breast cancer array with normal and other non-malignant breast tissues, with AR, ER, PR, Her-2 (neu) IHC results, 48 cases/96 cores, replaced by BR963; 96 cores/48 cases
TMA-BRD181 Breast disease tissue array, 18 cases/18 cores; 18 cores/18 cases
TMA-HRC041 HER2 IHC control array, 4 cases/4 cores; 4 cores/4 cases
TMA-BRN801 Breast normal adjacent tissue (NAT) and cancer tissue array, 80 cases/80 cores, replaced by BRN801a; 80 cores/80 cases
TMA-BRN801a Breast adjacent normal tissue array with breast cancer tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing BRN801; 80 cores/80 cases
TMA-HER2 Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases/10 cores; 10 cores/10 cases
TMA-BC08013 Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases/63 coress, replaced by BC08013a; 63 cores/63 cases
TMA-BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases/63 cores, replaced by BR8018; 63 cores/63 cases
TMA-BC08015 Breast carcinoma (multi-tissue combined panel) tissue array, 22 cases/63 cores, replaced by BR728; 63 cores/22 cases
TMA-BC08016 Breast carcinoma (multi-tissue combined panel) tissue array, 63 cases/63 cores, replaced by BR803; 63 cores/63 cases
TMA-BC08022 Breast carcinoma (combination of adjacent and normal) tissue array, 53 cases/63 cores, replaced by BR721; 63 cores/53 cases
TMA-BC08023 Breast carcinoma (combination of adjacent and normal) tissue array, 57 cases/63 cores; 63 cores/58 cases
TMA-BC08032 Infiltrating duct carcinoma (combination of adjacent and normal) tissue array, 57 cases/63 cores; 63 cores/57 cases
TMA-BR2085a High-density (188 cases/208 cores), multiple types of breast cancer of infiltrating ductal, lobular carcinoma and normal breast tissue array, replaced by BR2085c.; 208 cores/188 cases
TMA-BR2085b High-density (188 cases/208 cores), multiple types of breast cancer tissue array of infiltrating ductal, lobular carcinoma and normal breast; 208 cores/188 cases
TMA-BS08011 Breast infiltrating ductal carcinoma tissue array, 22 cases/63 cores, replaced by BR727 ; 63 cores/22 cases
TMA-BB08015 Breast ductal intraepithelial neoplasia and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores; 48 cores/24 cases
TMA-BC08013a Breast cancer tissue array with cancer adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC08013; 72 cores/72 cases
TMA-BC081115 Breast cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases/110 cores, replaced by BC081120; 110 cores/110 cases
TMA-BC081116 Breast cancer (IDC) tissue array, with adjacent normal tissue, including TNM and pathology grade, 110 cases/110 cores, replaced by BC081116a; 110 cores/110 cases
TMA-BC081116a Breast cancer tissue array with adjacent normal breast tissue as control, including TNM, clinical stage and pathology grade, 110 cases/110 cores, replacing BC081116; 110 cores/110 cases
TMA-BC081120 Breast cancer and adjacent normal tissue array, including TNM and pathology grade, 110 cases/110 cores, replacing BC081115; 110 cores/110 cases
TMA-BC08118 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 100 cases/100 cores; 100 cores/100 cases
TMA-BN08111 Breast hyperplasia and normal tissue array, 10 cases/30 cores; 30 cores/10 cases
TMA-BR041 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases/4 cores, replaced by BR042a; 4 cores/4 cases
TMA-BR042a Breast cancer tissue array, including TNM and pathology grade, 4 cases/4 cores, replacing BR042; 4 cores/4 cases
TMA-BR082 Breast cancer tissue array with HER2 IHC control, including TNM and pathology grade, 4 cases/8 cores; 8 cores/4 cases
TMA-BR082a Breast cancer tissue array, including TNM and pathology grade, 4 cases/8 cores; 8 cores/4 cases
TMA-BR082b Breast cancer tissue array, including pathology grade, 4 cases/8 cores; 8 cores/4 cases
TMA-BR10010 Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases/100 cores, replaced by BR10010b; 100 cores/50 cases
TMA-BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases/100 cores, replacing BR10010; 100 cores/50 cases
TMA-BR10010b Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, 50 cases/100 cores, replacing BR10010; 100 cores/50 cases
TMA-BR1002 Tissue microarray of breast cancer and normal tissue, 97 cases /100 cores, with stage and grade information, replaced by BR1002a; 100 cores/97 cases
TMA-BR1002a Breast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 100 cases/ 100 cores, replacing BR1002; 100 cores/100 cases
TMA-BR1003 Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data; 101 cores/47 cases
TMA-BR1004 Tissue array of breast carcinoma and matched metastasis in lymph nodes tissue arrays, 50 cases/100 cores, replaced by BR10010; 100 cores/50 cases
TMA-BR1005 Breast cancer and matched metastatic carcinoma of lymph node, 50 cases/100 cores, no overlaps with BR1001 or BR1004, replaced by BR1005a; 100 cores/50 cases
TMA-BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing BR1005; 100 cores/50 cases
TMA-BR1006 Breast tumor tissue array of varieties and normal adjacent tissue (NAT), 50 cases/100 cores; 100 cores/50 cases
TMA-BR1007 Breast cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-BR1008 Breast cancer, carcinoma metastasize to lymph nodes and adjacent normal tissue array, including TNM and pathology grade, 100 cases/100 cores, replacing BC08212; 100 cores/100 cases
TMA-BR1009 Breast cancer tissue array for antibody screening , including TNM and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-BR1101 Breast cancer tissue array with lymph node positive and negative, including TNM, clinical stage and pathology grade, 98cases/ 110cores; 110 cores/98 cases
TMA-BR1503a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b; 150 cores/75 cases
TMA-BR1503b Breast cancer tissue array, including TNM, clinical stage and pathology grade, with IHC results of Her-2, ER, PR, p53, AR and Ki67, 75 cases/150 cores, replacing BR1503a; 150 cores/75 cases
TMA-BR1504 Breast invasive ductal carcinoma tissue array, including TNM, pathology grade and IHC markers (ER, PR, Her-2 and Ki67) results, 75 cases/150 cores; 150 cores/75 cases
TMA-BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases/150 cores, no overlaps with BR1503 or BR1504, replaced by BR15; 150 cores/75 cases
TMA-BR1505a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, replacing BR1505; 150 cores/75 cases
TMA-BR1921 High-density breast invasive ductal and lobular carcinoma tissue array with normal tissues, grade, staging data and IHC markers (PR, ER, Her-2),192 cases/192 cores, replaced by BR1921a; 192 cores/192 cases
TMA-BR1921a Breast cancer tissue array with cancer adjacent tissue as control, including TNM, clinical stage and pathology grade, 190 cases/ 192 cores, replacing BR1921; 192 cores/190 cases
TMA-BR1922 Late stage breast cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-BR201 Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 20 cases/ 20 cores; 20 cores/20 cases
TMA-BR208 High-density, multiple breast cancer (1-3 grade) and normal breast tissue array, 70 cases/208 cores, replaced by BR208b; 208 cores/70 cases
TMA-BR20810 Breast tumor survey tissue array (4 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20811 Breast tumor survey tissue array (5 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20812 Breast tumor survey tissue array (6 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20813 Breast tumor survey tissue array (7 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20814 Breast tumor survey tissue array (8 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20815 Breast tumor survey tissue array (9 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20816 Breast tumor survey tissue array (10 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20817 Breast tumor survey tissue array (11 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20818 Breast tumor survey tissue array (12 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20819 Breast tumor survey tissue array (13 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR2082 Breast disease spectrum (breast cancer progression) tissue array, 206 cases/208 cores; 208 cores/206 cases
TMA-BR20820 Breast tumor survey tissue array (14 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20821 Breast tumor survey tissue array (15 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20822 Breast tumor survey tissue array (16 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20823 Breast tumor survey tissue array (17 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20824 Breast tumor survey tissue array (18 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20825 Breast tumor survey tissue array (19 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20826 Breast tumor survey tissue array (20 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20827 Breast tumor survey tissue array (21 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20828 Breast tumor survey tissue array (22 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20829 Breast tumor survey tissue array (23 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR2083 High-density breast cancer tissue array with normal tissue, stage and grade info, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20830 Breast tumor survey tissue array (24 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20831 Breast tumor survey tissue array (25 of 25), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR20832 Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-BR20833 Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-BR20834 Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-BR20835 Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-BR20836 Breast tumor survey tissue array (5 of 5), with adjacent normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-BR2085c Breast cancer tissue array, with normal tissue and adjacent normal tissue, including TNM and pathology grade, 188 cases/208 cores, replacing BR2085a; 208 cores/188 cases
TMA-BR2086 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 208 cases/208 cores, replacing BR2001; 208 cores/208 cases
TMA-BR2087 Breast tumor survey tissue array (1 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR2088 Breast tumor survey tissue array (2 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR2089 Breast tumor survey tissue array (3 of 25), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-BR208b TMA block of high-density (70 cases/208 cores), multiple breast cancer (I-3 grade) and normal breast tissue, replacing BR208; 208 cores/70 cases
TMA-BR2161 Breast cancer tissue array, including TNM and pathology grade, 216 cases/216 cores; 216 cores/216 cases
TMA-BR241 Breast cancer test tissue array with self-matched or unmatched normal adjacent tissues, 6 cases/24 cores.; 24 cores/6 cases
TMA-BR2410 Breast invasive lobular carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores; 24 cores/24 cases
TMA-BR242 Multiple breast cancer test tissue array with unmatched normal adjacent tissues, 12 cases/24 cores, replaced by BR244; 24 cores/12 cases
TMA-BR243 Breast cancer and adjacent normal tissue array, 6 cases/24 cores, replacing BR241; 24 cores/6 cases
TMA-BR243a Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases/24 cores, replaced by BR243f; 24 cores/6 cases
TMA-BR243b Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 6 cases/24 cores, replacing BR243; 24 cores/6 cases
TMA-BR243c Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by BR243d; 24 cores/6 cases
TMA-BR243d Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing BR243c; 24 cores/6 cases
TMA-BR243e Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing BR243a; 24 cores/6 cases
TMA-BR243f Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing BR243a; 24 cores/6 cases
TMA-BR243i Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing BR243h; 24 cores/6 cases
TMA-BR243j Breast cancer tissue array with matched adjacent normal breast tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by BR243k; 24 cores/6 cases
TMA-BR243k Breast cancer tissue array with matched adjacent breast tissue as contral, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing BR243j; 24 cores/6 cases
TMA-BR244 Breast cancer tissue array with adjacent normal tissues, with TNM and grade info, 12 cases/24 cores, replaced by BR245; 24 cores/12 cases
TMA-BR245 Breast carcinoma tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by BR246; 24 cores/12 cases
TMA-BR246 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by BR246a; 24 cores/12 cases
TMA-BR246a Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 12 cases/24 cores, replacing BR246; 24 cores/12 cases
TMA-BR247 Breast cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases/48 cores, 2 sections/sllide; 48 cores/24 cases
TMA-BR248 Breast cancer tissue array, including TNM and pathology grade, 24cases/24 cores, replaced by BR248a; 24 cores/24 cases
TMA-BR248a Breast cancer tissue array with normal tissue as control, including TNM and pathology grade, 24 cases/ 24 cores, replacing BR248; 24 cores/24 cases
TMA-BR249 Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 24 cases/ 24 cores; 24 cores/24 cases
TMA-BR401 Breast mastitis tissue array, 20 cases/40 cores; 40 cores/20 cases
TMA-BR402 Breast mastitis tissue array, 20 cases/ 40 cores; 40 cores/20 cases
TMA-BR451 Breast cancer tissue microarray with matched normal adjacent tissue and metastatic lymph nodes, 45cases/45 cores, with ER, PR and P53 IHC results; 45 cores/45 cases
TMA-BR480 Breast disease spectrum tissue array - progression array, 48 cases/48 cores; 48 cores/48 cases
TMA-BR481 Breast infiltrating ductal carcinoma not otherwise specified (NOS) and matched adjacent, 12 cases/48 cores; 48 cores/12 cases
TMA-BR482 Multiple breast cancer tissue array with normal tissues from autopsy, 24 cases/48 cores, with stage and grade info; 48 cores/24 cases
TMA-BR483 Multiple breast cancer tissue array with normal tissues from autopsy, with TNM, 48 cases/48 cores, replaced by BR483b; 48 cores/48 cases
TMA-BR483b Breast cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing BR483; 48 cores/48 cases
TMA-BR484 Breast cancer tissue array, including TNM and pathology grade, 48 cases/48 cores, replaced by BR484a; 48 cores/48 cases
TMA-BR484a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replaced by BR484b; 48 cores/48 cases
TMA-BR484b Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/ 48 cores, replacing BR484a; 48 cores/48 cases
TMA-BR485 Breast cancer and normal tissue array, including TNM and pathology grade, 2 serial sections, 48 cases/96 cores; 96 cores/48 cases
TMA-BR486 Breast invasive ductal carcinoma tissue array with matched adjacent normal breast tissue, including TNM and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-BR487 Triple negative breast cancer tissue array, including TNM, clinical stage and pathology grade, majority cases with negative of ER, PR, Her-2 in IHC, 48 cases/ 48 cores; 48 cores/48 cases
TMA-BR601a Breast fibroadenoma tissue array, 30 cases/ 60 cores, replacing BR601; 60 cores/30 cases
TMA-BR6161 High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores; 616 cores/322 cases
TMA-BR641 Breast invasive ductal carcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores; 64 cores/64 cases
TMA-BR642 Breast invasive lobular carcinoma tissue array, including TNM, clinical stage and pathology grade, 64 cases/ 64 cores; 64 cores/64 cases
TMA-BR701 Breast cancer tissue array, 70 cases/70 cores, with TNM data plus ER, PR and Her-2 (C-erbB-2, neu) IHC results, replaced by BR962; 70 cores/70 cases
TMA-BR721 Breast cancer tissue array with self-matching adjacent tissue and normal tissue, 24 cases/72 cores, replacing BC08022; 72 cores/24 cases
TMA-BR722 Breast disease spectrum tissue array, 66 cases/72 cores, including normal, precancerous and cancer in different stages; 72 cores/66 cases
TMA-BR723 Breast various pathology developmental process tissue array, including TNM and pathology grade, 71 cases/72 cores; 72 cores/71 cases
TMA-BR724 Breast cancer, adjacent and adjacent normal tissue array, 66 cases/72 cores; 72 cores/66 cases
TMA-BR725 Breast cancer, adjacent and adjacent normal tissue array, 68 cases/72 cores; 72 cores/68 cases
TMA-BR726 Breast cancer tissue array and normal tissue array, with TNM and grade, 24 cases/72 cores; 72 cores/24 cases
TMA-BR727 Breast cancer and normal tissue array, with TNM, stage and grade info, 24 cases/72 cores, replacing BS08011; 72 cores/24 cases
TMA-BR728 Breast carcinoma tissue array, with stage and grade info, 24 cases/72 cores, replacing BC08015; 72 cores/24 cases
TMA-BR801 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases/80 cores, replaced by BR804; 80 cores/40 cases
TMA-BR8010 Breast fibroadenoma tissue array (including normal, lobular, invasive carcinoma and metastasis in lymph nodes), 71 cases/80 cores; 80 cores/71 cases
TMA-BR8011 Breast intraductal carcinoma tissue microarray with normal adjacent tissue, 80 cases/80 cores; 80 cores/80 cases
TMA-BR8012 Breast cancer and normal tissue array with stage and grade info, 40 cases/80 cores, replaced by BR8014; 80 cores/40 cases
TMA-BR8013 Advanced breast cancer and normal tissue array, with stage, TNM and pathology grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-BR8014 Breast cancer and normal tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replacing BR8012; 80 cores/40 cases
TMA-BR8015 Breast cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases/80 cores, replacing BC08014; 80 cores/80 cases
TMA-BR8016 Middle-advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-BR8017 Middle-advanced stage breast cancer tissue array, with metastasis tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-BR8018 Breast invasive ductal carcinoma tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing BR808, BC08014; 80 cores/80 cases
TMA-BR802 Breast cancer tissue array, with matched or unmatched adjacent normal tissue array, 40 cases/80 cores, no overlaps with BR801, BR803 and BR1001, replaced by BR802b; 80 cores/40 cases
TMA-BR802b Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including TNM and pathology grade, 47cases/80cores, replacing BR802; 80 cores/47 cases
TMA-BR803 Breast carcinoma (multi-tissue combined panel) tissue array, 79 cases/80 cores, replaced by BR803a; 80 cores/79 cases
TMA-BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing BR803; 80 cores/80 cases
TMA-BR804 Breast tumor tissue array, with matched tumor and adjacent normal tissue, 40 cases/80 cores, replaced by BR804a; 80 cores/40 cases
TMA-BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replacing BR804; 80 cores/40 cases
TMA-BR805 Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-BR806 Breast hyperplasia tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-BR807 Medullary carcinoma of breast tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-BR808 Tissue array of multiple types of breast cancer and normal breast tissue, 80 cases/80 cores, replaced by BR8018; 80 cores/80 cases
TMA-BR809 Breast invasive lobular carcinoma tissue array with adjacent normal tissue, 79 cases/80 cores; 80 cores/79 cases
TMA-BR812 Breast cancer tissue array with normal tissues from autopsy, 40 cases/80 cores, with TNM data; 80 cores/40 cases
TMA-BR951 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER/PR/p53 IHC results and survival data, 31 cases/95 cores, replaced by BR952; 95 cores/31 cases
TMA-BR952 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER/PR/p53 IHC results and survival data, 31 cases/95 cores; 95 cores/31 cases
TMA-BR953 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER/PR/p53 IHC results and survival data, 31 cases/95 cores, replaced by BR954; 95 cores/31 cases
TMA-BR954 Breast cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and ER/PR/p53 IHC results and survival data, 31 cases/95 cores, replacing BR953; 95 cores/31 cases
TMA-BR963 Breast disease spectrum tissue array, including TNM and pathology grade, stage, TNM and IHC markers (AR, PR, ER, Her-2, Ki67, CK14 and p53), 48 cases/96 cores, replaced by BR963a; 96 cores/48 cases
TMA-BR963a Breast disease spectrum tissue array, including TNM, clinical stage, pathology grade and IHC markers (PR, ER, Her-2), 48 cases/96 cores, replacing BR963; 96 cores/48 cases
TMA-BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-BR965 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 49 cases/96 cores; 96 cores/49 cases
TMA-BRC1021 Breast cancer tissue array, 102 cases/102 cores; 102 cores/102 cases
TMA-BRC1501 Breast cancer mid-density tissue array, non-overlapping with either BRC1502 or BRC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-BRC1502 Breast cancer mid-density tissue array, non-overlapping with either BRC1501 or BRC1503, 75 cases/150 cores; 150 cores/75 cases
TMA-BRC1503 Breast cancer mid-density tissue array, non-overlapping with BRC1501 or BRC1502, 75 cases/150 cores; 150 cores/75 cases
TMA-BRC2281 High density breast cancer tissue array, 228 cases/228 cores; 228 cores/228 cases
TMA-BRC481 Breast cancer and normal tissue array, 16 cases/48 cores; 48 cores/16 cases
TMA-BRC491 Human breast invasive ductal carcinoma (IDC) tissue array, non-overlapping with BRC711, 49 cases/49 cores; 49 cores/49 cases
TMA-BRC51 Breast cancer tissue array BLOCK, Her-2 IHC marker; 5 cores/5 cases
TMA-BRC711 Human breast invasive ductal cancer tissue array, non-overlapping with BRC491, 71 cases/72 cores; 71 cores/71 cases
TMA-BRC961 Breast cancer array with normal and other non-malignant breast tissues, non-overlapping with BRC962, with AR/ER/PR/Her-2(neu) IHC results, 48 cases/96 cores; 96 cores/48 cases
TMA-BRC962 Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases/96 cores; 96 cores/48 cases
TMA-BRM481 Tissue array of breast carcinoma metastasis in lymph nodes, 24 cases/48 cores; 48 cores/24 cases
TMA-BRM961 Breast cancer tissue array containing primary and matched metastatic tumors (in lymph nodes) and adjacent normal breast tissue, 48 casea/96 cores; 96 cores/48 cases
TMA-BRM961a Breast cancer, matched metastatic carcinoma and cancer adjacent normal breast tissue array, including TNM, clinical stage and pathology grade, 48 cases/ 96 cores,; 96 cores/48 cases
TMA-ERC031 Estrogen receptor (ER) IHC control array, 3 cases/3 cores; 3 cores/3 cases
TMA-PM2-ER ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER/Ki67/PR/Her-2, 10 cases/10 cores; 11 cores/11 cases
TMA-PM2-PR PR Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer, 11 cases/11 cores; 11 cores/11 cases
TMA-T081 Breast cancer test tissue array, with normal breast tissues as control, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by T085; 24 cores/6 cases
TMA-T082 Breast cancer test tissue array, with normal tissue as control, including TNM, stage and grade, 12 cases/24 cores, replaced by T084; 24 cores/12 cases
TMA-T083 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replaced by T087; 24 cores/6 cases
TMA-T084 Breast cancer test tissue array, with normal control tissue, with TNM, Grade and Stage, 12 cases/24 cores, replaced by T086a; 24 cores/12 cases
TMA-T085 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by T088; 24 cores/6 cases
TMA-T086 Breast cancer test tissue array, with normal tissue, including TNM and pathology grade, 12 cases/24 cores, replacing T084, replaced by T086a; 24 cores/12 cases
TMA-T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases/24 cores, replaced by T086b; 24 cores/12 cases
TMA-T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T086c; 24 cores/12 cases
TMA-T086c Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T086b; 24 cores/12 cases
TMA-T087 Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replaced by T087a; 24 cores/6 cases
TMA-T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replaced by T087b; 24 cores/6 cases
TMA-T087b Breast cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replacing T087a; 24 cores/6 cases
TMA-T088 Breast cancer tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases/24 cores, replaced by T088a; 24 cores/6 cases
TMA-T088a Breast cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing T088; 24 cores/6 cases
TMA-T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-BR1001 Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004; 100 cores/50 cases
TMA-BR2001 Breast cancer high-density tissue array, 196 cases/200 cores, replaced by BR2086; 200 cores/196 cases
TMA-BR811 Breast cancer tissue array with normal tissues from autopsy, 80 cases/80 cores, with grade and stage data; 80 cores/80 cases
TMA-BR601 Breast fibroma and sclerosing adenosis tissue microarray, 30 cases/60 cores, replaced by BR601a; 60 cores/30 cases
Endometrium
TMA-EMC1501 Endometrial cancer mid-density tissue array, non-overlapping with EMC1502, 75 cases/150 cores; 150 cores/75 cases
TMA-EMC1021 Endometrial cancer tissue array, 102 caese/102 cores; 102 cores/102 cases
TMA-EMC1502 Endometrial cancer mid-density tissue array, non-overlapping with EMC1501, 75 caese/150 cores; 150 cores/75 cases
TMA-EMC241 Endometrium cancer tissue array, 12 cases/24 cores; 24 cores/12 cases
TMA-EMC961 Endometrial cancer and normal tissue array, non-overlapping with EMC962, 48 cases/96 cores; 96 cores/48 cases
TMA-BC09012 Endometrial carcinoma (multi-tissue combined panel) tissue array, 63 cases/63 cores, replaced by BC09012a; 63 cores/63 cases
TMA-BC09012a Endometrial carcinoma tissue array, clinical stage and pathology grade, 63 cases/ 63 cores, replacing BC09012; 63 cores/63 cases
TMA-BS09011 Uteral leiomyoma (hysteromyoma) tissue array, 30 cases/60 cores; 60 cores/30 cases
TMA-EM1021 Endometrium cancer and normal tissue array, including TNM and pathology grade, 102 cases/102 cores; 102 cores/102 cases
TMA-EMC962 Endometrial cancer and normal tissue array, non-overlapping with EMC961,48 cases/96 cores; 96 cores/48 cases
TMA-T091 Endometrial cancer test tissue array, with normal endometriual tissue as control, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T092 Endometrium cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T094; 24 cores/12 cases
TMA-T093 Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T094 Endometrium cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12cases/ 24cores, replacing T092; 24 cores/12 cases
TMA-T095 Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-UT1001 Endometrial cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-UT1002 Endometrium cancer tissue array for antibody screening, including TNM and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-UT240 Endometrioid adenocarcinoma and hyperplasia tissue array with adjacent tissue as control, including TNM, clinical stage and pathology grade, 24 cases/24 cores; 24 cores/24 cases
TMA-UT241 Uterine endometrial cancer tissue array with normal tissue from autopsy, 12 cases/24 cores, with TNM data; 24 cores/12 cases
TMA-UT242 Endometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores; 48 cores/24 cases
TMA-UT242a Endometrium cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases/24 cores; 24 cores/24 cases
TMA-UT243 Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by UT243a; 24 cores/12 cases
TMA-UT243a Endometrium cancer tissue array with matched adjacent endometrium tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing UT243; 24 cores/12 cases
TMA-UT244 Choriocarcinoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores; 24 cores/12 cases
TMA-UT481 Endometrium cancer tissue array, including TNM and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-UT501 Endometrioid adenocarcinoma and normal tissue array with TNM and grade, 50 cases/50 cores; 50 cores/50 cases
TMA-UT721 Endometrioid adenocarcinoma and normal tissue array with clinical stage and grade information, 24 cases/72 cores; 72 cores/24 cases
TMA-UT801 Endometrial disease spectrum (endometrial cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-UT803 Endometrioid carcinoma, adjacent and normal tissue array, with grade and stage information, 40 cases/80 cores; 80 cores/40 cases
TMA-UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-UTN801 Endometrium tissue array, including TNM, clinical stage and pathology grade, 79 cases/80 cores; 80 cores/79 cases
Uterus
TMA-BC10021 Cervix carcinoma (combination of margin and normal tissues) tissue array, 64 cases/72 cores; 72 cores/64 cases
TMA-BB10011 Cervical intraepithelial neoplasia and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores; 48 cores/24 cases
TMA-BC10025 Cervical cancer and normal tissue array, 54 cases/54 cores; 54 cores/54 cases
TMA-CIN481 Cervical intraepithelial neoplasia tissue array with cervical disease spectrum, 48 cases/48 cores (*SEE NOTE in description); 48 cores/48 cases
TMA-CR1001 Multiple uterine carcinoma tissue array with normal tissue, 49 cases/100 cores; 100 cores/49 cases
TMA-CR1002 Cervix carcinoma for antibody screening array, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-CR1003 Cervix cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-CR1921 Middle-advanced stage uterine cervix cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-CR208 Cervical cancer high density tissue array, with normal cervix tissue as control, 69 cases/208 cores, with grade and stage; 208 cores/69 cases
TMA-CR2081 High-density cervix cancer tissue array with normal tissues, with stage and grade info, 104 cases/208 cores; 208 cores/104 cases
TMA-CR2082 High-density cervical cancer tissue array with normal tissues, with stage and grade info, 69 cases/208 cores; 208 cores/69 cases
TMA-CR2083 Uterine cervical cancer and cancer adjacent normal tissue survey tissue array (1 of 5), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-CR2084 Cervical cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-CR2085 Cervix cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-CR2086 Cervix tumor tissue array (4 of 5), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-CR2087 Uterine cervical cancer tissue survey tissue array (5 of 5), including TNM and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-CR2088 Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-CR2089 Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-CR241 Cervix cancer test tissue array with self-matching or unmatched normal adjacent tissue, 11 cases/24 cores; 24 cores/11 cases
TMA-CR242 Multiple cervix cancer test tissue array with self-matching or unmatched normal adjacent tissues, 22 cases/24 cores; 24 cores/12 cases
TMA-CR243 Uterine cervix cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases/48 cores, 2 sections/slide; 48 cores/24 cases
TMA-CR244 Uterine cervix cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases/24 cores, replacing CR241; 24 cores/12 cases
TMA-CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by CR245a; 24 cores/12 cases
TMA-CR245a Cervix cancer tissue array with matched adjacent cervix tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores,replacing CR245; 24 cores/12 cases
TMA-CR481 Cervical cancer tissue array with normal adjacent tissues, 24 cases/48 cores, with grade and stage data; 48 cores/24 cases
TMA-CR482 Multiple cervix cancer tissue array with 4 normal tissues control from autopsy, 24 cases/48 cores, with grade and stage data; 48 cores/24 cases
TMA-CR483 Multiple cervix cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with TNM data; 48 cores/48 cases
TMA-CR484 Cervix squamous cell carcinoma tissue array with matched adjacent cervix tissue, including TNM and pathology grade, 16 cases/48 cores; 48 cores/16 cases
TMA-CR485 Cervix cancer and adjacent normal tissue array, including TNM and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-CR501 Cervical cancer and normal tissue array with TNM and grade, 50 cases/50 cores; 50 cores/50 cases
TMA-CR601 Cervical carcinoma tissue array with cervical disease spectrum (normal, inflammation, CIN, malignant I-III), 59 cases/60 cores, replaced by CR602; 60 cores/59 cases
TMA-CR602 Tissue array of uterine cervical disease spectrum (cervical cancer, CIN, inflammation and adjacent normal tissue), 60 cases/60 cores, replacing CR601; 60 cores/60 cases
TMA-CR6161 High-density uterine cervix cancer array, with stage, grade and normal cervical tissue, 322 cases/616 cores; 616 cores/322 cases
TMA-CR701 Cervical carcinoma, adjacent tissue and adjacent normal tissue array, including TNM and pathology grade, 70 cases/70 cores; 70 cores/70 cases
TMA-CR721 Uterine cervix cancer and normal tissue array, with grade and stage data, 24 cases/72 cores; 72 cores/24 cases
TMA-CR802 Cervical cancer tissue array, matched or unmatched tumor and adjacent normal tissue, 74 cases/80 cores; 80 cores/74 cases
TMA-CR803 Multiple (uterine cervix) cervical squamous cancer tissue array, 80 cases/80 cores, replacing BS10011; 80 cores/80 cases
TMA-CR804 Cervical cancer and normal tissue array with TNM and grade, 40 cases/80 cores; 80 cores/40 cases
TMA-CR805 Cervix cancer and normal tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-CR806 Mid-advanced stage uterine cervix cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-CR811 Cervical cancer tissue array with normal tissues from autopsy, 40 cases/80 cores, with grade and TNM data; 80 cores/40 cases
TMA-CXC1021 Cervix cancer tissue array, 102 cases/102 cores; 102 cores/102 cases
TMA-CXC1501 Cervical cancer mid-density tissue array, 75 cases/150 cores; 150 cores/75 cases
TMA-CXC241 Cervical cancer tissue array, 12 cases/24 cores; 24 cores/12 cases
TMA-CXC481 Cervix cancer and normal tissue array, 16 cases/48 cores; 48 cores/16 cases
TMA-CXC961 Cervical cancer and normal tissue array, non-overlapping with CXC962, 48 cases/96 cores; 96 cores/48 cases
TMA-CXC962 Cervical cancer and normal tissue array, non-overlapping with CXC961, 48 cases/96 cores; 96 cores/48 cases
TMA-T101 Cervix cancer test tissue array, with normal cervix control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T102 Cervix cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T102a; 24 cores/12 cases
TMA-T102a Cervix cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T102; 24 cores/12 cases
TMA-T103 Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-UT802 Uteral cancer (multi-types of uterine carcinomas and diseases) tissue array, 80 cases/80 cores; 80 cores/80 cases
Ovary
TMA-BC11011 Ovarian carcinoma (multi-tissue combined panel) tissue array (replaced by OV802), 70 cases/72 cores; 72 cores/70 cases
TMA-BC11012 Ovarian carcinoma (multi-tissue combined panel) tissue array, 70 cases/72 cores, replaced by BC11012a; 72 cores/72 cases
TMA-OV802 Multiple ovarian carcinoma and normal tissue array, with stage and TNM info, 78 cases/80 cores, replacing BC11011; 80 cores/78 cases
TMA-OV806 Normal ovarian tissue array, 30 cases/60 cores; 60 cores/30 cases
TMA-BC110118 Ovarian cancer tissue array, including TNM and pathology grade, 72 cases/72 cores, replacing BC11012; 72 cores/72 cases
TMA-BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases/72 cores, replacing BC11012; 72 cores/72 cases
TMA-BC111109 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases/70 cores; 70 cores/70 cases
TMA-BC111110 Ovary cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 70 cases/70 cores, replaced by OV701; 70 cores/70 cases
TMA-BC11115 Ovary serous papillary adenocarcinoma, lymph node metastasis with adjacent normal ovary tissue array, including TNM and pathology grade, 100 cases/100 cores; 100 cores/100 cases
TMA-OV1001 Ovarian disease spectrum (ovarian cancer progression) tissue array, 100 cases/100 cores, replaced by OV1005; 100 cores/100 cases
TMA-OV1002 Ovarian cancer (multiple types) tissue array, 100 cases/100 cores; 100 cores/100 cases
TMA-OV1003 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-OV1004 Ovarian cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-OV1005 Ovarian disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases/100 cores, replaced by OV1005a; 100 cores/100 cases
TMA-OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases/100 cores, replacing OV1005; 100 cores/100 cases
TMA-OV1501 Ovarian cancer tissue array, with TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-OV1502 Ovary adenocarcinoma tissue array, including TNM and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-OV1921 Late stage ovarian tumor tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-OV2001 Ovarian cancer high-density (200 cases/200 cores) tissue array; 200 cores/200 cases
TMA-OV208 Ovarian cancer and normal tissue high density (69 cases/208 cores) tissue microarray, with grade and stage data; 208 cores/69 cases
TMA-OV20810 Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-OV20811 Ovary cancer tissue array (2 of 4), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-OV20812 Ovary cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-OV20813 Ovary cancer tissue array (4 of 4), including TNM and pathology grade, 208 cases/208 cores; 208 cores/208 cases
TMA-OV20814 Ovary adenocarcinoma tissue array, including TNM and pathology grade, 208 cases/208 cores, replacing OV2084; 208 cores/208 cases
TMA-OV2082 Ovary cancer tissue array with normal tissues, with TNM and grade info, 104 cases/208 cores; 208 cores/104 cases
TMA-OV2083 High-density ovarian cancer tissue array with normal tissues, with stage and grade info, 69 cases/208 cores; 208 cores/69 cases
TMA-OV2084 Ovarian cancer tissue array with normal adjacent ovary, TNM, clinical stage and pathology grade, 208 cases/208 cores, replaced by OV20814; 208 cores/208 cases
TMA-OV2085 Ovary cancer survey tissue array (1 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-OV2086 Ovary cancer survey tissue array (2 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-OV2087 Ovary cancer survey tissue array (3 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-OV2088 Ovary cancer survey tissue array (4 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-OV2089 Ovary cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-OV2161 Ovary adenocarcinoma tissue array, including TNM and pathology grade, 216 cases/216 cores; 216 cores/216 cases
TMA-OV241 Ovarian cancer test tissue array with self-matching or unmatched normal adjacent tissues, 10 cases/24 cores, replaced by OV241a; 24 cores/10 cases
TMA-OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing OV241; 24 cores/12 cases
TMA-OV242 Multiple ovarian cancer test tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-OV243 Ovary cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores; 48 cores/24 cases
TMA-OV481 Ovarian cancer tissue array with unmatched normal adjacent tissues, 24 cases/48 cores, with stage and grade data; 48 cores/24 cases
TMA-OV482 Multiple ovarian cancer tissue array with 4 normal tissues control from autopsy, (24 cases/48 cores) with grade and stage info; 48 cores/24 cases
TMA-OV483 Multiple ovarian cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with stage and grade info; 48 cores/48 cases
TMA-OV484 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-OV485 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 2 serial sections, 48 cases/96 cores; 96 cores/48 cases
TMA-OV602 Tissue array of ovarian granulosa-theca cell tumor (GTCT, malignant and benign) and cysts, 60 cases/60 cores; 60 cores/60 cases
TMA-OV603 Ovarian serous cystadenoma tissue array, 30 cases/60 cores, replaced by OV603a; 60 cores/30 cases
TMA-OV603a Ovarian serous cystadenoma tissue array with normal tissue as control, 30 cases/60 cores, replacing OV603; 60 cores/30 cases
TMA-OV6161 High-density ovarian cancer array, with stage and grade information, 322 cases/616 cores; 616 cores/322 cases
TMA-OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases/70 cores, replacing BC111110; 70 cores/70 cases
TMA-OV702a Ovary cancer tissue array with adjacent normal tissue as control, including TNM and pathology grade, 70 cases/70 cores; 70 cores/70 cases
TMA-OV721 Ovary cancer and normal tissue array, with grade and stage data, 24 cases/72 cores; 72 cores/24 cases
TMA-OV801 Ovarian cancer tissue array, with matched or unmatched adjacent normal tissue, 70 cases/80 cores; 80 cores/70 cases
TMA-OV8010 Mid-advanced stage ovary cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-OV8011 Ovarian epithelial cancer tissue array with cancer adjacent tissue as control, including TNM, stage and pathology grade, 80 cases/ 80 cores; 80 cores/80 cases
TMA-OV803 Ovarian adenocarcinoma tissue array, 80 cases/80 cores, replaced by OV803a; 80 cores/80 cases
TMA-OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing OV803; 80 cores/80 cases
TMA-OV804 Ovarian metastatic carcinoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-OV805 Ovarian teratoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-OV807 Ovarian cancer tissue array with normal tissue, grade and TNM data, 40 cases/80 cores; 80 cores/40 cases
TMA-OV808 Ovarian cancer metastasis tissue array, 40 cases/80 cores; 80 cores/40 cases
TMA-OV809 Ovary cancer and normal tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-OV811 Ovarian cancer tissue array with normal tissues from autopsy, 35 cases/80 cores, with stage and grade data; 80 cores/40 cases
TMA-OV951 Ovary cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage and survival data, 38 cases/95 cores,; 95 cores/38 cases
TMA-OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-OV962 Ovarian cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-OVC1021 Ovary cancer tissue array, 102 cases/102 cores; 102 cores/102 cases
TMA-OVC1501 Ovarian cancer mid-density tissue array, 75 cases/150 cores; 150 cores/75 cases
TMA-OVC2281 Hidensity ovarian cancer tissue array containing 8 cases of normal/benign conditions and 220 cases of cancers with grading and TNM staging data, 228 cases/228 cores; 228 cores/228 cases
TMA-OVC241 Ovary cancer tissue array, 12 cases/24 cores; 24 cores/12 cases
TMA-OVC961 Ovarian cancer and normal tissue array, non-overlapping with OVC962, 48 cases/96 cores; 96 cores/48 cases
TMA-OVC962 Ovarian cancer and normal tissue array, non-overlapping with OVC961, 48 cases/96 cores; 96 cores/48 cases
TMA-T111 Ovary cancer test tissue array, with normal ovary control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T112 Ovary cancer test tissue array, with normal control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T112a; 24 cores/12 cases
TMA-T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T112; 24 cores/12 cases
TMA-T113 Ovarian cancer test tissue array, with normal ovary tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T113a Ovary cancer test tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replacing T113; 24 cores/6 cases
TMA-T114 Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
Bladder
TMA-BC12012 Bladder carcinoma (multi-tissue combined panel) tissue array, 63 cases/63 cores, replaced by BL802; 63 cores/63 cases
TMA-BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases/63 cores, replacing BC12011; 63 cores/63 cases
TMA-BL1001 Bladder cancer tissue array for antibody screening, including TNM, clinical stage and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-BL1002 Bladder cancer and normal tissue array, including TNM and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores; 150 cores/75 cases
TMA-BL1921 Mid-advanced stage bladder cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-BL208 Tissue microarray of bladder cancer and normal tissue, high density (69 cases/208 cores) with grade and stage data; 208 cores/69 cases
TMA-BL2081 Bladder cancer high density tissue array, 203 cases/208 cores; 208 cores/203 cases
TMA-BL2082 Bladder disease spectrum (bladder cancer progression) tissue array, 202 cases/208 cores; 208 cores/202 cases
TMA-BL241 Bladder cancer tissue array with self-matching normal adjacent tissues, 10 cases/24 cores; 24 cores/10 cases
TMA-BL242 Bladder cancer tissue array, with normal tissue, including TNM and pathology grade, 24 cases/48 cores; 48 cores/24 cases
TMA-BL243 Bladder cancer tissue array with normal tissues from autopsy, 12 cases/24 cores with stage and grade data; 24 cores/12 cases
TMA-BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores; 24 cores/12 cases
TMA-BL481 Bladder cancer tissue array with unmatched normal adjacent tissues, 48 cases/48 cores, with stage and grade data; 48 cores/48 cases
TMA-BL482 Bladder cancer tissue array, including TNM and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-BL801 Bladder cancer tissue array, with adjacent normal tissue, pathology grade and TNM stage, 53 cases/80 cores, replaced by BL806; 80 cores/53 cases
TMA-BL802 Bladder cancer tissue array with normal tissue, 80 cases/80 cores, replacing BC12012; 80 cores/80 cases
TMA-BL803 Bladder cancer and normal tissue array with TNM and grade data, 40 cases/80 cores; 80 cores/40 cases
TMA-BL804 Bladder disease spectrum (urocystic cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-BL805 Mid-advanced stage bladder cancer tissue array, with metastasis tissue, including TNM and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-BL806 Bladder cancer tissue array, with matched adjacent normal tissue (NAT), including TNM and pathology grade, 80 cases/80 cores, replacing BL801; 80 cores/80 cases
TMA-BLC1501 Bladder cancer mid-density tissue array, 75 cases/150 cores; 150 cores/75 cases
TMA-BLC241 Bladder cancer tissue array, 12 cases/24 cores; 24 cores/12 cases
TMA-BLC661 Bladder cancer tissue array, 33 cases/66 cores; 66 cores/33 cases
TMA-BNC12011 Normal bladder tissue array, including TNM, clinical stage and pathology grade, 40 cases/ 80 cores; 80 cores/40 cases
TMA-T121 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by T121a; 24 cores/6 cases
TMA-T121a Bladder cancer test tissue array, with normal bladder control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing T121; 24 cores/6 cases
TMA-T122 Bladder cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T124; 24 cores/12 cases
TMA-T123 Bladder cancer test tissue array, with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T124a; 24 cores/12 cases
TMA-T124a Bladder cancer tissue array with normal bladder tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T124; 24 cores/12 cases
TMA-T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
Pancreas
TMA-PA721 Pancreatic cancer (multi-tissue combined panel), 24 cases/72 cores, replacing BC14012; 72 cores/24 cases
TMA-BC14012 Pancreatic cancer (multi-tissue combined panel), 24 cases/63 cores, replaced by PA721; 63 cores/24 cases
TMA-BBS14011 Pancreatitis tissue array, 48 cases/48 cores; 48 cores/48 cases
TMA-BIC14011 Pancreas intraepithelial neoplasia, pancreatitis and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores; 48 cores/24 cases
TMA-PA1001 Multiple pancreatic cancer tissue array with unmatched normal adjacent tissues, with TNM data, 50 cases/100 cores; 100 cores/50 cases
TMA-PA1002 Pancreas cancer tissue array for antibody screening, with normal tissue, including TNM and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-PA1003 Pancreas cancer tissue array for antibody screening, including TNM and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-PA1921 Mid-advanced stage pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-PA207 High-density (69 cases/207 cores), multiple pancreatic cancer (1-3 grade) and normal pancreatic tissue array, replaced by PA2072; 207 cores/69 cases
TMA-PA2072 Pancreatic cancer tissue array, with normal tissue, including TNM and pathology grade, 69 cases/207 cores, replacing PA207; 207 cores/69 cases
TMA-PA207b High-density (69 cases/207 cores), multiple pancreatic cancer (I-4 grade) and normal pancreatic tissue array block; 207 cores/69 cases
TMA-PA2081 Pancreatic disease spectrum (pancreatic cancer progression) tissue array with pathology grade and TNM information, 101 cases/208 cores, replaced by PA2081a; 208 cores/101 cases
TMA-PA2081a Pancreas disease spectrum (pancreatic cancer progression) tissue array, including TNM, clinical stage and pathology grade, 103 cases/208 cores, replacing PA2081; 208 cores/103 cases
TMA-PA2082 High-density pancreatic cancer and normal tissue array, with stage and grade info, 101 cases/208 cores; 208 cores/101 cases
TMA-PA241 Pancreatic cancer test tissue array with self-matching normal adjacent tissue, 6 cases/24 cores, replaced by PA241b; 24 cores/6 cases
TMA-PA241b Pancreas adenocarcinoma tissue array with matched adjacent normal pancreas tissue, including TNM and pathology grade, 6 cases/24 cores, replacing PA241; 24 cores/6 cases
TMA-PA242 Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, 12 cases/24 cores, replaced by PA242a; 24 cores/12 cases
TMA-PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing PA242; 24 cores/12 cases
TMA-PA243 Pancreas cancer tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 24 cases/48 cores; 48 cores/24 cases
TMA-PA481 Multiple pancreatic cancer with 4 normal tissues control from autopsy, 24 cases/48 cores, with grade and stage; 48 cores/24 cases
TMA-PA482 Multiple pancreatic cancer tissue array with 4 normal tissue control from autopsy, 24 cases/48 cores, with TNM data; 48 cores/24 cases
TMA-PA483 Multiple pancreatic cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with grade and stage data, replaced by PA483b; 48 cores/48 cases
TMA-PA483a Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases/48 cores, replacing PA483; 48 cores/48 cases
TMA-PA483b Pancreas cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing PA483; 48 cores/48 cases
TMA-PA484 Pancreas adenocarcinoma tissue array, including TNM and pathology grade, 24 cases/48 cores; 48 cores/24 cases
TMA-PA485 Pancreatitis and matched pancreatic cancer tissue array, including TNM, clinical stage and pathology grade, 43 cases/48 cores; 48 cores/43 cases
TMA-PA722 Pancreatic cancer and normal tissue array, with TNM and pathology grade, 24 cases/72 cores; 72 cores/24 cases
TMA-PA801 Multiple pancreatic cancer tissue array with unmatched normal adjacent tissue, with stage and grade info, 70 cases/80 cores, replaced by PA802; 80 cores/70 cases
TMA-PA802 Multiple pancreatic cancer tissue array with unmatched normal tissues, with TNM data, 78 cases/80 cores, replacing PA801, to be replaced by PA805; 80 cores/78 cases
TMA-PA803 Pancreatic duct adenocarcinoma and normal tissue array with TNM and grade info, 40 cases/80 cores; 80 cores/40 cases
TMA-PA804 Pancreatic cancer and normal tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-PA805 Pancreatic cancer tissue array, with adjacent normal tissue and normal tissue, including TNM and pathology grade, 80 cases/80 cores, replaced by PA805a; 80 cores/80 cases
TMA-PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing PA805; 80 cores/80 cases
TMA-PA961 Pancreatic cancer and normal tissue array, including TNM, clinical stage and pathology grade, 96 cases/96 cores; 96 cores/96 cases
TMA-PA961a Pancreatic cancer tissue array with normal pancreatic tissue, including TNM, clinical stage and pathology grade, 96 cases/96 cores, replacing PA961; 96 cores/96 cases
TMA-PAC481 Pancreatic cancer tissue array, 24 cases/48 cores; 48 cores/24 cases
TMA-PAN241 Pancreas tissue array with pancreas cancer tissue as control, including TNM and pathology grade, 24 cases/24 cores; 24 cores/24 cases
TMA-PAN801 Pancreas tissue array with pancreas cancer tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores; 80 cores/80 cases
TMA-T141 Pancreatic cancer test tissue array, with normal pancreas control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by T141a; 24 cores/6 cases
TMA-T141a Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases/24 cores, replacing T141; 24 cores/6 cases
TMA-T142 Pancreatic cancer test tissue array, with normal tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T142a; 24 cores/12 cases
TMA-T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases/24 cores, replacing T142; 24 cores/12 cases
TMA-T143 Pancreatic cancer test tissue array, with normal pancreatic tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T151 Thyroid cancer test tissue array, with normal thyroid control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
Thyroid
TMA-THD181 Common diseases of the thyroid, 18 cases/18 cores; 18 cores/18 cases
TMA-BC15012 Thyroid carcinoma (multi-tissue combined panel) tissue array, 23 cases/63 cores; 63 cores/23 cases
TMA-T152 Thyroid cancer tissue array, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T153 Thyroid cancer test tissue array, with normal thyroid gland tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-TH201 Thyroid disease spectrum tissue array, including TNM, clinical stage, 20 cases/ 20 cores; 20 cores/20 cases
TMA-TH208 Thyroid cancer tissue microarray with normal tissue control, high density (60 cases/208 cores), with clinical stage data; 208 cores/69 cases
TMA-TH241 Thyroid cancer tissue array with self-matching normal adjacent tissues, 10 cases/24 cores; 24 cores/10 cases
TMA-TH242 Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases/24 cores; 24 cores/12 cases
TMA-TH481 Thyroid cancer tissue array with unmatched normal adjacent tissues, 48 cases/48 cores, with grade and stage info; 48 cores/48 cases
TMA-TH641 Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 32 cases/64 cores; 64 cores/32 cases
TMA-TH721 Thyroid cancer and normal tissue array with clinical stage and grade info, 24 cases/72 cores; 72 cores/24 cases
TMA-TH801 Thyroid cancer tissue array, with matched or unmatched adjacent normal tissue, 68 cases/80 cores, no overlaps with TH802, replaced by TH801a; 80 cores/68 cases
TMA-TH8010 Thyroid cancer and normal tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-TH801a Thyroid cancer tissue array with matched or unmatched adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 74 cases/80 cores, replacing TH801; 80 cores/74 cases
TMA-TH802 Thyroid cancer and adenoma tissue array, 80 cases/80 cores, no overlaps with TH801, replaced by TH802a; 80 cores/80 cases
TMA-TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases/80 cores, replacing TH802; 80 cores/80 cases
TMA-TH803 Thyroid papillary cancer tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-TH804 Normal thyroid gland tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-TH805 Goiter and thyroiditis tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-TH806 Thyroid medullary cancer tissue array and normal tissues, 40 cases/80 cores, with grade and stage data; 80 cores/40 cases
TMA-TH807 Thyroid disease spectrum tissue array, 75 cases/80 cores; 80 cores/75 cases
TMA-TH808 Thyroid cancer and normal tissue array, with grade and stage data, 40 cases/80 cores; 80 cores/40 cases
TMA-TH809 Thyroid cancer metastasis tissue array, 40 cases/80 cores, replaced by TH809a; 80 cores/40 cases
TMA-TH809a Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases/80 cores, replacing TH809; 80 cores/40 cases
TMA-TH961 Thyroid disease tissue array, including TNM, clinical stage, 48 cases/ 96 cores; 96 cores/48 cases
TMA-THC241 Thyroid cancer array, 12 cases/24 cores; 24 cores/12 cases
TMA-THC961 Thyroid cancer tissue array, 48 cases/96 cores; 96 cores/48 cases
Nasopharynx and Larynx
TMA-LP208 High density larynx and pharynx cancer tissue array with normal tissue (69 cases/208 core) including stage and grade data; 208 cores/69 cases
TMA-LP241 Larynx and pharynx cancer tissue array with self-matching normal adjacent tissues, 10 cases/24 cores; 24 cores/10 cases
TMA-LP481 Larynx and pharynx cancer tissue array with unmatched normal tissues, 48 cases/48, cores with stage and grade data; 48 cores/48 cases
TMA-LP721 Laryngeal cancer and normal tissue array, with grade and TNM information, 24 cases/72 cores; 72 cores/24 cases
TMA-LP801 Larynx and pharynx cancer tissue array, with matched adjacent normal tissue, 70 cases/80 cores; 80 cores/70 cases
TMA-LP802 Laryngeal disease spectrum (progression) tissue array, 78 cases/80 cores; 80 cores/78 cases
TMA-LP803 Laryngeal squamous cell carcinoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-LP804 Laryngeal cancerous, cancer adjacent and normal tissue array, with grade and stage info, 40 cases/80 cores; 80 cores/40 cases
TMA-NH1001 Nasopharynx disease spectrum (nasopharynx cancer progression) tissue array, 49 cases/100 cores; 100 cores/49 cases
TMA-NPC111 Nasopharyngeal carcinoma tissue array, 11 cases/11 cores, (*SEE NOTE in description); 11 cores/11 cases
TMA-NPC481 Nasopharyngeal carcinoma tissue array, 48 cases/49 cores; 49 cores/48 cases
TMA-NPC961 Nasopharyngeal carcinoma tissue array, non-overlapping with NPC962, >50 cases/96 cores; 96 cores/50 cases
TMA-NPC962 Nasopharyngeal carcinoma tissue array, non-overlapping with NPC961, 96 cases/96 cores; 96 cores/96 cases
TMA-T161 Nasopharyngeal and laryngeal cancer test tissue array, 6 cases/24 cores; 24 cores/6 cases
TMA-T163 Nose, pharyngeal and laryngeal cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
Brain
TMA-NGL481 Nervous system glioma tissue array, 24 cases/48 cores; 48 cores/24 cases
TMA-NGL961 Nervous system glioma tissue array, 48 cases/96 cores; 96 cores/48 cases
TMA-NST961 Nervous system tumor tissue array, 48 cases/96 cores; 96 cores/48 cases
TMA-BS17011 Brain glioblastoma tissue array, 21 cases/63 cores, replaced by GL811; 63 cores/21 cases
TMA-BS17015 Brain glioma tissue array, 63 cases/63 cores, replaced by BS17015a; 63 cores/62 cases
TMA-BS17016 Brain glioma tissue array, 33 cases/63 cores, replaced by BS17016a; 63 cores/33 cases
TMA-BS17017 Brain gliocytoma tissue array, 63 cases/63 cores; 63 cores/63 cases
TMA-BS17018 Brain glioblastoma tissue array, 33 cases/63 cores, replaced by GL805; 63 cores/33 cases
TMA-BC17012 Medulloblastoma of brain tissue array, 20 cases/60 cores, replaced by BC17012a; 60 cores/20 cases
TMA-BC17012a Medulloblastoma of brain tissue array with normal tissue as control, 23 cases/ 63 cores, replaced by BC17012b; 63 cores/23 cases
TMA-BC17012b Medulloblastoma of brain tissue array with normal tissue as control, 23 cases/ 63 cores, replacing BC17012a; 63 cores/23 cases
TMA-BC17013 Brain astrocytoma and meningioma tissue array, 120 cases/120 cores; 120 cores/120 cases
TMA-BNC17011 Normal brain tissue array, 26 cases/ 80 cores; 80 cores/26 cases
TMA-BS17015a Brain cancer tissue array, including pathology grade, 63 cases/ 63 cores, replacing BS17015; 63 cores/63 cases
TMA-BS17016a Brain glioblastoma tissue array, including pathology grade, 40 cases/80 cores, replacing BS17016; 80 cores/40 cases
TMA-CNS2081 Central nerve disease spectrum (central nerve tumor progression) tissue array, 104 cases/208 cores; 208 cores/104 cases
TMA-CNS801 Brain disease spectrum (brain cancer progression) tissue array, with stage, TNM and grade info, 79 cases/80 cores; 80 cores/79 cases
TMA-GL1001 Multiple brain cancer and normal adjacent tissue array, 100 cases/100 cores; 100 cores/100 cases
TMA-GL1002 Brain tumor and normal tissue array, 50 cases/100 cores; 100 cores/50 cases
TMA-GL1003 Brain tumor tissue array for antibody screening, 25 cases/100 cores; 100 cores/25 cases
TMA-GL1921 Mid-advanced stage brain tumor tissue array, including pathology grade, 96 cases/192 cores; 192 cores/96 cases
TMA-GL208 Brain primary tumor high density (69 cases/208 cores) tissue microarray of astrocytoma, glioblastoma, glioblastoma multiforme (GBM) and normal tissue; 208 cores/69 cases
TMA-GL2082 Brain tumor (meningioma, astrocytoma and glioblastoma) tissue array, 104 cases/208 cores; 208 cores/104 cases
TMA-GL2083 Brain tumor and normal tissue array with pathology grade, 208 cases/208 cores, replaced by GL2083a; 208 cores/208 cases
TMA-GL2083a Brain tumor tissue array, including TNM, clinical stage and pathology grade, 208 cases/208 cores, replacing GL2083; 208 cores/208 cases
TMA-GL241 Multiple brain cancer tissue array with self-matching normal adjacent tissues, 10 cases/24 cores, replaced by GL241a; 24 cores/10 cases
TMA-GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases/24 cores, replacing GL241; 24 cores/10 cases
TMA-GL242 Brain tumor tissue array, with normal tissue, 2 serial sections, 24 cases/48 cores; 48 cores/24 cases
TMA-GL481 Astrocytoma and glioblastoma tissue array with unmatched normal adjacent tissues, 48 cases/48 cores; 48 cores/48 cases
TMA-GL482 Brain tumor tissue array, with normal tissue, 48 cases/48 cores; 48 cores/48 cases
TMA-GL721 Brain tumor and normal tissue array with TNM and grade info, 24 cases/72 cores; 72 cores/24 cases
TMA-GL722 Brain glioma (astrocytoma) tissue array, 24 cases/72 cores; 72 cores/24 cases
TMA-GL801 Brain glioma tissue array, with matched or unmatched adjacent normal tissue, 76 cases/80 cores; 80 cores/76 cases
TMA-GL802 Glioblastoma (grade IV) tissue array, 40 cases/80 cores, replaced by GL805; 80 cores/40 cases
TMA-GL803 Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a; 80 cores/78 cases
TMA-GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases/80 cores, replacing GL803; 80 cores/80 cases
TMA-GL804 Brain tumor and normal tissue array with grade and TNM data, 40 cases/80 cores; 80 cores/40 cases
TMA-GL805 Glioblastoma multiforme (GBM) tissue array, 40 cases/80 cores, replaced by GL806; 80 cores/40 cases
TMA-GL806 Brain glioblastoma multiforme(GBM) tissue array, 40 cases/80 cores, replaced by GL806a; 80 cores/40 cases
TMA-GL806a Brain glioblastoma multiforme(GBM) tissue array, 40 cases/80 cores, replaced by GL806b; 80 cores/40 cases
TMA-GL806b Brain glioblastoma tissue array with normal brain tissue as control, including pathology grade, 40 cases/80 cores, replacing GL806a; 80 cores/40 cases
TMA-GL807 Brain glioma and normal tissue array, including pathology grade, 40 cases/80 cores; 80 cores/40 cases
TMA-GL808 Brain tumor tissue array, with matched adjacent normal tissue, 80 cases/80 cores; 80 cores/80 cases
TMA-GL811 Brain tumor and normal tissue array, with pathology grade, 27 cases/81 cores, replacing BS17011; 81 cores/27 cases
TMA-GL961 Nervous system tumor tissue array, including clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-MG801 Meningioma of central nerve tissue array, 80 cases/80 cores, replaced by MG801a; 80 cores/80 cases
TMA-MG801a Meningioma of central nerve tissue array, 80 cases/80 cores, replacing MG801; 80 cores/80 cases
TMA-MG802 Brain tumor tissue array, 40 cases/80 cores; 80 cores/40 cases
TMA-PIT501 Normal pituitary gland tissue array, 25 cases/50 cores; 50 cores/25 cases
TMA-T171 Brain glioma test tissue array, with normal brain tissues as control, including pathology grade, 6 cases/24 cores, replaced by T174a; 24 cores/6 cases
TMA-T172 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T175; 24 cores/12 cases
TMA-T173 Brain cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores, replaced by T173a; 24 cores/6 cases
TMA-T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases/24 cores, replacing T173; 24 cores/6 cases
TMA-T174 Brain tumor test tissue array, with normal tissue, including TNM and pathology grade, 6 cases/24 cores, replacing T171; 24 cores/6 cases
TMA-T174a Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases/24 cores, replacing T171; 24 cores/6 cases
TMA-T175 Brain tumor tissue array with normal brain tissue as control, including pathology grade, 12 cases/24 cores, replacing T172; 24 cores/12 cases
TMA-T176 Brain tumor tissue array, including pathology grade, 6 cases/24 cores; 24 cores/6 cases
Prostate
TMA-BC19012 Prostate carcinoma (multi-tissue combined panel) tissue array, 33 cases/63 cores, replaced by PR808; 63 cores/33 cases
TMA-BC19013 Prostate carcinoma (multi-tissue combined panel) tissue array, 33 cases/63 cores; 63 cores/33 cases
TMA-BC19014 Prostate carcinoma tissue array, 31 cases/63 cores; 63 cores/31 cases
TMA-BC19015 Prostate carcinoma tissue array, 9 cases/27 cores; 27 cores/9 cases
TMA-BC19017 Prostate carcinoma tissue array, 33 cases/63 cores, replaced by BC19017a; 63 cores/33 cases
TMA-BC19111 Normal prostate tissue array, with prostate tumor and hyperplasia, 11 cases/30 cores; 30 cores/11 cases
TMA-BB19012 Prostate intraepithelial neoplasia and cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores; 48 cores/24 cases
TMA-BC19017a Prostate cancer and hyperplasia tissue array, including TNM, clinical stage and pathology grade, 32 cases/ 63 cores, replacing BC19017; 63 cores/32 cases
TMA-BC19019 Prostate cancer and hyperplasia tissue array, 33 cases/63 cores, replacing BC19011; 66 cores/33 cases
TMA-BC19021 Prostate cancer, adjacent normal tissue and normal tissue array, including TNM, clinical stage and pathology grade, 20 cases/72 cores, replaced by BC19021a; 72 cores/20 cases
TMA-BC19021a Prostate cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade, 28 cases/72 cores, replacing BC19021; 72 cores/28 cases
TMA-BNS19011 Normal prostate tissue array, 24 cases/ 48 cores,; 48 cores/24 cases
TMA-PR1001 Prostate cancer tissue array, including TNM and pathology grade, 25 cases/100 cores; 100 cores/25 cases
TMA-PR207b High-density prostate cancer (1-4 grade) and normal prostate tissue array, 70 cases/208 cores, replaced by PR208; 208 cores/70 cases
TMA-PR208 High-density prostate cancer tissue array(1-4 grade), normal prostate and placenta (as control), 70 cases/208 cores, replacing PR207b; 208 cores/70 cases
TMA-PR2085a High-density (114 cases/208 cores) prostate adenocarcinoma (grade 1-4) and normal prostate (from autopsy and cancer adjacent) tissue array, replaced by PR2085b; 208 cores/114 cases
TMA-PR2085b High-density prostate cancer tissue array, including TNM, pathology grade, Gleason grade and Gleason scores, 114 cases/208 cores, replacing PR2085a; 208 cores/114 cases
TMA-PR241 Prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases/24 cores, replaced by PR243; 24 cores/12 cases
TMA-PR242 Multiple prostate cancer test tissue array with unmatched normal adjacent tissue, 12 cases/24 cores, replaced by PR242a; 24 cores/12 cases
TMA-PR242a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing PR242; 24 cores/12 cases
TMA-PR243 Prostate cancer and normal tissue array, with stage and grade info, 12 cases/24 cores, replaced by PR243a; 24 cores/12 cases
TMA-PR243a Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing PR243; 24 cores/12 cases
TMA-PR481 Prostate cancer tissue array with unmatched normal prostate tissues, 24 cases/48 cores, with grades, stages and Gleason scores; 48 cores/24 cases
TMA-PR482 Multiple prostate cancer tissue array with 4 normal tissue control from autopsy, with TNM and Gleason Scores, 24 cases/48 cores; 48 cores/24 cases
TMA-PR483 Multiple prostate cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores, with stage, grade and Gleason score info, replaced by PR483a; 48 cores/48 cases
TMA-PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing PR483; 48 cores/48 cases
TMA-PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases/48 cores; 48 cores/24 cases
TMA-PR631 Prostatic carcinoma tissue array with 3 cases of normal prostate tissue from autopsy, 33 cases/63 cores, with grade and Gleason scores; 63 cores/33 cases
TMA-PR632 Prostate cancer, hyperplasia with normal tissue array, with Gleason scores and stage information, 21cases/63 cores; 63 cores/21 cases
TMA-PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases/63 cores, replacing PR8010; 63 cores/63 cases
TMA-PR721 Prostate cancer normal prostate tissue array with TNM, grade and Gleason scores, 24 cases/72 cores; 72 cores/24 cases
TMA-PR751 Prostate cancer, PIN (prostatic intraepithelial neoplasia) and hyperplasia tissue array, 75 cases/75 cores, with grade and Gleason's Score data; 75 cores/75 cases
TMA-PR752 Prostate cancer and hyperplasia tissue array, including TNM and pathology grade, 75 cases/75 cores; 75 cores/75 cases
TMA-PR753 Prostate cancer and hyperplasia tissue array, including TNM and pathology grade, 75 cases/75 cores; 75 cores/75 cases
TMA-PR801 Prostate cancer tissue array with unmatched normal prostate tissue, 78 cases/80 cores, replaced by PR803; 80 cores/78 cases
TMA-PR8010 Prostate cancer tissue array, including TNM and pathology grade, 80 cases/80 cores, replaced by PR633; 80 cores/80 cases
TMA-PR8011 Prostate disease spectrum tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing PR805; 80 cores/80 cases
TMA-PR802 Prostate carcinoma tissue array, 80 cases/80 cores, no overlaps with PR801, replaced by PR8010; 80 cores/80 cases
TMA-PR803 Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases/80 cores, replacing PR801, replaced by PR803a; 80 cores/80 cases
TMA-PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing PR803; 80 cores/80 cases
TMA-PR804 Hyperplasia and carcinoma of prostate tissue array, 80 cases/80 cores, with grade and Gleason score information; 80 cores/80 cases
TMA-PR805 Prostate disease spectrum (prostatic cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-PR806 Prostate adenocarcinoma and normal tissue array with stage and Gleason Scores, 40 cases/80 cores; 80 cores/40 cases
TMA-PR807 Prostate cancer, hyperplasia and normal tissue array, with stage (Gleason Scores) and grade info, 79 cases/80 cores; 80 cores/79 cases
TMA-PR807a Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases/80 cores, replacing PR807; 80 cores/79 cases
TMA-PR808 Prostate cancer and normal tissue array, with TNM, stage, Gleason's score and grade info, 40 cases/80 cores, replacing BC19012; 80 cores/40 cases
TMA-PR809 Prostate cancer and hyperplasia tissue array, with stage and grade, 40 cases/80 cores, replacing BC19019; 80 cores/40 cases
TMA-PR951 Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases/95 cores, with TNM and Gleason scores, replaced by PR952; 95 cores/48 cases
TMA-PR952 Prostate adenocarcinoma tissue array with matched normal adjacent tissue and metastatic bones, 40 cases/95 cores, with TNM and Gleason scores, replaced by PR953; 95 cores/48 cases
TMA-PR953 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR954; 95 cores/40 cases
TMA-PR954 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR955; 95 cores/40 cases
TMA-PR955 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR956; 95 cores/40 cases
TMA-PR956 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replaced by PR956a; 95 cores/40 cases
TMA-PR956a Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases/95 cores, replacing PR956; 95 cores/40 cases
TMA-PRC481 Prostate cancer tissue array, 24 cases/48 cores; 48 cores/24 cases
TMA-PRC961 Prostate cancer tissue array, 48 cases/96 cores; 96 cores/48 cases
TMA-T191 Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T192 Prostate cancer test tissue array, with normal control tissue, including TNM, clinical stage, pathology grade, gleason grade and gleason score, 12 cases/24 cores, replaced by T195; 24 cores/12 cases
TMA-T193 Prostate cancer test tissue array, with normal prostate tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T194 Prostate cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases/24 cores, replaced by T195; 24 cores/12 cases
TMA-T195 Prostate adenocarcinoma tissue array, including TNM and pathology grade, 12 cases/24 cores, 2 serial sections, replaced by T195a; 24 cores/12 cases
TMA-T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T195; 24 cores/12 cases
TMA-T196 Prostate cancer test tissue array (4x (2x3) array),including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
Lymphoma
TMA-HL801 Hodgkin's lymphoma tissue array, 45 cases/80 cores, replaced by HL801a; 80 cores/45 cases
TMA-LM208 High density tissue microarray of Hodgkin's Disease, Non-Hodgkin's lymphoma and normal lymph node tissues, 69 cases/208 cores; 208 cores/69 cases
TMA-LM241 Multiple lymphoma tissue array with normal tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-LM481 Multiple lymphoma tissue array with normal tissues, 48 cases/48 cores, replaced by LM481a; 48 cores/48 cases
TMA-LM801 Lymphoma (Hodgkin's and non-Hodgkin's disease) tissue array, 80 cases/80 cores, replaced by LM801a; 80 cores/80 cases
TMA-LM802 Lymphoma (Hodgkin's and non-Hodgkin's disease) tissue array, 80 cases/80 cores, replaced by NHL803; 80 cores/80 cases
TMA-NHL801 Non-Hodgkin's lymphoma tissue array, 42 cases/80 cores, no overlaps with NHL802; 80 cores/42 cases
TMA-NHL802 Non-Hodgkin's lymphoma tissue array, 42 cases/80 cores, no overlaps with NHL801, replaced by NHL803a; 80 cores/42 cases
TMA-BNC20011 Normal lymph node tissue array, 30 cases/ 60 cores,; 60 cores/30 cases
TMA-BS20011 Lymphoma tissue array, 30 cases/30 cores, replaced by BS20011a; 30 cores/30 cases
TMA-BS20011a Lymphoma tissue array, 30 cases/ 30 cores, replacing BS20011; 30 cores/30 cases
TMA-HL481 Hodgkin's lymphoma tumor tissue array, 48 cases/48 cores; 48 cores/48 cases
TMA-HL801a Hodgkin's lymphoma tissue array, 45 cases/80 cores, replacing HL801; 80 cores/45 cases
TMA-LM481a Multiple lymphoma tissue array with normal tissue as control, 48cases/ 48cores, replacing LM481; 48 cores/48 cases
TMA-LM482 Myeloma, lymphoma and normal tissue array, 48 cases/48 cores, replaced by LM482a; 48 cores/48 cases
TMA-LM482a Lymphoma tissue array with normal lymph node tissue as control, 48 cases/48 cores, replaced by LM482b; 48 cores/48 cases
TMA-LM482b Lymphoma tissue array with normal lymph node tissue as control, 48 cases/48 cores, replacing LM482a; 48 cores/48 cases
TMA-LM721 Lymphoma and normal lymph node tissue array, 24 cases/72 cores; 72 cores/24 cases
TMA-LM801a Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases/80 cores, replacing LM801; 80 cores/80 cases
TMA-LM803 Lymphoma and normal lymph node tissue array, 40 cases/80 cores; 80 cores/40 cases
TMA-LY1001 Diffuse large-B cell lymphoma tissue array, 100 cases/100 cores, replaced by LY1001a; 100 cores/100 cases
TMA-LY1001a Diffuse large-B cell lymphoma tissue array, 100 cases/100 cores, replacing LY1001; 100 cores/100 cases
TMA-LY121 Diffuse large B-cell lymphoma tissue array, 12 cases/12 cores, replaced by LY121a; 12 cores/12 cases
TMA-LY121a Diffuse large B-cell lymphoma tissue array, 12 cases/12 cores, replacing LY121; 12 cores/12 cases
TMA-LY1501 Lymphoma tumor tissue array, 75 cases/150 cores; 150 cores/75 cases
TMA-LY201 Lymphoma tissue array, 20 cases/ 20 cores; 20 cores/20 cases
TMA-LY2081 Lymphoma tumor survey tissue array (1 of 5), with normal tissue, 104 cases/208 cores; 208 cores/104 cases
TMA-LY2082 Lymphoma survey tissue array (2 of 5), 104 cases/208 cores; 208 cores/104 cases
TMA-LY2083 Lymphoma survey tissue array (3 of 5), 104 cases/208 cores; 208 cores/104 cases
TMA-LY2084 Lymphoma tumor survey tissue array (4 of 5), 104 cases/208 cores; 208 cores/104 cases
TMA-LY2085 Lymphoma tumor survey tissue array (5 of 5), 104 cases/208 cores; 208 cores/104 cases
TMA-LY2086 Lymphoma tissue array, 208 cases/208 cores, replaced by LY2086a; 208 cores/208 cases
TMA-LY2086a Lymphoma tissue array, 208 cases/208 cores, replacing LY2086; 208 cores/208 cases
TMA-LY2087 Lymphoma tumor survey tissue array (2 of 3), 208 cases/208 cores; 208 cores/208 cases
TMA-LY2088 Lymphoma tumor tissue array, 208 cases/208 cores; 208 cores/208 cases
TMA-LY6161 High-density lymphoma and normal lymph node tissue array, 322 cases/616 cores; 616 cores/322 cases
TMA-LYM1501 Lymphoma mid-density tissue array, non-overlapping with LYM1502, 75 cases/150 cores; 150 cores/75 cases
TMA-LYM1502 Lymphoma mid-density tissue array, non-overlapping with LYM1501, 75 cases/150 cores; 150 cores/75 cases
TMA-LYM181 Lymphoma tissue array, 18 cases/18 cores; 18 cores/18 cases
TMA-LYM401 Lymphoma array, together with LYM321, LYM761 and LYM771 forming the lymphoma array set, 39 cases/40 cores; 40 cores/39 cases
TMA-NHL401 Lymphoma, multiple myeloma and lymph node tissue array, 40 cases/40 cores, replaced by NHL401a; 40 cores/40 cases
TMA-NHL401a Lymphoma, myeloma and lymph node tissue array, 40 cases/40 cores, replacing NHL401; 40 cores/40 cases
TMA-NHL481 Lymphoma tissue array, 48 cases/48 cores, replaced by NHL482; 48 cores/48 cases
TMA-NHL482 Lymphoma tissue array, 48 cases/48 cores, replaced by NHL482a; 48 cores/48 cases
TMA-NHL482a Lymphoma cancer tissue array, 48 cases/48 cores, replacing NHL482; 48 cores/48 cases
TMA-NHL483 Non-Hodgkin's lymphoma tumor tissue array, 48 cases/48 cores; 48 cores/48 cases
TMA-NHL802a Non-Hodgkin's lymphoma tissue array, 42 cases/80 cores, replacing NHL802; 80 cores/42 cases
TMA-NHL803 Lymphoma tissue array, 80 cases/80 cores, replacing LM802; 80 cores/80 cases
TMA-NHL803b Lymphoma tissue array, 80 cases/80 cores, replaced by NHL803d; 80 cores/80 cases
TMA-NHL803c Lymphoma tissue array, 80 cases/80 cores, replacing NHL803b; 80 cores/80 cases
TMA-NHL803d Lymphoma tissue array, 80 cases/80 cores, replacing NHL803b; 80 cores/80 cases
TMA-T201 Lymphoma test tissue array, with normal lymph node control tissues, 6 cases/24 cores; 24 cores/6 cases
TMA-T203 Lymphatic tissue tumor test tissue array, with normal tissue, 12 cases/24 cores, replaced by T203a; 24 cores/12 cases
TMA-T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases/24 cores, replacing T203; 24 cores/12 cases
TMA-T204 Lymphoma test tissue array, with normal tissue as control, 2 serial sections, 6 cases/24 cores, replaced by T204a; 24 cores/6 cases
TMA-T204a Lymphoma tissue tissue array with normal tissue as control, 2 serial sections, 6 cases/24 cores, replacing T204; 24 cores/6 cases
TMA-T205 Lymphoma tissue array, 6 cases/24 cores; 24 cores/6 cases
Skin
TMA-BC21011 Skin malignant tumor tissue array, 78 cases/78 cores (squamous carcinoma, adenocarcinoma, basal cell carcinoma, sarcoma, melanoma), replaced by BC21014; 78 cores/78 cases
TMA-BC21014 Skin malignant tumor tissue array, 78 cases/78 cores, replacing BC21011; 78 cores/78 cases
TMA-SK181 Malignant melanoma with and benign nevus tissue array, clinical stage and pathology grade, 18 cases/18 cores; 18 cores/18 cases
TMA-SK208 Skin cancer and normal tissue high density (69 cases/208 core) tissue microarray; 208 cores/69 cases
TMA-SK2081 Skin disease spectrum (dermatic cancer progression) tissue array, 102 cases/208 cores; 208 cores/102 cases
TMA-SK241 Skin cancer test tissue array with unmatched normal adjacent tissues, 12 cases/24 cores replaced by SK241a; 24 cores/12 cases
TMA-SK241a Skin cancer tissue array with adjacent normal skin tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing SK241; 24 cores/12 cases
TMA-SK242 Multiple skin cancer test tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-SK243 Age grouped female skin tissue array, 12 cases/24 cores, replaced by SK244; 24 cores/12 cases
TMA-SK244 Age grouped female skin tissue array, 12 cases/24 cores, replaced by SK244a; 24 cores/12 cases
TMA-SK244a Age grouped female skin tissue array, 12 cases/24 cores, replacing SK244; 24 cores/12 cases
TMA-SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases/24 cores; 24 cores/24 cases
TMA-SK481 Skin cancer tissue array with corresponding (unmatched) normal adjacent tissues, 24 cases/48 cores; 48 cores/24 cases
TMA-SK482 Multiple skin cancer tissue array with 4 normal tissue control from autopsy, 24 cases/48 cores; 48 cores/24 cases
TMA-SK483 Multiple skin squamous cell carcinoma tissue array with normal tissues control from autopsy, 48 cases/48 cores; 48 cores/48 cases
TMA-SK484 Skin basal cell cancer tissue array with normal tissue control from autopsy, 48 cases/48 cores; 48 cores/48 cases
TMA-SK721 Skin cancer and normal tissue array, with stage and grade info, 24 cases/72 cores; 72 cores/24 cases
TMA-SK801 Skin cancer tissue array, with matched or unmatched adjacent normal tissue, 80 cases/73 cores, replaced by SK801b; 80 cores/73 cases
TMA-SK801b Skin squamous cell carcinoma tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing SK801; 80 cores/80 cases
TMA-SK802 Skin squamous cell carcinoma (SCC) tissue array, with pathology grade and clinical stage, 80 cases/80 cores, no overlaps with SK801, replaced by SK802a; 80 cores/80 cases
TMA-SK802a Skin squamous cell cancer tissue array with normal skin tissue, including TNM, clinical stage and pathology grade,, 80 cases/80 cores, replacing SK802; 80 cores/80 cases
TMA-SK803 Skin basal cell cancer (BCC) and benign nevus tissue array, 52 cases/100 cores; 100 cores/52 cases
TMA-SK804 Skin cancerous and normal tissue array, with stage and grade info, 40 cases/80 cores; 80 cores/40 cases
TMA-SK805 Skin disease spectrum (dermatic cancer progression) tissue array, 79 cases/80 cores; 80 cores/79 cases
TMA-SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases/96 cores; 96 cores/48 cases
TMA-SKD241 Skin disease tissue array, 24 cases/24 cores; 24 cores/24 cases
TMA-SKT1501 Skin cancer mid-density tissue array, 75 cases/150 cores; 150 cores/75 cases
TMA-SKT961 Skin cancer and normal tissue array, 48 cases/96 cores; 96 cores/48 cases
TMA-T211 Skin cancer test tissue array, with normal skin control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T212 Skin cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replaced by T212a; 24 cores/12 cases
TMA-T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T212; 24 cores/12 cases
TMA-T213 Skin cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
Penis
TMA-PE241 Penis cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-PE601 Penis disease spectrum (penis tumor progression) tissue array, 59 cases/60 cores; 60 cores/59 cases
TMA-PE801 Penile (penis) carcinoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-T221 Penis cancer test tissue array, with normal penis control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T223 Penis cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
Testis
TMA-BC23011 Testis tumor combination, 24 cases/72 cores; 72 cores/24 cases
TMA-BC23012 Testis tumor tissue array, 23 cases/63 cores; 63 cores/23 cases
TMA-TE241 Testis cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-TE481 Testis cancer tissue array with unmatched normal adjacent tissues, 48 cases/48 cores, with stage data; 48 cores/48 cases
TMA-T231 Testis cancer test tissue array, with normal testis control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replaced by T231a; 24 cores/6 cases
TMA-T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases/24 cores, replacing T231; 24 cores/6 cases
TMA-T233 Testis cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-TE2081 Testis disease spectrum (testicular cancer progression) tissue array, with TNM data, 104 cases/208 cores; 208 cores/104 cases
TMA-TE242 Testis cancer tissue array, with adjacent normal tissue, including TNM and pathology grade, 12 cases/24 cores, replacing TE241; 24 cores/12 cases
TMA-TE482 Testis tumor tissue array, including TNM, 24 cases/48 cores; 48 cores/24 cases
TMA-TE802 Testis seminoma and lymphoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-TE803 Testis disease spectrum (testicular cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-TEN601 Normal testis tissue array, 30 cases/ 60 cores; 60 cores/30 cases
TMA-TET481 Human testis cancer tissue array, 24 cases/48 cores; 48 cores/24 cases
Soft Tissue
TMA-SFT961 Soft tissue tumor tissue array, 48 cases/96 cores; 96 cores/48 cases
TMA-BC24011 Soft tissue tumor (multi-tissue combined panel) tissue array, 63 cases/63 cores; 63 cores/63 cases
TMA-BC24021 Leiomyosarcoma and Rhabdomyosarcoma tissue array with normal muscles controls, 39 cases/75 cores, replaced by SO751; 75 cores/39 cases
TMA-OM601 Metastatic carcinoma of epiploon tissue array, 60 cases/60 cores; 60 cores/60 cases
TMA-SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases/96 cores; 96 cores/48 cases
TMA-SFD241 Human soft tissue disease tissue array, 24 cases/24 cores; 24 cores/24 cases
TMA-SO1001 Peripheral nerve disease spectrum (peripheroneural cancer progression) tissue array, 50 cases/100 cores; 100 cores/50 cases
TMA-SO208 Soft tissue sarcoma high density tissue array with normal controls, 69 cases/208 cores, with grade and stage data; 208 cores/69 cases
TMA-SO2081 Muscle disease spectrum (smooth muscle and striated muscle cancer progression) tissue array, 104 cases/208 cores; 208 cores/104 cases
TMA-SO2083 Adipose tissue disease spectrum (adipose tumor progression) tissue array, 104 cases/208 cores; 208 cores/104 cases
TMA-SO2084 Fibrous tissue disease spectrum (fibrous tissue cancer progression) tissue array, 104 cases/208 cores; 208 cores/104 cases
TMA-SO241 Soft tissue cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-SO481 Soft tissue cancer tissue array with unmatched normal adjacent tissues, 48 cases/48 cores, with TNM information; 48 cores/48 cases
TMA-SO482 Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 48 cases/48 cores; 48 cores/48 cases
TMA-SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases/75 cores, replacing BC24021; 75 cores/39 cases
TMA-SO801 Soft tissue cancer tissue array, with matched or unmatched adjacent normal tissue, 78 cases/80 cores; 80 cores/78 cases
TMA-SO8010 Blood vessel disease spectrum (blood vessel cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-SO8011 Smooth muscle and striated muscle disease spectrum (cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-SO8012 Soft tissue cancer tissue array, with normal tissue, including TNM and pathology grade, 40 cases/80 cores; 80 cores/40 cases
TMA-SO802 Malignant fibrohistiocytoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-SO803 Liparomphalus and liposarcoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-SO804 Leiomyosarcoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-SO805 Neurilemmoma of peripheral nerve tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-SO806 Leiomyoma of uterus tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-SO807 Interstitialoma of gastrointestinal tract tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-SO808 Schwannoma (neurilemmoma or neurinoma) of central nerve tissue array, 30 cases/60 cores; 60 cores/30 cases
TMA-SO809 Sarcoma tissue array of soft tissue (adipose, fibrous tissue, smooth muscle and skeletal muscle), 80 cases/80 cores; 80 cores/80 cases
TMA-SS1001 Synovial sarcoma tissue array, including TNM, clinical stage and pathology grade, 50 cases/100 cores; 100 cores/50 cases
TMA-T241 Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T242 Soft tissue cancer test tissue array, with normal tissue, including TNM and clinical stage, 12 cases/24 cores; 24 cores/12 cases
TMA-T243 Soft tissue tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-T244 Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases/24 cores; 24 cores/6 cases
Bone and Cartilage
TMA-BO241 Bone and cartilage cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-BO242 Human normal bone tissue array, 12 cases/24 cores, replaced by BO243; 24 cores/12 cases
TMA-BO481 Bone and cartilage tumor tissue array with unmatched normal tissue, 48 cases/48 cores with TNM data; 48 cores/48 cases
TMA-BO601 Bone giant cell tumor tissue array, 30 cases/60 cores; 60 cores/30 cases
TMA-BS26011 Osteosarcoma tissue array, 32 cases/63 cores, replaced by OS804; 63 cores/32 cases
TMA-BS36011 Cartilages sarcoma (Chondrosarcoma) tissue array, 25 cases/75 cores, replaced by OS803; 75 cores/25 cases
TMA-BCC26012 Osteochondroma tissue array with cancer adjacent normal tissue as control, 24 cases/ 24 cores; 24 cores/24 cases
TMA-BO2081 Bone disease spectrum (bone tumor progression) tissue array, 104 cases/208 cores; 208 cores/104 cases
TMA-BO243 Human normal bone and osteosarcoma tissue array, 12 cases/24 cores, replaced by BO244; 24 cores/12 cases
TMA-BO244 Human normal bone and osteosarcoma tissue array, 12 cases/24 cores, replaced by BO244b; 24 cores/12 cases
TMA-BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases/24 cores; 24 cores/12 cases
TMA-BO244b Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases/24 cores, replacing BO244; 24 cores/12 cases
TMA-BO801 Bone and cartilage disease spectrum (bone and cartilage cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-OS208 High density (208 core) tissue microarray of osteosarcoma, chondrosarcoma, giant cell tumor of bone and normal tissue, with TNM data, 69 cases/208 cores; 208 cores/69 cases
TMA-OS801 Osteosarcoma and chondrosarcoma tissue array, with matched or unmatched adjacent normal tissue, 79 cases/80 cores, replaced by OS802; 80 cores/79 cases
TMA-OS802 Osteosarcoma and chondrosarcoma tissue array, with stage, grade and TNM data, 80 cases/80 cores, replacing OS801 and BC26111; 80 cores/80 cases
TMA-OS803 Chondrosarcoma tissue tissue array, 27 cases/80 cores, replacing BS36011; 80 cores/27 cases
TMA-OS804 Osteosarcoma tissue tissue array, with stage and grade, 40 cases/80 cores, replaced by OS804a; 80 cores/40 cases
TMA-OS804a Osteosarcoma tissue array, including TNM, clinical stage and pathology grade, 40 cases/ 80 cores, replacing OS804; 80 cores/40 cases
TMA-T261 Bone and cartilage cancer test tissue array, with normal bone and cartilage tissue as control, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T262 Bone cancer test tissue array, with normal control tissue, including TNM and clinical stage, 12 cases/24 cores; 24 cores/12 cases
TMA-T263 Bone and cartilage tumor tissue array, with normal tissue, including TNM, 6 cases/24 cores; 24 cores/6 cases
TMA-T264 Bone and cartilage malignant tumor tissue array, including TNM and clinical stage, 6 cases/24 cores; 24 cores/6 cases
Oral Cavity
TMA-BC27011 Multiple organs, diseased tissue array of oral cavity, 47 cases/48 cores; 48 cores/47 cases
TMA-OR208 Oral cavity squamous cell carcinoma and normal tissues high density (69 cases/208 cores) tissue microarray) with grade and TNM (stage) info; 208 cores/69 cases
TMA-OR481 Oral cavity (tongue and parotid) cancer tissue array, 48 cases/48 cores.; 48 cores/48 cases
TMA-OR601 Oral squamous cancer tissue array with normal oral control tissue, 60 cases/60 cores, replaced by OR601a; 60 cores/60 cases
TMA-OR1001 Tonsil disease spectrum (tonsil tumor progression) tissue array, 50 cases/100 cores; 100 cores/50 cases
TMA-OR1002 Tonsil disease spectrum tissue array, 50 cases/100 cores; 100 cores/50 cases
TMA-OR2081 Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores; 208 cores/98 cases
TMA-OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases/60 cores, replacing OR601; 60 cores/60 cases
TMA-OR801 Parotid gland disease spectrum (parotidean cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-OR802 Oral cavity disease spectrum (oral cavity cancer progression) tissue array, 79 cases/80 cores; 80 cores/79 cases
TMA-T271 Oral cavity tumor test tissue array, with normal oral cavity control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T273 Oral cavity cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
Spleen
TMA-SP1001 Spleen disease spectrum (splenic cancer progression) tissue array, 50 cases/100 cores; 100 cores/50 cases
TMA-SP241 Spleen cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-SP242 Multiple spleen cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-SP481 Spleen cancer tissue array with unmatched normal adjacent tissues, 12 cases/48 cores; 48 cores/24 cases
TMA-SP482 Multiple spleen cancer tissue array with unmatched normal adjacent tissues, 28 cases/48 cores; 48 cores/28 cases
TMA-SPN481 Normal spleen tissue array, 24 cases/ 48 cores; 48 cores/24 cases
TMA-T321 Spleen tumor test tissue array, with normal spleen control tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-T323 Spleen tumor tissue array, with normal tissue, including TNM, 6 cases/24 cores; 24 cores/6 cases
Bone Marrow
TMA-BM241 Bone marrow tissue array, 12 cases/24 cores; 24 cores/12 cases
TMA-BM481 Normal bone marrow tissue array, 24 cases/48 cores; 48 cores/24 cases
TMA-BN29011 Normal bone marrow tissue array, 60 cases/60 cores; 60 cores/60 cases
TMA-BM482 Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a; 48 cores/24 cases
TMA-BM483 Bone marrow tumor and adjacent normal tissue array, including TNM and pathology grade, 24 cases/48 cores, replacing BM482; 48 cores/24 cases
TMA-BM483a Bone tumor, PNET, lymphoma and adjacent normal tissue array, including TNM and pathology grade, 24 cases/48 cores, replacing BM482; 48 cores/24 cases
TMA-T291 Multiple myeloma test tissue array, with normal bone marrow tissue as control, 6 cases/24 cores, replaced by T291a; 24 cores/6 cases
TMA-T291a Myeloma tissue array with normal tissue as control, 6 cases/24 cores, replacing T291; 24 cores/6 cases
TMA-T293 Bone marrow tumor and normal tissue array, including TNM, 6 cases/24 cores, replaced by T293a; 24 cores/6 cases
TMA-T293a Bone marrow tumor and normal tissue array, including TNM, 6 cases/24 cores, replacing T293; 24 cores/6 cases
Heart
TMA-CVD231 Cardiovascular disease tissue array, non-overlapping with CVD481, 23 cases/23 cores; 23 cores/23 cases
TMA-CVD481 Cardiovascular disease tissue array, no overlapping with CVD231, 24 cases/48 cores; 48 cores/24 cases
TMA-BC30011 Heart tissue array, 13 cases/34 cores, replaced by BC30013; 34 cores/13 cases
TMA-BC30013 Heart disease and normal tissue array, replacing BC30011, 18 cases/36 cores; 36 cores/18 cases
TMA-CV481 Cardiovascular disease tissue array, including TNM and clinical stage, 24 cases/48 cores; 48 cores/24 cases
TMA-HE1001 Heart disease spectrum (heart tumor progression) tissue array, 50 cases/100 cores; 100 cores/50 cases
TMA-T301 Heart tumor test tissue array, with normal heart tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-CV241 Cardiovascular disease tissue array, including TNM and clinical stage, 24 cases/24 cores; 24 cores/24 cases
Head and Neck
TMA-HND181 Head and neck disease tissue array, 18 cases/18 cores; 18 cores/18 cases
TMA-HNT1021 Head and neck disease tissue array (with inflammatory, benign and malignant tumor tissue), 102 cases/102 cores; 102 cores/102 cases
TMA-HNT961 Head and neck disease tissue array, 48 cases/96 cores; 96 cores/48 cases
TMA-BC34011 Head and neck squamous cell carcinoma tissue array, 24 cases/63 cores, replaced by HN811; 63 cores/24 cases
TMA-BC34111 Multiple head and neck squamous cell carcinoma tissue array with normal tissue, 36 cases/72 cores, replaced by HN811; 72 cores/26 cases
TMA-HN241 Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases/24 cores, replaced by HN241a; 24 cores/12 cases
TMA-HN242 Multiple Head & Neck cancer test tissue array with unmatched normal adjacent tissue, 12 cases/24 cores, replaced by HN242a; 24 cores/12 cases
TMA-HN481 Head & Neck cancer tissue array with unmatched normal adjacent tissues, 24 cases/48 cores with stage and grade data; 48 cores/24 cases
TMA-HN482 Multiple Head & Neck cancer tissue array with normal tissue from autopsy, 48 cases/48 cores with stage and grade data, replaced by HN483; 48 cores/48 cases
TMA-HN241a Head and neck cancer tissue array with adjacent normal head and neck tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing HN241; 24 cores/12 cases
TMA-HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing HN242; 24 cores/12 cases
TMA-HN483 Multiple head and neck cancer with normal tissue array, including TNM and pathology grade, 48 cases/48 cores, replacing HN482; 48 cores/48 cases
TMA-HN801 Multiple head and neck tumor tissue array with normal tissue, 40 cases/80 cores, replaced by HN801a; 80 cores/40 cases
TMA-HN801a Head and neck squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replacing HN801; 80 cores/40 cases
TMA-HN802 Multiple head and neck tumor with normal tissue array, with stage and grade info, 80 cases/80 cores; 80 cores/80 cases
TMA-HN803 Head and neck squamous cancer tissue array, including TNM and pathology grade, 80 cases/80 cores, replaced by HN803a; 80 cores/80 cases
TMA-HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing HN803; 80 cores/80 cases
TMA-HN811 Head and Neck tumor and normal tissue array, including TNM, clinical stage and pathology grade, 27 cases/81 cores, replacing BC34111; 81 cores/27 cases
TMA-HN811a Head and neck tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 27 cases/81 cores, replacing HN811; 81 cores/27 cases
TMA-T342 Head & Neck cancer test tissue array, with normal tongue and epiglottis control tissue, including TNM, clinical stage and pathology grade, 12 cases/24 cores; 24 cores/12 cases
TMA-T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
Vulva
TMA-UV1001 Vulval disease spectrum (vulva cancer progression) tissue array, 46 cases/100 cores; 100 cores/46 cases
TMA-UV241 Vulvar (vulva) cancer tissue array with unmatched normal adjacent tissues, 12 cases/24 cores; 24 cores/12 cases
TMA-UV801 Vulva malignant tumor tissue array, 39 cases/78 cores; 78 cores/39 cases
Melanoma
TMA-BCC38018 Mucosa malignant melanoma tissue array, 40 cases/80 cores; 80 cores/40 cases
TMA-BCC38218 Metastatic malignant melanoma tissue array, 50 cases/100 cores; 100 cores/50 cases
TMA-ME1001 Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, replaced by ME1003, 100 cases/100 cores; 100 cores/100 cases
TMA-ME1002 Malignant melanoma and normal tissue array, 50 cases/100 cores, replaced by ME1002a; 100 cores/50 cases
TMA-ME1002a Malignant melanoma tissue array with normal tissue as control, 50cases/ 100cores, replacing ME1002; 100 cores/50 cases
TMA-ME1003 Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004; 100 cores/100 cases
TMA-ME1004 Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, 100 cases/100 cores, replaced by ME1004a; 100 cores/100 cases
TMA-ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replacing ME1004; 100 cores/100 cases
TMA-ME207 High-density (69 cases/207 cores), multiple primary melanoma, metastatic and normal tissues array, replaced by ME208; 207 cores/69 cases
TMA-ME207b High-density (69 cases/207 cores), multiple primary melanoma, metastatic and normal skin tissue array block; 207 cores/69 cases
TMA-ME208 Multiple primary melanoma, metastatic melanoma and normal skin tissue array, 69 cases/208 cores, replacing ME207; 208 cores/69 cases
TMA-ME2081 Mid-density malignant melanoma and normal tissue array, 104 cases/208 cores; 208 cores/104 cases
TMA-ME2082 Malignant melanoma tissue array, including TNM and clinical stage, 208 cases/208 cores, replaced by ME2082a; 208 cores/208 cases
TMA-ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases/208 cores, replaced by ME2082b; 208 cores/208 cases
TMA-ME2082b Malignant melanoma tissue array with normal skin tissue, including TNM and clinical stage, 208 cases/208 cores, replacing ME2082a; 208 cores/208 cases
TMA-ME241 Multiple melanoma tissue array with normal tissues, 12 cases/24 cores, replaced by ME241a; 24 cores/12 cases
TMA-ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases/24 cores, replacing ME241; 24 cores/12 cases
TMA-ME242 Low-density malignant melanoma array, with stage and grade info, 24 cases/24 cores, replaced by ME242a; 24 cores/24 cases
TMA-ME242a Malignant melanoma array with cancer adjacent normal tissue as contral, including TNM, clinical stage and pathology grade, 24 cases/24 cores, replacing ME242; 24 cores/24 cases
TMA-ME481 Multiple melanoma tissue array with normal skin tissues, 48 cases/48 cores, replaced by ME481a; 48 cores/48 cases
TMA-ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases/48 cores, replacing ME481; 48 cores/48 cases
TMA-ME482 Malignant melanoma array with matched normal tissue control, stage and TNM, 48 cases/48 cores; 48 cores/48 cases
TMA-ME483 Melanoma tissue array, including TNM and clinical stage, 48 cases/48 cores; 48 cores/48 cases
TMA-ME801 Malignant melanoma tissue array, 80 cases/80 cores, replaced by ME804; 80 cores/80 cases
TMA-ME802 Malignant melanoma with normal skin tissue array, 40 cases/80 cores, replacing BS38011; 80 cores/40 cases
TMA-ME803 Malignant melanoma array with matched and unmatched normal skin tissue control, with stage and TNM, 80 cases/80 cores, replaced by ME803a; 80 cores/80 cases
TMA-ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases/80 cores, replacing ME803; 80 cores/80 cases
TMA-ME804 Malignant melanoma tissue array, including TNM and clinical stage, 80 cases/80 cores, replaced by ME804a; 80 cores/80 cases
TMA-ME804a Malignant melanoma tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing ME804; 80 cores/80 cases
TMA-T381 Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 6 cases/24 cores, replaced by T385; 24 cores/6 cases
TMA-T382 Malignant melanoma test tissue array, with normal skin control tissue, including TNM and clinical stage, 12 cases/24 cores, replaced by T382a; 24 cores/12 cases
TMA-T382a Malignant melanoma test tissue array with normal skin tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T382; 24 cores/12 cases
TMA-T385 Malignant melanoma test tissue array, with normal skin tissue as control, including TNM and clinical stage, 6 cases/24 cores, replaced by T385a; 24 cores/6 cases
TMA-T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases/24 cores, replacing T385; 24 cores/6 cases
TMA-T386 Malignant melanoma test tissue array, with normal skin tissue, including TNM and clinical stage, 6 cases/24 cores, replacing T385; 24 cores/6 cases
TMA-T388 Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases/24 cores; 24 cores/6 cases
Endocrine
TMA-EN801 Endocrine tumor tissue array, 40 cases/80 cores, replaced by EN801a; 80 cores/40 cases
TMA-EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases/80 cores, replacing EN801; 80 cores/40 cases
TMA-ENS2081 Endocrine system benign, alignant tumor and normal tissue array, including TNM, clinical stage and pathology grade, 104 cases/208 cores; 208 cores/104 cases
TMA-T002 Endocrine organ cancer test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases/24 cores; 24 cores/6 cases
Lymphatic Tissue
TMA-LN801 Normal lymphatic (lymph node, thymus, spleen, tonsil and appendix) tissue array, 80 cases/80 cores, replaced by LN802; 80 cores/80 cases
TMA-LY241 Lymphatic tissue array, 12 cases/24 cores, replaced by LY241a; 24 cores/12 cases
TMA-LY481 Lymphatic tissue array, 24 cases/48 cores; 48 cores/24 cases
TMA-LY241a Lymphatic tissue array with normal tissue as control, 12 cases/ 24 cores, replacing LY241; 24 cores/12 cases
Mesothelium
TMA-MS481 Human mesothelioma tissue array, 24 cases/48 cores, replaced by MS481a; 48 cores/24 cases
TMA-MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases/48 cores, replacing MS481; 48 cores/24 cases
TMA-MS801 Mesothelioma tissue array with normal mesothelium, with stage and TNM data, 40 cases/80 cores; 80 cores/40 cases
TMA-T391 Mesothelioma test tissue array, with normal mesothelium tissue as control, including TNM and clinical stage, 6 cases/24 cores, replaced by T392; 24 cores/6 cases
TMA-T392 Mesothelioma test tissue array, with normal mesothelial control tissue, including TNM and clinical stage, 6 cases/24 cores, replacing T391; 24 cores/6 cases
Intestine
TMA-SM208 Small intestine cancer, metastatic lymph nodes and normal tissue high density tissue microarray, 69 cases/208 core, with stage and grade data; 208 cores/69 cases
TMA-SM2081 Small intestine disease (cancer progression) spectrum tissue array, 95 cases/208 cores; 208 cores/95 cases
TMA-SM241 Small intestine adenocarcinoma tissue array (including normal adjacent tissue), 6 cases/24 cores; 24 cores/6 cases
TMA-SM801 Small intestine carcinoma and normal tissue array, 77 cases/80 cores; 80 cores/77 cases
TMA-SM242 Small intestine adenocarcinoma with normal tissue array, 12 cases/24 cores; 2 cores/12 cases
TMA-SM802 Small intestine disease spectrum (small intestine cancer progression) tissue array, with grade, stage and TNM data, 72 cases/80 cores; 80 cores/72 cases
TMA-SMN601 Normal small intestine tissue array, including TNM, clinical stage and pathology grade, 30 cases/ 60 cores; 60 cores/30 cases
TMA-T421 Small intestine cancer test tissue array, with normal small intestine tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
Adrenal Gland
TMA-AD2081 Adrenal gland disease spectrum (adrenal cancer progression) tissue array, 100 cases/200 cores; 200 cores/100 cases
TMA-AG801 Adrenal tumor tissue array, 80 cases/80 cores; 80 cores/80 cases
Embryonic tumors (Germinoma)
TMA-BC35111 Retinoblastoma and normal adjacent tissue array, 17 cases/34 cores, replaced by BC35111a; 34 cores/17 cases
TMA-BC35111a Retinoblastoma tissue array with adjacent normal eye tissue as control, including TNM and clinical stage, 20 cases/40 cores, replacing BC35111; 40 cores/20 cases
TMA-T001 Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases/24 cores, replaced by T001a; 24 cores/6 cases
TMA-T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases/24 cores, replacing T001; 24 cores/6 cases
Appendix
TMA-T413 Appendix cancer test tissue array, with normal tissue, including TNM and pathology grade, 2 serial sections, 6 cases/24 cores; 24 cores/6 cases
TMA-VA1001 Vermiform appendix disease spectrum (vermiform appendix tumor progression) tissue array, 50 cases/100 cores; 100 cores/50 cases
Thymus
TMA-T461 Thymus cancer test tissue array, with normal control tissues, including TNM, clinical stage and pathology grade, 6 cases/24 cores; 24 cores/6 cases
TMA-THY761 Thymus disease spectrum (thymic cancer progression) tissue array, 76 cases/76 cores; 76 cores/76 cases
Fallopian tube
TMA-UTE601 Fallopian tube disease spectrum (fallopian tube cancer progression) tissue array, 30 cases/60 cores; 60 cores/30 cases
Metatasis
TMA-LY802 Lymph node metastatic squamous cell carcinoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-LY803 Lymphatic metastatic adenocarcinoma tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-MET181 Metastatic cancer tissue array, 18 cases/18 cores; 18 cores/18 cases
TMA-MET961 Metastatic cancer tissue array, 48 cases/96 cores; 96 cores/48 cases
Parasite
TMA-BCC49001 Parasite infection tissue array with matched tumor as control, including TNM, clinical stage and pathology grade, 20cases/ 80cores; 80 cores/20 cases
TMA-BIC49001 Parasite infection tissue array, 12cases/ 24cores; 24 cores/12 cases
Mouse
TMA-AMS541 Mouse(FBV strain) normal tissue array, cover 22 organs/anatomic sites, 3 cases/54 cores; 54 cores/3 cases
TMA-AMS542 Mouse(KM strain) normal tissue array, cover 22 organs/anatomic sites, 3 cases/54 cores; 54 cores/3 cases
TMA-AMS544 Mouse normal tissue array, covering 22 organ/anatomic sites, 3 cases/54 cores; 54 cores/3 cases
TMA-BM01011 Liver, kidney, lung, muscle, brain, heart, stomach, spleen tissue array, 160 cases/160 cores, replaced by MO1601; 160 cores/160 cases
TMA-MO01011 Mouse stomach tissue array, 100 cases/100 cores, 50 from different male, 50 from different female; 100 cores/100 cases
TMA-MO03011 Mouse liver tissue array, 100 cases/100 cores, 50 male and 50 female; 100 cores/100 cases
TMA-MO04011 Mouse lung tissue array, 100 cases/100 cores, 50 male and 50 female; 100 cores/100 cases
TMA-MO07011 Mouse kidney tissue array, 100 cases/100 cores, 50 male and 50 female; 100 cores/100 cases
TMA-MO1001 Mouse normal kidney tissue array, 100 cases/100 cores; 100 cores/100 cases
TMA-MO1002 Mouse spleen tissue array, 100 cases/100 cores, 50 male and 50 female, replacing MO32011; 100 cores/100 cases
TMA-MO1601 Mouse tissue array of liver, kidney, lung, muscle, brain, heart, stomach, spleen, 160 cases/160 cores, replaced by MO1601a; 160 cores/160 cases
TMA-MO1601a Mouse multiple organ normal tissue array, 160 cases/160 cores, replacing MO1601; 160 cores/160 cases
TMA-MO17011 Mouse brain tissue array, 100 cases/100 cores, 50 male and 50 female; 100 cores/100 cases
TMA-MO24011 Mouse muscle tissue array, 100 cases/100 cores, 50 male and 50 female; 100 cores/100 cases
TMA-MO30011 Mouse heart tissue array, 100 cases/100 cores, 50 male and 50 female; 100 cores/100 cases
TMA-MO32011 Mouse spleen tissue array, 100 cases/100 cores, 50 male and 50 female, replaced by MO1002; 100 cores/100 cases
TMA-MO541 Mouse multiple organ normal tissue array, 24 cases/54 cores,replaced by MO541a; 54 cores/24 cases
TMA-MO541a Mouse multiple organ normal tissue array, 22 cases/ 54 cores, replacing MO541; 54 cores/22 cases
Fetus
TMA-BE01014 Multiple organ, normal fetus tissue array, 26 cases/78 cores, replaced by BE01014a; 78 cores/26 cases
TMA-BE01014a Multiple organ normal tissue of fetus tissue array, 26 organs/78 cores, replacing BE01014; 78 cores/8 cases
TMA-BE01015 Multiple organ, normal fetus tissue array, 50 cases/50 cores; 50 cores/50 cases
Rat
TMA-BR01015 Multiple organ, normal tissue array, 8 normal tissues, 160 cases/160 cores, replacing BR01011; 160 cores/160 cases
TMA-RAT901 Rat multiple organs, normal tissue array, 22 cases/90 cores, replacing BR01013; 90 cores/22 cases
TMA-TR011 Rat normal stomach test tissue array, 6 cases/24 cores; 24 cores/6 cases
TMA-TR041 Rat normal lung test tissue array, 6 cases/24 cores; 24 cores/6 cases
TMA-ART661 Rat(Wistar strain) normal tissue array, covering all major organs, non-overlapping with ART662, 22 cases/66 cores; 66 cores/22 cases
TMA-RA161 Multiple organs normal tissue array of rat, 8 cases/16 cores; 16 cores/8 cases
TMA-RA162 Multiple organs normal tissue array of rat, 8 cases/16 cores; 16 cores/8 cases
TMA-TR071 Rat normal kidney test tissue array, 6 cases/24 cores; 24 cores/6 cases
TMA-TR301 Rat normal heart test tissue array, 6 cases/24 cores; 24 cores/6 cases
Monkey
TMA-ASM221 Cyno monkey normal tissue array, 22 cases/22 cores; 22 cores/22 cases
TMA-FCY450 Frozen cynomolgus monkey multiple organ normal tissue array, 45 cases/ 45 cores; 45 cores/45 cases
TMA-CyFDA FDA normal organ tissue array of cynomolgus monkey, 99 cases/99 cores, replaced by CyFDA1; 99 cores/99 cases
TMA-CyFDA1 FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs/99 cores, replaced by CyFDA1a; 99 cores/34 cases
TMA-RhFDA1 FDA normal organ tissue array of rhesus monkey, 99 cases/99 cores; 99 cores/99 cases
TMA-RhFDA2 FDA normal organ tissue array (TMA) block of rhesus monkey, 99 cases/99 cores; 99 cores/99 cases
TMA-CyFDA1a FDA multiple organ normal tissue array of cynomolgus monkey, 32 organs/99 cores, replacing CyFDA1; 99 cores/32 cases
Cell Arrays
TMA-CMA241 Human tumor cell array, 12 cell lines/24 cores, replaced by CMA241a; 24 cores/12 cases
TMA-CMA241a Human tumor cell array, 12 cell lines/24 cores, replacing CMA241; 24 cores/12 cases
Frozen Tissue Arrays
TMA-FRA781-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases/78 cores; 42 cores/14 cases
TMA-FRA781-2 FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases/78 cores; 36 cores/13 cases
TMA-FRA901-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases/45 cores, replaced by FRA901a-1; 45 cores/15 cases
TMA-FRA901-2 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases/45 cores, replaced by FRA901a-2; 45 cores/15 cases
TMA-FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases/45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; 45 cores/45 cases
TMA-FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases/45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; 45 cores/45 cases
TMA-BRF401 Breast cancer frozen tissue array, with normal tissue, 40 cases/40 cores, Her-2 and ER/PR IHC are supplied when purchase; 40 cores/40 cases
TMA-BRF401i Breast cancer frozen tissue array, with normal tissue, 40 cases/40 cores, Her-2 and ER/PR IHC are supplied when purchase; 40 cores/40 cases
TMA-BRF404 Breast invasive ductal carcinoma forzen tissue array, 20 cases/40 cores; 40 cores/20 cases
TMA-FBN401 Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases/40 cores; 40 cores/20 cases
TMA-FBN404 Multiple organ normal frozen tissue array, 20 cases/40 cores; 40 cores/20 cases
TMA-FBN406 Multiple organ normal frozen tissue array, 20 cases/40 cores, replacing FBN404; 40 cores/20 cases
TMA-FBN406a Multiple organ normal frozen tissue array, 20 organs/40 cores, replaced by FBN406b; 40 cores/20 cases
TMA-FBN406b Multiple organ normal frozen tissue array, 20 organs/40 cores, replacing FBN406a; 40 cores/20 cases
TMA-FBN407 Multiple organ normal frozen tissue array, 20 cases/40 cores, replaced by FBN407a; 40 cores/20 cases
TMA-FBN407a Multiple organ normal frozen tissue array, 20 cases/40 cores, replaing FBN407, replaced by FBN407b; 40 cores/20 cases
TMA-FBN407b Multiple organ normal frozen tissue array, 20 cases/40 cores, replacing FBN407a; 40 cores/20 cases
TMA-FCO404 Frozen colon cancer tissue array, 20 cases/40 cores; 40 cores/20 cases
TMA-FCO405 Frozen colon cancer tissue array with matched cancer adjacent tissue as control, 20 cases/40 cores; 40 cores/20 cases
TMA-FDA901 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides.; 45 cores/45 cases
TMA-FDA902 FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replaced ; 45 cores/45 cases
TMA-FDA902a FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ, spanning two frozen tissue microarray slides, rep; 90 cores/45 cases
TMA-FDA902b FDA Standard Frozen Tissue Array (2 slide set), for therapeutic and diagnostic monoclonal antibody validation recommanded by FDA, 90 tissue cores of 30 organs, 3 individual donors per organ, replacing; 45 cores/45 cases
TMA-FDG281f Normal dog multiple organ frozen tissue array, 28 cases/28 cores; 28 cores/28 cases
TMA-FDG281m Normal male dog multiple organ frozen tissue array, 24 organs/24 cores; 28 cores/28 cases
TMA-FES401 Frozen esophagus cancer tissue array, 20 cases/40 cores; 40 cores/20 cases
TMA-FFE301 Human normal fetal frozen tissue array, total of 15 major organs from one case, 15 organs/30 cores, replaced by FFE302; 30 cores/15 cases
TMA-FFE302 Fetal multiple organ normal frozen tissue array, 15 cases/30 cores, replacing FFE301; 30 cores/15 cases
TMA-FFE302a Fetal multiple organ normal frozen tissue array, 15 organs/30 cores, replaced by FFE302b; 30 cores/15 cases
TMA-FFE302b Fetal multiple organ normal frozen tissue array, 15 organs/30 cores, replacing FFE302a; 30 cores/15 cases
TMA-FLV401 Frozen liver cancer tissue array, 20 cases/40 cores; 40 cores/20 cases
TMA-FLV402 Frozen liver cancer tissue array with matched cancer adjacent tissue as control, 20 cases/40 cores; 40 cores/20 cases
TMA-FLV420 Frozen liver disease tissue array, 20 cases/40 cores; 40 cores/20 cases
TMA-FMC281 Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases/28 cores, previously named FMC401; 28 cores/14 cases
TMA-FMC401 Multiple organ cancer frozen tissue array, 20 cases/40 cores; 40 cores/20 cases
TMA-FMC402 Multiple organ cancer frozen tissue array, with normal tissue 40 cases/40 cores, replaced by FMC402a; 40 cores/40 cases
TMA-FMC405 Multiple organ carcinoma frozen tissue array, including TNM and clinical stage, 40 cases/40 cores, replaced by FMC405a; 40 cores/40 cases
TMA-FMC406 Digestive system carcinoma frozen tissue array, including TNM and clinical stage information, 40 cases/40 cores; 40 cores/40 cases
TMA-FMC408 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases/40 cores; 40 cores/40 cases
TMA-FMC409 Multiple organ cancer frozen tissue array, 20 cases/40 cores,replacing FMC401; 40 cores/20 cases
TMA-FMC409a Frozen multiple organ cancer tissue array, 20 cases/40 cores, replacing FMC409; 40 cores/20 cases
TMA-FMO721 FDA standard normal mouse multiple organ frozen tissue array, two slides, 24 cases/72 cores; 72 cores/24 cases
TMA-FMO901 FDA standard normal mouse multiple organ frozen tissue array, two slides set, each contains 15 organs/45 cores, replaced by FMO901a; 90 cores/30 cases
TMA-FMO901a FDA standard normal mouse multiple organ frozen tissue array, two slides set, each contains 15 organs/45 cores, replacing FMO901; 90 cores/30 cases
TMA-FMS151 Brains of multiple species frozen tissue array, 14 cases/15 cores; 15 cores/14 cases
TMA-FMS152 Liver of multiple species frozen tissue array, 14 cases/15 cores; 15 cores/14 cases
TMA-FRA781 Standard normal rat multiple organ frozen tissue array, two slides, 26 cases/78 cores; 78 cores/26 cases
TMA-FRA901 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide one, 15 cases/45 cores; 45 cores/15 cases
TMA-FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases/45 cores, 2 slides set, replacing FRA901; 45 cores/45 cases
TMA-FRB281f Normal female rabbit multiple organ frozen tissue array, 28 organs/28 cores; 28 cores/28 cases
TMA-FRB281m Normal male rabbit multiple organ frozen tissue array, 25 organs/25 cores; 25 cores/25 cases
TMA-FRB901 FDA standard normal rabbit multiple organ frozen tissue array, slide one, 15 organs/45 cores; 45 cores/45 cases
TMA-FRE401 Frozen rectum cancer tissue array, 20 cases/40 cores; 40 cores/20 cases
TMA-FST401 Frozen stomach cancer tissue array, 20 cases/40 cores; 40 cores/20 cases
TMA-PRF281 Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases/28 cores; 28 cores/28 cases
TMA-FCO401 Colorectal organ carcinoma frozen tissue array, including TNM, clinical stage, 40 cases/40 cores, replaced by FCO401a; 40 cores/40 cases
TMA-FCO401a Frozen colorectal adenocarcinoma tissue array, including TNM and clinical stage, 40 cases/40 cores, replacing FCO401; 40 cores/40 cases
TMA-FMC282 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 28 cases/28 cores, replaced by FMC282a; 28 cores/28 cases
TMA-FMC282a Multiple organ cancer frozen tissue array, including pathology grade, 28 cases/28 cores, replaced by FMC282c; 28 cores/28 cases
TMA-FMC282c Multiple organ cancer frozen tissue array, including pathology grade, 28 cases/28 cores, replacing FMC282a; 28 cores/28 cases
TMA-FMC402a Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases/40 cores, replaced by FMC402b; 40 cores/40 cases
TMA-FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases/40 cores, replacing FMC402a; 40 cores/40 cases
TMA-FMC405a Multiple organ cancer frozen tissue array, including pathology grade, 40 cases/40 cores, replacing FMC405; 40 cores/40 cases
TMA-FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases/40 cores; 40 cores/40 cases
TMA-FMC407 Multiple organ cancer frozen tissue array, including TNM and clinical stage, 40 cases/40 cores; 40 cores/40 cases
TMA-FMC407b Multiple organ cancer frozen tissue array, including TNM information, 40 cases/40 cores, replacing FMC407; 40 cores/40 cases
TMA-FOV401 Ovarian cancer frozen tissue array, including pathology grade, 20 cases/40 cores; 40 cores/20 cases
Dog
TMA-FDG282m Normal male dog multiple organ frozen tissue array, 24 cases/24 cores; 24 cores/24 cases
TMA-DGF281 Normal female dog multiple organs tissue array, 28 organs/ 28cores; 28 cores/28 cases
TMA-DGM281 Normal male dog multiple organs tissue array, 25 organs/ 25cores; 25 cores/25 cases
Other
TMA-AC451 Multiple organ condyloma acuminatum tissue array, 45 cases/45 cores; 45 cores/45 cases
TMA-GA2081 Gallbladder disease spectrum (cholecystic cancer progression) tissue array, 103 cases/208 cores; 208 cores/103 cases
TMA-GA801 Gallbladder disease spectrum (gallbladder cancer progression) tissue array, 80 cases/80 cores; 80 cores/80 cases
TMA-GIP541 Visceral peritoneum tissue array, 27 cases/54 cores; 54 cores/27 cases
TMA-UR1001 Ureter and urethra disease spectrum tissue array, with stage, grade and TNM data, 50 cases/100 cores; 100 cores/50 cases
[US biomax] [About us] [Tissue Array] [Services] [Support] [Contact us]

USBiomax ©2006, All rights reserved, http://usbiomax.com